DELAWARE | 57-0923789 | |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Large accelerated filer | x | Accelerated filer | o | Non-accelerated filer | o | Smaller reporting company | o | Emerging growth company | o |
Page | |
Item 1. Financial Statements (Unaudited) | |
Exhibit 3.1 | |
Exhibit 3.2 | |
Exhibit 10.1 | |
Exhibit 10.2 | |
Exhibit 10.3 | |
Exhibit 31.1 | |
Exhibit 31.2 | |
Exhibit 32.1 | |
Exhibit 32.2 | |
Exhibit 101 |
December 31, 2018 | March 31, 2018 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 234,359 | $ | 286,846 | |||
Accounts receivable, net (1) | 147,848 | 146,561 | |||||
Inventories, net | 233,337 | 204,386 | |||||
Prepaid expenses and other current assets | 40,294 | 41,160 | |||||
Total current assets (1) | 655,838 | 678,953 | |||||
Property, plant and equipment, net of accumulated depreciation of $867,313 and $866,614 as of December 31, 2018 and March 31, 2018, respectively | 438,265 | 405,316 | |||||
Goodwill | 40,294 | 40,294 | |||||
Intangible assets, net | 55,170 | 59,907 | |||||
Equity method investments | 12,861 | 12,016 | |||||
Deferred income taxes | 11,722 | 13,837 | |||||
Other assets (1) | 17,107 | 12,600 | |||||
Total assets (1) | $ | 1,231,257 | $ | 1,222,923 | |||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Current portion of long-term debt | $ | 28,416 | $ | 20,540 | |||
Accounts payable | 144,418 | 139,989 | |||||
Accrued expenses (1) | 98,279 | 125,119 | |||||
Income taxes payable | 3,684 | 2,010 | |||||
Total current liabilities (1) | 274,797 | 287,658 | |||||
Long-term debt | 277,260 | 304,083 | |||||
Other non-current obligations (1) | 125,856 | 152,249 | |||||
Deferred income taxes (1) | 14,911 | 15,058 | |||||
Total liabilities (1) | 692,824 | 759,048 | |||||
Stockholders’ equity: | |||||||
Preferred stock, par value $0.01, authorized 10,000 shares, none issued | — | — | |||||
Common stock, par value $0.01, authorized 175,000 shares, issued 57,819 and 56,641 shares at December 31, 2018 and March 31, 2018, respectively | 578 | 566 | |||||
Additional paid-in capital | 462,882 | 462,737 | |||||
Retained earnings (1) | 113,664 | 3,370 | |||||
Accumulated other comprehensive income (loss) (1) | (38,691 | ) | (2,798 | ) | |||
Total stockholders’ equity (1) | 538,433 | 463,875 | |||||
Total liabilities and stockholders’ equity (1) | $ | 1,231,257 | $ | 1,222,923 |
Three Months Ended | Nine Months Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net sales (1) | $ | 350,175 | $ | 306,576 | $ | 1,027,024 | $ | 882,090 | |||||||
Operating costs and expenses: | |||||||||||||||
Cost of sales (1) | 226,425 | 214,288 | 694,888 | 630,781 | |||||||||||
Selling, general and administrative expenses | 48,271 | 47,751 | 149,071 | 125,799 | |||||||||||
Research and development (1) | 11,357 | 9,907 | 33,040 | 28,690 | |||||||||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||||||||
(Gain) loss on write down and disposal of long-lived assets | 788 | (902 | ) | 1,611 | (922 | ) | |||||||||
Total operating costs and expenses (1) | 288,559 | 274,574 | 880,232 | 790,884 | |||||||||||
Operating income (loss) (1) | 61,616 | 32,002 | 146,792 | 91,206 | |||||||||||
Non-operating (income) expense: | |||||||||||||||
Interest income | (572 | ) | (252 | ) | (1,325 | ) | (413 | ) | |||||||
Interest expense | 4,480 | 7,407 | 18,803 | 25,732 | |||||||||||
Acquisition (gain) loss | — | (310 | ) | — | (137,183 | ) | |||||||||
Other (income) expense, net | 14,006 | 4,769 | 6,646 | 21,061 | |||||||||||
Income (loss) before income taxes and equity income (loss) from equity method investments (1) | 43,702 | 20,388 | 122,668 | 182,009 | |||||||||||
Income tax expense (benefit) (1) | 2,600 | 2,037 | 9,200 | 6,041 | |||||||||||
Income (loss) before equity income (loss) from equity method investments (1) | 41,102 | 18,351 | 113,468 | 175,968 | |||||||||||
Equity income (loss) from equity method investments | (296 | ) | 238 | (301 | ) | 75,879 | |||||||||
Net income (loss) (1) | $ | 40,806 | $ | 18,589 | $ | 113,167 | $ | 251,847 | |||||||
Net income (loss) per basic share | $ | 0.70 | $ | 0.33 | $ | 1.96 | $ | 4.91 | |||||||
Net income (loss) per diluted share | $ | 0.69 | $ | 0.32 | $ | 1.91 | $ | 4.31 | |||||||
Dividends declared per share | $ | 0.05 | — | $ | 0.05 | — | |||||||||
Weighted-average shares outstanding: | |||||||||||||||
Basic | 58,010 | 56,778 | 57,717 | 51,340 | |||||||||||
Diluted | 59,111 | 58,937 | 59,116 | 58,431 |
Three Months Ended | Nine Months Ended | ||||||||||||||
December 31, | December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net income (loss) (1) | $ | 40,806 | $ | 18,589 | $ | 113,167 | $ | 251,847 | |||||||
Other comprehensive income (loss): | |||||||||||||||
Foreign currency translation gains (losses) (1) | (5,152 | ) | 6,516 | (32,504 | ) | 20,481 | |||||||||
Defined benefit pension plans, net of tax | 139 | 147 | 426 | (6 | ) | ||||||||||
Defined benefit post-retirement plan adjustments | (38 | ) | (47 | ) | (116 | ) | (141 | ) | |||||||
Equity interest in investee's other comprehensive income (loss) | 8 | (5 | ) | (9 | ) | 5,568 | |||||||||
Foreign exchange contracts | (2,605 | ) | (5,330 | ) | (1,855 | ) | (6,807 | ) | |||||||
Excluded component of fair value hedges | (1,835 | ) | — | (1,835 | ) | — | |||||||||
Other comprehensive income (loss) (1) | (9,483 | ) | 1,281 | (35,893 | ) | 19,095 | |||||||||
Total comprehensive income (loss) (1) | $ | 31,323 | $ | 19,870 | $ | 77,274 | $ | 270,942 |
Nine Months Ended December 31, | |||||||
Operating activities: | 2018 | 2017 | |||||
Net income (loss) (1) | $ | 113,167 | $ | 251,847 | |||
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities, net of effect of acquisitions: | |||||||
Depreciation and amortization (1) | 38,405 | 37,366 | |||||
Equity (income) loss from equity method investments | 301 | (75,879 | ) | ||||
Acquisition (gain) loss | — | (137,183 | ) | ||||
Non-cash debt and financing costs | 1,085 | 1,820 | |||||
(Gain) loss on early extinguishment of debt | 15,988 | 486 | |||||
Stock-based compensation expense | 10,011 | 4,837 | |||||
Receivable write down | 84 | 162 | |||||
(Gain) loss on write down and disposal of long-lived assets | 1,611 | (922 | ) | ||||
Pension and other post-retirement benefits | 3,823 | 3,897 | |||||
Change in deferred income taxes (1) | 1,395 | (3,792 | ) | ||||
Change in operating assets (1) | (42,130 | ) | 25,820 | ||||
Change in operating liabilities (1) | (61,485 | ) | (26,258 | ) | |||
Other (1) | 472 | 582 | |||||
Net cash provided by (used in) operating activities (1) | 82,727 | 82,783 | |||||
Investing activities: | |||||||
Capital expenditures | (77,650 | ) | (30,925 | ) | |||
Acquisitions, net of cash received | — | 167,129 | |||||
Proceeds from sale of assets | 169 | 1,227 | |||||
Proceeds from dividend | 776 | 2,731 | |||||
Contributions to equity method investments | (2,000 | ) | — | ||||
Net cash provided by (used in) investing activities | (78,705 | ) | 140,162 | ||||
Financing activities: | |||||||
Payments on revolving line of credit | — | (33,881 | ) | ||||
Payments of long-term debt | (332,063 | ) | (361,625 | ) | |||
Proceeds from issuance of debt | 293,348 | 334,978 | |||||
Early extinguishment of debt costs | (3,234 | ) | — | ||||
Debt issuance costs | (1,797 | ) | (5,002 | ) | |||
Proceeds from exercise of stock warrants | — | 8,838 | |||||
Proceeds from exercise of stock options | 480 | 5,122 | |||||
Payment of dividends | (2,873 | ) | — | ||||
Net cash provided by (used in) financing activities | (46,139 | ) | (51,570 | ) | |||
Net increase (decrease) in cash, cash equivalents and restricted cash | (42,117 | ) | 171,375 | ||||
Effect of foreign currency fluctuations on cash, cash equivalents and restricted cash (1) | (7,236 | ) | 3,017 | ||||
Cash, cash equivalents, and restricted cash, at beginning of fiscal period | 286,846 | 109,774 | |||||
Cash, cash equivalents, and restricted cash, at end of fiscal period | 237,493 | 284,166 | |||||
Less: Restricted cash at end of period | 3,134 | — | |||||
Cash and cash equivalents at end of period | $ | 234,359 | $ | 284,166 |
• | Inventory price protection and ship-from stock and debit (“SFSD”) programs, |
• | Distributor rights of returns, |
• | Sales allowances, and |
• | Limited assurance warranties |
December 31, 2018 | March 31, 2018 | ||||||
Contract liabilities - current (Accrued expenses) | $ | 256 | $ | 256 | |||
Contract liabilities - noncurrent (Other non-current obligations) | 320 | 513 | |||||
Total contract liabilities | $ | 576 | $ | 769 |
• | Level 1—Quoted prices in active markets for identical assets or liabilities. |
• | Level 2—Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. |
• | Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. |
Carrying Value December 31, | Fair Value December 31, | Fair Value Measurement Using | Carrying Value March 31, | Fair Value March 31, | Fair Value Measurement Using | ||||||||||||||||||||||||||||||||||
2018 | 2018 | Level 1 | Level 2 (3) | Level 3 | 2018 | 2018 | Level 1 | Level 2 (3) | Level 3 | ||||||||||||||||||||||||||||||
Assets (Liabilities): | |||||||||||||||||||||||||||||||||||||||
Money markets (1)(2) | $ | 63,701 | $ | 63,701 | $ | 63,701 | $ | — | $ | — | $ | 83,891 | $ | 83,891 | $ | 83,891 | $ | — | $ | — | |||||||||||||||||||
Derivative assets | 4,951 | 4,951 | — | 4,951 | — | 1,154 | 1,154 | — | 1,154 | — | |||||||||||||||||||||||||||||
Derivative liabilities | (4,273 | ) | (4,273 | ) | — | (4,273 | ) | — | — | — | — | — | — | ||||||||||||||||||||||||||
Total debt | (305,676 | ) | (315,905 | ) | — | (315,905 | ) | — | (324,623 | ) | (343,125 | ) | — | (343,125 | ) | — |
December 31, 2018 | March 31, 2018 | ||||||
Raw materials and supplies | $ | 95,023 | $ | 88,408 | |||
Work in process | 68,464 | 65,417 | |||||
Finished goods | 86,556 | 66,907 | |||||
Subtotal | 250,043 | 220,732 | |||||
Inventory reserves | (16,706 | ) | (16,346 | ) | |||
Inventories, net | $ | 233,337 | $ | 204,386 |
As of March 31, 2018 | |||||||||||
As Previously Reported | ASC 606 Adjustments | As Adjusted | |||||||||
Assets | |||||||||||
Account receivable, net | $ | 144,076 | $ | 2,485 | $ | 146,561 | |||||
Total current assets | 676,468 | 2,485 | 678,953 | ||||||||
Other assets | 10,431 | 2,169 | 12,600 | ||||||||
Total assets | 1,218,269 | 4,654 | 1,222,923 | ||||||||
Liabilities and Stockholders' Equity | |||||||||||
Accrued expenses | $ | 122,377 | $ | 2,742 | $ | 125,119 | |||||
Total current liabilities | 284,916 | 2,742 | 287,658 | ||||||||
Deferred income taxes | 14,571 | 487 | 15,058 | ||||||||
Other non-current obligations | 151,736 | 513 | 152,249 | ||||||||
Total liabilities | 755,306 | 3,742 | 759,048 | ||||||||
Retained earnings (deficit) | 2,675 | 695 | 3,370 | ||||||||
Accumulated other comprehensive income (loss) | (3,015 | ) | 217 | (2,798 | ) | ||||||
Total stockholders' equity | 462,963 | 912 | 463,875 | ||||||||
Total liabilities and stockholders' equity | 1,218,269 | 4,654 | 1,222,923 |
Three Months Ended December 31, 2017 | |||||||||||
As Previously Reported | ASC 606 Adjustments | As Adjusted | |||||||||
Net sales | $ | 306,408 | $ | 168 | $ | 306,576 | |||||
Operating costs and expenses: | |||||||||||
Cost of sales | 213,947 | 341 | 214,288 | ||||||||
Research and development | 10,005 | (98 | ) | 9,907 | |||||||
Operating income (loss) | 32,077 | (75 | ) | 32,002 | |||||||
Income tax expense | 2,060 | (23 | ) | 2,037 | |||||||
Net income (loss) | 18,641 | (52 | ) | 18,589 |
Nine Months Ended December 31, 2017 | |||||||||||
As Previously Reported | ASC 606 Adjustments | As Adjusted | |||||||||
Net sales | $ | 881,879 | $ | 211 | $ | 882,090 | |||||
Operating costs and expenses: | |||||||||||
Cost of sales | 629,905 | 876 | 630,781 | ||||||||
Research and development | 29,057 | (367 | ) | 28,690 | |||||||
Operating income (loss) | 91,504 | (298 | ) | 91,206 | |||||||
Income tax expense | 6,090 | (49 | ) | 6,041 | |||||||
Net income (loss) | 252,096 | (249 | ) | 251,847 |
Three Months Ended December 31, 2017 | |||||||||||
As Previously Reported | ASC 606 Adjustments | As Adjusted | |||||||||
Net income (loss) | $ | 18,641 | $ | (52 | ) | $ | 18,589 | ||||
Foreign currency translation gains (losses) | 6,503 | 13 | 6,516 | ||||||||
Other comprehensive income (loss) | 1,268 | 13 | 1,281 | ||||||||
Total comprehensive income (loss) | 19,909 | (39 | ) | 19,870 |
Nine Months Ended December 31, 2017 | |||||||||||
As Previously Reported | ASC 606 Adjustments | As Adjusted | |||||||||
Net income (loss) | $ | 252,096 | $ | (249 | ) | $ | 251,847 | ||||
Foreign currency translation gains (losses) | 20,301 | 180 | 20,481 | ||||||||
Other comprehensive income (loss) | 18,915 | 180 | 19,095 | ||||||||
Total comprehensive income (loss) | 271,011 | (69 | ) | 270,942 |
Nine Months Ended December 31, 2017 | |||||||||||
As Previously Reported | ASC 606 Adjustments | As Adjusted | |||||||||
Operating activities | |||||||||||
Net income (loss) | $ | 252,096 | $ | (249 | ) | $ | 251,847 | ||||
Depreciation and amortization | 36,694 | 672 | 37,366 | ||||||||
Change in deferred income taxes | (3,792 | ) | — | (3,792 | ) | ||||||
Change in operating assets | 26,296 | (476 | ) | 25,820 | |||||||
Change in operating liabilities | (26,316 | ) | 58 | (26,258 | ) | ||||||
Other | 499 | 83 | 582 | ||||||||
Net cash provided by (used in) operating activities | 82,695 | 88 | 82,783 | ||||||||
Effect of foreign currency fluctuations on cash | 3,105 | (88 | ) | 3,017 |
December 31, 2018 | March 31, 2018 | ||||||
Term Loan Credit Agreement (1) | $ | — | $ | 318,782 | |||
TOKIN Term Loan Facility (2) | 291,152 | — | |||||
Customer Advances (3) | 8,870 | — | |||||
Other (4) | 5,654 | 5,841 | |||||
Total debt | 305,676 | 324,623 | |||||
Current maturities | (28,416 | ) | (20,540 | ) | |||
Total long-term debt | $ | 277,260 | $ | 304,083 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Contractual interest expense | $ | 4,034 | $ | 6,680 | $ | 17,775 | $ | 23,762 | |||||||
Capitalized interest | (41 | ) | (41 | ) | (161 | ) | (80 | ) | |||||||
Amortization of debt issuance costs | 53 | 98 | 262 | 410 | |||||||||||
Amortization of debt (premium) discount | 383 | 570 | 780 | 1,326 | |||||||||||
Imputed interest on acquisition-related obligations | 14 | 28 | 43 | 84 | |||||||||||
Interest expense on capital lease | 37 | 72 | 104 | 230 | |||||||||||
Total interest expense | $ | 4,480 | $ | 7,407 | $ | 18,803 | $ | 25,732 |
December 31, 2018 | March 31, 2018 | |||||||||||||||||||||||
Carrying Amount | Accumulated Amortization | Net Amount | Carrying Amount | Accumulated Amortization | Net Amount | |||||||||||||||||||
Indefinite Lived Intangible Assets: | ||||||||||||||||||||||||
Trademarks | $ | 15,213 | $ | — | $ | 15,213 | $ | 15,474 | $ | — | $ | 15,474 | ||||||||||||
Amortizing Intangibles: | ||||||||||||||||||||||||
Patents (10 - 18 years) | 26,662 | (11,691 | ) | 14,971 | 26,662 | (10,625 | ) | 16,037 | ||||||||||||||||
Customer relationships (10 - 21 years) | 38,296 | (13,310 | ) | 24,986 | 40,131 | (11,735 | ) | 28,396 | ||||||||||||||||
Other | 222 | (222 | ) | — | 238 | (238 | ) | — | ||||||||||||||||
Total amortizing intangibles | 65,180 | (25,223 | ) | 39,957 | 67,031 | (22,598 | ) | 44,433 | ||||||||||||||||
Total intangible assets | $ | 80,393 | $ | (25,223 | ) | $ | 55,170 | $ | 82,505 | $ | (22,598 | ) | $ | 59,907 |
Total expected to be incurred | Incurred during quarter ended December 31, 2018 | Cumulative incurred to date | |||||||||||||||||||
Restructuring Plan | Segment | Personnel Reduction Costs | Relocation & Exit Costs | Personnel Reduction Costs | Relocation & Exit Costs | Personnel Reduction Costs | Relocation & Exit Costs | ||||||||||||||
US overhead function relocation to Fort Lauderdale, FL | Corporate | $ | 2,655 | $ | 909 | $ | — | $ | — | $ | 2,655 | $ | 909 | ||||||||
TOKIN operational & overhead function reduction in force | MSA, Corporate, and Solid Capacitors (1) | 5,293 | — | 696 | — | 5,093 | — | ||||||||||||||
Tantalum powder facility relocation | Solid Capacitors | 897 | 2,098 | — | — | — | — | ||||||||||||||
Axial electrolytic production relocation from Granna to Evora | Film and Electrolytic | 1,200 | 2,600 | — | 778 | — | 778 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Personnel reduction costs | $ | 961 | $ | 3,278 | $ | 877 | $ | 4,389 | |||||||
Relocation and exit costs | 757 | 252 | 745 | 2,147 | |||||||||||
Restructuring charges | $ | 1,718 | $ | 3,530 | $ | 1,622 | $ | 6,536 |
Three Months Ended December 31, 2018 | Three Months Ended December 31, 2017 | ||||||||||||||
Personnel Reductions | Manufacturing Relocations | Personnel Reductions | Manufacturing Relocations | ||||||||||||
Beginning of period | $ | 2,837 | $ | 310 | $ | 1,494 | $ | 312 | |||||||
Costs charged to expense | 961 | 757 | 3,278 | 252 | |||||||||||
Costs paid or settled | (1,258 | ) | (757 | ) | (444 | ) | (252 | ) | |||||||
Change in foreign exchange | 16 | 9 | 49 | (1 | ) | ||||||||||
End of period | $ | 2,556 | $ | 319 | $ | 4,377 | $ | 311 |
Nine Months Ended December 31, 2018 | Nine Months Ended December 31, 2017 | ||||||||||||||
Personnel Reductions | Manufacturing Relocations | Personnel Reductions | Manufacturing Relocations | ||||||||||||
Beginning of period | $ | 9,629 | $ | 330 | $ | 999 | $ | 406 | |||||||
TOKIN opening balance | — | — | — | 314 | |||||||||||
Costs charged to expense | 877 | 745 | 4,389 | 2,147 | |||||||||||
Costs paid or settled | (7,702 | ) | (745 | ) | (1,080 | ) | (2,553 | ) | |||||||
Change in foreign exchange | (248 | ) | (11 | ) | 69 | (3 | ) | ||||||||
End of period | $ | 2,556 | $ | 319 | $ | 4,377 | $ | 311 |
Foreign Currency Translation (1)(2) | Post-Retirement Benefit Plan Adjustments | Defined Benefit Pension Plans, Net of Tax (3) | Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) | Foreign Exchange Contracts | Excluded Component of Fair Value Hedges | Net Accumulated Other Comprehensive Income (Loss) (2) | |||||||||||||||||||||
Balance at September 30, 2018 | $ | (17,637 | ) | $ | 801 | $ | (14,544 | ) | $ | 268 | $ | 1,904 | $ | — | $ | (29,208 | ) | ||||||||||
Other comprehensive income (loss) before reclassifications (4) | (3,543 | ) | — | — | 8 | (2,435 | ) | (3,407 | ) | (9,377 | ) | ||||||||||||||||
Amounts reclassified out of AOCI | (1,609 | ) | (38 | ) | 139 | — | (170 | ) | 1,572 | (106 | ) | ||||||||||||||||
Other comprehensive income (loss) | (5,152 | ) | (38 | ) | 139 | 8 | (2,605 | ) | (1,835 | ) | (9,483 | ) | |||||||||||||||
Balance at December 31, 2018 | $ | (22,789 | ) | $ | 763 | $ | (14,405 | ) | $ | 276 | $ | (701 | ) | $ | (1,835 | ) | $ | (38,691 | ) |
Foreign Currency Translation (1)(2) | Post-Retirement Benefit Plan Adjustments | Defined Benefit Pension Plans, Net of Tax (3) | Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) | Foreign Exchange Contracts | Excluded Component of Fair Value Hedges | Net Accumulated Other Comprehensive Income (Loss) (2) | |||||||||||||||||||||
Balance at September 30, 2017 (5) | $ | (11,591 | ) | $ | 1,040 | $ | (15,151 | ) | $ | 274 | $ | 1,430 | $ | — | $ | (23,998 | ) | ||||||||||
Other comprehensive income (loss) before reclassifications | 6,516 | — | — | (5 | ) | (7,130 | ) | — | (619 | ) | |||||||||||||||||
Amounts reclassified out of AOCI | — | (47 | ) | 147 | — | 1,800 | — | 1,900 | |||||||||||||||||||
Other comprehensive income (loss) | 6,516 | (47 | ) | 147 | (5 | ) | (5,330 | ) | — | 1,281 | |||||||||||||||||
Balance at December 31, 2017 | $ | (5,075 | ) | $ | 993 | $ | (15,004 | ) | $ | 269 | $ | (3,900 | ) | $ | — | $ | (22,717 | ) |
Foreign Currency Translation (1)(2) | Post-Retirement Benefit Plan Adjustments | Defined Benefit Pension Plans, Net of Tax (3) | Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) | Foreign Exchange Contracts | Excluded Component of Fair Value Hedges | Net Accumulated Other Comprehensive Income (Loss) (2) | |||||||||||||||||||||
Balance at March 31, 2018 | $ | 9,715 | $ | 879 | $ | (14,831 | ) | $ | 285 | $ | 1,154 | $ | — | $ | (2,798 | ) | |||||||||||
Other comprehensive income (loss) before reclassifications (4) | (30,895 | ) | — | — | (9 | ) | (2,130 | ) | (3,407 | ) | (36,441 | ) | |||||||||||||||
Amounts reclassified out of AOCI | (1,609 | ) | (116 | ) | 426 | — | 275 | 1,572 | 548 | ||||||||||||||||||
Other comprehensive income (loss) | (32,504 | ) | (116 | ) | 426 | (9 | ) | (1,855 | ) | (1,835 | ) | (35,893 | ) | ||||||||||||||
Balance at December 31, 2018 | $ | (22,789 | ) | $ | 763 | $ | (14,405 | ) | $ | 276 | $ | (701 | ) | $ | (1,835 | ) | $ | (38,691 | ) |
Foreign Currency Translation (1)(2) | Post-Retirement Benefit Plan Adjustments | Defined Benefit Pension Plans, Net of Tax (3) | Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) | Foreign Exchange Contracts | Excluded Component of Fair Value Hedges | Net Accumulated Other Comprehensive Income (Loss) (2) | |||||||||||||||||||||
Balance at March 31, 2017 | $ | (25,556 | ) | $ | 1,134 | $ | (14,998 | ) | $ | (5,299 | ) | $ | 2,907 | $ | — | $ | (41,812 | ) | |||||||||
Other comprehensive income (loss) before reclassifications | 20,481 | — | — | 5,568 | (9,711 | ) | — | 16,338 | |||||||||||||||||||
Amounts reclassified out of AOCI | — | (141 | ) | (6 | ) | — | 2,904 | — | 2,757 | ||||||||||||||||||
Other comprehensive income (loss) | 20,481 | (141 | ) | (6 | ) | 5,568 | (6,807 | ) | — | 19,095 | |||||||||||||||||
Balance at December 31, 2017 | $ | (5,075 | ) | $ | 993 | $ | (15,004 | ) | $ | 269 | $ | (3,900 | ) | $ | — | $ | (22,717 | ) |
December 31, 2018 | March 31, 2018 | |||||||
Nippon Yttrium Co., Ltd ("NYC") | $ | 8,095 | $ | 8,148 | ||||
NT Sales Co., Ltd ("NTS") | 1,110 | 998 | ||||||
Novasentis Inc. (“Novasentis”) | 2,938 | 2,870 | ||||||
KEMET Jianghai Electronics Components Co., Ltd (“KEMET Jianghai”) | 718 | — | ||||||
$ | 12,861 | $ | 12,016 |
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||
2018 | 2017 | 2018 | 2017 | |||||||||||||
KEMET's sales to NTS | $ | 12,805 | $ | 12,837 | $ | 37,402 | $ | 38,802 | ||||||||
NTS' sales to KEMET | 495 | 278 | 1,266 | 1,002 |
Three Months Ended December 31, 2018 | |||||||||||||||
Solid Capacitors | Film and Electrolytic | MSA | Total | ||||||||||||
Primary geographical markets | |||||||||||||||
Asia and the Pacific Rim ("APAC") | $ | 101,566 | $ | 12,193 | $ | 19,233 | $ | 132,992 | |||||||
Europe, the Middle East, and Africa ("EMEA") | 47,863 | 28,718 | 517 | 77,098 | |||||||||||
North and South America ("Americas") | 79,782 | 9,053 | 2,550 | 91,385 | |||||||||||
Japan and Korea ("JPKO") | 9,472 | 207 | 39,021 | 48,700 | |||||||||||
$ | 238,683 | $ | 50,171 | $ | 61,321 | $ | 350,175 | ||||||||
Sales channel | |||||||||||||||
OEM | $ | 70,426 | $ | 18,768 | $ | 57,929 | $ | 147,123 | |||||||
Distributor | 124,467 | 25,277 | 2,022 | 151,766 | |||||||||||
EMS | 43,790 | 6,126 | 1,370 | 51,286 | |||||||||||
$ | 238,683 | $ | 50,171 | $ | 61,321 | $ | 350,175 | ||||||||
Major product lines | |||||||||||||||
Tantalum | $ | 143,680 | $ | — | $ | — | $ | 143,680 | |||||||
Ceramics | 95,003 | — | — | 95,003 | |||||||||||
Film and Electrolytic | — | 50,171 | — | 50,171 | |||||||||||
MSA | — | — | 61,321 | 61,321 | |||||||||||
$ | 238,683 | $ | 50,171 | $ | 61,321 | $ | 350,175 |
Three Months Ended December 31, 2017 | |||||||||||||||
Solid Capacitors | Film and Electrolytic (1) | MSA | Total (1) | ||||||||||||
Primary geographical markets | |||||||||||||||
APAC | $ | 93,549 | $ | 13,997 | $ | 16,694 | $ | 124,240 | |||||||
EMEA | 37,174 | 31,122 | 548 | 68,844 | |||||||||||
Americas | 56,574 | 6,349 | 2,174 | 65,097 | |||||||||||
JPKO | 7,752 | — | 40,643 | 48,395 | |||||||||||
$ | 195,049 | $ | 51,468 | $ | 60,059 | $ | 306,576 | ||||||||
Sales channel | |||||||||||||||
OEM | $ | 67,267 | $ | 20,804 | $ | 58,094 | $ | 146,165 | |||||||
Distributor | 92,898 | 24,651 | 1,837 | 119,386 | |||||||||||
EMS | 34,884 | 6,013 | 128 | 41,025 | |||||||||||
$ | 195,049 | $ | 51,468 | $ | 60,059 | $ | 306,576 | ||||||||
Major product lines | |||||||||||||||
Tantalum | $ | 126,625 | $ | — | $ | — | $ | 126,625 | |||||||
Ceramics | 68,424 | — | — | 68,424 | |||||||||||
Film and Electrolytic | — | 51,468 | — | 51,468 | |||||||||||
MSA | — | — | 60,059 | 60,059 | |||||||||||
$ | 195,049 | $ | 51,468 | $ | 60,059 | $ | 306,576 |
Nine Months Ended December 31, 2018 | |||||||||||||||
Solid Capacitors | Film and Electrolytic | MSA | Total | ||||||||||||
Primary geographical markets | |||||||||||||||
APAC | $ | 308,473 | $ | 40,490 | $ | 55,376 | $ | 404,339 | |||||||
EMEA | 135,401 | 92,157 | 1,920 | 229,478 | |||||||||||
Americas | 216,231 | 22,546 | 7,048 | 245,825 | |||||||||||
JPKO | 27,872 | 561 | 118,949 | 147,382 | |||||||||||
$ | 687,977 | $ | 155,754 | $ | 183,293 | $ | 1,027,024 | ||||||||
Sales channel | |||||||||||||||
OEM | $ | 215,365 | $ | 61,303 | $ | 173,416 | $ | 450,084 | |||||||
Distributor | 349,046 | 76,607 | 7,215 | 432,868 | |||||||||||
EMS | 123,566 | 17,844 | 2,662 | 144,072 | |||||||||||
$ | 687,977 | $ | 155,754 | $ | 183,293 | $ | 1,027,024 | ||||||||
Major product lines | |||||||||||||||
Tantalum | $ | 426,047 | $ | — | $ | — | $ | 426,047 | |||||||
Ceramics | 261,930 | — | — | 261,930 | |||||||||||
Film and Electrolytic | — | 155,754 | — | 155,754 | |||||||||||
MSA | — | — | 183,293 | 183,293 | |||||||||||
$ | 687,977 | $ | 155,754 | $ | 183,293 | $ | 1,027,024 |
Nine Months Ended December 31, 2017 | |||||||||||||||
Solid Capacitors | Film and Electrolytic (1) | MSA | Total (1) | ||||||||||||
Primary geographical markets | |||||||||||||||
APAC | $ | 261,520 | $ | 42,460 | $ | 56,245 | $ | 360,225 | |||||||
EMEA | 112,139 | 88,289 | 1,494 | 201,922 | |||||||||||
Americas | 169,317 | 16,200 | 5,912 | 191,429 | |||||||||||
JPKO | 25,459 | — | 103,055 | 128,514 | |||||||||||
$ | 568,435 | $ | 146,949 | $ | 166,706 | $ | 882,090 | ||||||||
Sales channel | |||||||||||||||
OEM | $ | 193,182 | $ | 63,539 | $ | 156,254 | $ | 412,975 | |||||||
Distributor | 265,290 | 66,278 | 10,024 | 341,592 | |||||||||||
EMS | 109,963 | 17,132 | 428 | 127,523 | |||||||||||
$ | 568,435 | $ | 146,949 | $ | 166,706 | $ | 882,090 | ||||||||
Major product lines | |||||||||||||||
Tantalum | $ | 368,479 | $ | — | $ | — | $ | 368,479 | |||||||
Ceramics | 199,956 | — | — | 199,956 | |||||||||||
Film and Electrolytic | — | 146,949 | — | 146,949 | |||||||||||
MSA | — | — | 166,706 | 166,706 | |||||||||||
$ | 568,435 | $ | 146,949 | $ | 166,706 | $ | 882,090 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Operating income (loss) (1): | |||||||||||||||
Solid Capacitors | $ | 95,105 | $ | 60,991 | $ | 249,456 | $ | 170,417 | |||||||
Film and Electrolytic (2) | 3,383 | 499 | 8,686 | 3,890 | |||||||||||
MSA | 5,774 | 9,932 | 18,961 | 18,055 | |||||||||||
Corporate | (42,646 | ) | (39,420 | ) | (130,311 | ) | (101,156 | ) | |||||||
$ | 61,616 | $ | 32,002 | $ | 146,792 | $ | 91,206 | ||||||||
Depreciation and amortization expense: | |||||||||||||||
Solid Capacitors | $ | 6,866 | $ | 6,900 | $ | 21,401 | $ | 21,490 | |||||||
Film and Electrolytic (2) | 2,434 | 2,728 | 7,252 | 8,281 | |||||||||||
MSA | 1,144 | (478 | ) | 3,801 | 1,026 | ||||||||||
Corporate | 2,319 | 2,203 | 5,951 | 6,569 | |||||||||||
$ | 12,763 | $ | 11,353 | $ | 38,405 | $ | 37,366 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Restructuring charges: | |||||||||||||||
Solid Capacitors | $ | — | $ | 121 | $ | (18 | ) | $ | 841 | ||||||
Film and Electrolytic | 1,025 | 2,309 | 1,026 | 2,574 | |||||||||||
MSA | 452 | — | 452 | — | |||||||||||
Corporate | 241 | 1,100 | 162 | 3,121 | |||||||||||
$ | 1,718 | $ | 3,530 | $ | 1,622 | $ | 6,536 |
Pension | Other Benefits | ||||||||||||||
Three Months Ended December 31, | Three Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net service cost | $ | 1,233 | $ | 1,307 | $ | — | $ | — | |||||||
Interest cost | 478 | 425 | 3 | 3 | |||||||||||
Expected return on net assets | (531 | ) | (501 | ) | — | — | |||||||||
Amortization: | |||||||||||||||
Actuarial (gain) loss | 107 | 91 | (39 | ) | (47 | ) | |||||||||
Prior service cost | 23 | 20 | — | — | |||||||||||
Total net periodic benefit (income) costs | $ | 1,310 | $ | 1,342 | $ | (36 | ) | $ | (44 | ) |
Pension | Other Benefits | ||||||||||||||
Nine Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net service cost | $ | 3,699 | $ | 3,926 | $ | — | $ | — | |||||||
Interest cost | 1,434 | 1,274 | 9 | 9 | |||||||||||
Expected return on net assets | (1,594 | ) | (1,502 | ) | — | — | |||||||||
Amortization: | 0 | ||||||||||||||
Actuarial (gain) loss | 322 | 271 | (116 | ) | (141 | ) | |||||||||
Prior service cost | 69 | 60 | — | — | |||||||||||
Total net periodic benefit (income) costs | $ | 3,930 | $ | 4,029 | $ | (107 | ) | $ | (132 | ) |
• | stock options, including incentive stock options, entitling the optionee to favorable tax treatment under Section 422 of the Internal Revenue Code; |
• | stock appreciation rights; |
• | restricted stock and restricted stock units (“RSUs”); |
• | other share-based awards; and |
• | performance awards. |
Shares | ||
May 18, 2019 | 56 | |
May 18, 2020 | 120 | |
May 18, 2021 | 122 | |
Total shares granted (1) (2) | 298 |
2018/2019 | 2017/2018 | 2016/2017 | |||||||
Time-based award vested | 63 | 198 | 191 | ||||||
Performance-based award vested | — | — | 173 |
Shares | Weighted- average Fair Value on Grant Date | |||||
Non-vested restricted stock at March 31, 2018 | 1,405 | $ | 9.82 | |||
Granted | 292 | 21.81 | ||||
Vested | (1,066 | ) | 9.49 | |||
Forfeited | (21 | ) | 7.78 | |||
Non-vested restricted stock at December 31, 2018 | 610 | $ | 16.21 |
Three Months Ended December 31, 2018 | Three Months Ended December 31, 2017 | ||||||||||||||||||||||
Stock Options | Restricted Stock | LTIPs | Stock Options | Restricted Stock | LTIPs | ||||||||||||||||||
Cost of sales | $ | — | $ | 321 | $ | 345 | $ | — | $ | 210 | $ | 192 | |||||||||||
Selling, general and administrative expenses | — | 547 | 220 | — | 1,262 | 490 | |||||||||||||||||
Research and development | — | 22 | 79 | — | 12 | 40 | |||||||||||||||||
Total | $ | — | $ | 890 | $ | 644 | $ | — | $ | 1,484 | $ | 722 |
Nine Months Ended December 31, 2018 | Nine Months Ended December 31, 2017 | ||||||||||||||||||||||
Stock Options | Restricted Stock | LTIPs | Stock Options | Restricted Stock | LTIPs | ||||||||||||||||||
Cost of sales | $ | — | $ | 1,022 | $ | 919 | $ | — | $ | 549 | $ | 505 | |||||||||||
Selling, general and administrative expenses | — | 6,236 | 1,580 | — | 2,345 | 1,294 | |||||||||||||||||
Research and development | — | 54 | 200 | — | 31 | 113 | |||||||||||||||||
Total | $ | — | $ | 7,312 | $ | 2,699 | $ | — | $ | 2,925 | $ | 1,912 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Numerator: | |||||||||||||||
Net income (loss) (1) | $ | 40,806 | $ | 18,589 | $ | 113,167 | $ | 251,847 | |||||||
Denominator: | |||||||||||||||
Weighted-average shares outstanding: | |||||||||||||||
Basic | 58,010 | 56,778 | 57,717 | 51,340 | |||||||||||
Assumed conversion of employee stock grants | 1,101 | 2,159 | 1,399 | 2,384 | |||||||||||
Assumed conversion of warrants | — | — | — | 4,707 | |||||||||||
Diluted | 59,111 | 58,937 | 59,116 | 58,431 | |||||||||||
Net income (loss) per basic share | $ | 0.70 | $ | 0.33 | $ | 1.96 | $ | 4.91 | |||||||
Net income (loss) per diluted share | $ | 0.69 | $ | 0.32 | $ | 1.91 | $ | 4.31 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||
Assumed conversion of employee stock grants | 76 | 164 | — | 134 |
Fair Value of Derivative Instruments | ||||||||||||||||||||||||||||
December 31, 2018 | March 31, 2018 | |||||||||||||||||||||||||||
Hedge Designation | Balance Sheet Location | As Presented | Offset | Gross | As Presented | Offset | Gross | |||||||||||||||||||||
Derivative Assets | ||||||||||||||||||||||||||||
Cross-currency swaps | Fair Value | Other assets | $ | 4,951 | $ | — | $ | 4,951 | $ | — | $ | — | $ | — | ||||||||||||||
Foreign exchange contracts | Cash Flow | Prepaid and other current assets | — | 434 | 434 | 1,154 | — | 1,154 | ||||||||||||||||||||
Derivative Liabilities | ||||||||||||||||||||||||||||
Cross-currency swaps | Net Investment | Other non-current obligations | 3,571 | — | 3,571 | — | — | — | ||||||||||||||||||||
Foreign exchange contracts | Cash Flow | Accrued expenses | 702 | 434 | 1,136 | — | — | — |
• | An amortizing cross-currency swap with an initial notional value of JPY 16.5 billion. The notional value is amortized by approximately JPY 1.4 billion every six months and matures on September 30, 2024. The Company receives interest in JPY on March 31 and September 30 of each year based on the JPY notional value and JPY Libor plus 2.00% . Interest payments are made in USD on March 31 and September 30 of each year based on the USD equivalent of the JPY notional value and USD Libor plus 2.70%. |
• | A non-amortizing cross-currency swap with a notional value of JPY 16.5 billion maturing on September 30, 2024. The Company receives interest in JPY on March 31 and September 30 of each year based on the JPY notional value and JPY Libor plus 2.25% . Interest payments are made in USD on March 31 and September 30 of each year based on the USD equivalent of the JPY notional value and USD Libor plus 3.15%. |
• | An amortizing cross-currency swap with an initial notional value of JPY 33.0 billion. The notional amount is amortized by approximately JPY 1.4 billion every six months and matures on September 30, 2024. Interest payments are made by the Company in JPY on March 31 and September 30 of each year based on the JPY notional value and a fixed rate of 2.61%. The Company receives interest in USD on March 31 and September 30 of each year based on the USD equivalent of the JPY notional value and a fixed rate of 6.25%. |
Three Months Ended December 31, 2018 | ||||||||||||||||
Gain (Loss) | ||||||||||||||||
Derivative Instrument | Hedge Designation | Location of Gain (Loss) Recognized in Statements of Operations | Recognized in AOCI | Reclassified from AOCI to Income | Recorded Directly to Income | |||||||||||
Cross-currency swaps (1) | Fair Value | Other income/expense, net | $ | (3,407 | ) | $ | (1,572 | ) | $ | 8,358 | ||||||
Cross-currency swaps (2) | Net Investment | Other income/expense, net | (3,571 | ) | 1,609 | — | ||||||||||
Foreign exchange contracts (3) | Cash Flow | Cost of sales | (2,435 | ) | 170 | — |
Three-Months Ended December 31, 2017 | ||||||||||||||||
Gain (Loss) | ||||||||||||||||
Derivative Instrument | Hedge Designation | Location of Gain (Loss) Recognized in Statements of Operations | Recognized in AOCI | Reclassified from AOCI to Income | Recorded Directly to Income | |||||||||||
Cross-currency swaps (1) | Fair Value | Other income/expense, net | $ | — | $ | — | $ | — | ||||||||
Cross-currency swaps (2) | Net Investment | Other income/expense, net | — | — | — | |||||||||||
Foreign exchange contracts (3) | Cash Flow | Cost of sales | (7,130 | ) | (1,800 | ) | — |
Nine Months Ended December 31, 2018 | ||||||||||||||||
Gain (Loss) | ||||||||||||||||
Derivative Instrument | Hedge Designation | Location of Gain (Loss) Recognized in Statements of Operations | Recognized in AOCI | Reclassified from AOCI to Income | Recorded Directly to Income | |||||||||||
Cross-currency swaps (1) | Fair Value | Other income/expense, net | $ | (3,407 | ) | $ | (1,572 | ) | $ | 8,358 | ||||||
Cross-currency swaps (2) | Net Investment | Other income/expense, net | (3,571 | ) | 1,609 | — | ||||||||||
Foreign exchange contracts (3) | Cash Flow | Cost of sales | (2,130 | ) | (275 | ) | — |
Nine Months Ended December 31, 2017 | ||||||||||||||||
Gain (Loss) | ||||||||||||||||
Derivative Instrument | Hedge Designation | Location of Gain (Loss) Recognized in Statements of Operations | Recognized in AOCI | Reclassified from AOCI to Income | Recorded Directly to Income | |||||||||||
Cross-currency swaps (1) | Fair Value | Other income/expense, net | $ | — | $ | — | $ | — | ||||||||
Cross-currency swaps (2) | Net Investment | Other income/expense, net | — | — | — | |||||||||||
Foreign exchange contracts (3) | Cash Flow | Cost of sales | (9,711 | ) | (2,904 | ) | — |
Three Months Ended December 31, 2018 | Three Months Ended December 31, 2017 | |||||||||||||||
Cost of sales | Other income (expense), net | Cost of sales (3) | Other income (expense), net | |||||||||||||
Total income (expense) in Statements of Operations | $ | (226,425 | ) | $ | (14,006 | ) | $ | (214,288 | ) | $ | (4,769 | ) | ||||
Fair value hedging impact | ||||||||||||||||
Cross-currency swaps: | ||||||||||||||||
Gain (loss) on hedged item | — | (8,358 | ) | — | — | |||||||||||
Gain (loss) on derivative instrument (1) | — | 6,786 | — | — | ||||||||||||
Cash flow hedging impact | ||||||||||||||||
Foreign exchange contracts: | ||||||||||||||||
Gain (loss) reclassified from AOCI to income (2) | 170 | — | (1,800 | ) | — |
Nine Months Ended December 31, 2018 | Nine Months Ended December 31, 2017 | |||||||||||||||
Cost of sales | Other income (expense), net | Cost of sales (3) | Other income (expense), net | |||||||||||||
Total income (expense) in Statements of Operations | $ | (694,888 | ) | $ | (6,646 | ) | $ | (630,781 | ) | $ | (21,061 | ) | ||||
Fair value hedging impact | ||||||||||||||||
Cross-currency swaps: | ||||||||||||||||
Gain (loss) on hedged item | — | (8,358 | ) | — | — | |||||||||||
Gain (loss) on derivative instrument (1) | — | 6,786 | — | — | ||||||||||||
Cash flow hedging impact | ||||||||||||||||
Foreign exchange contracts: | ||||||||||||||||
Gain (loss) reclassified from AOCI to income (2) | (275 | ) | — | (2,904 | ) | — |
Total expected to be incurred | Incurred during quarter ended December 31, 2018 | Cumulative incurred to date | |||||||||||||||||||
Restructuring Plan | Segment | Personnel Reduction Costs | Relocation & Exit Costs | Personnel Reduction Costs | Relocation & Exit Costs | Personnel Reduction Costs | Relocation & Exit Costs | ||||||||||||||
US overhead function relocation to Fort Lauderdale, FL | Corporate | $ | 2,655 | $ | 909 | $ | — | $ | — | $ | 2,655 | $ | 909 | ||||||||
TOKIN operational & overhead function reduction in force | MSA, Corporate, and Solid Capacitors | 5,293 | — | 696 | — | 5,093 | — | ||||||||||||||
Tantalum powder facility relocation | Solid Capacitors | 897 | 2,098 | — | — | — | — | ||||||||||||||
Axial electrolytic production relocation from Granna to Evora | Film and Electrolytic | 1,200 | 2,600 | — | 778 | — | 778 |
Three Months Ended December 31, | |||||||||||||
2018 | % to Total Sales | 2017 | % to Total Sales | ||||||||||
Net sales (1) | $ | 350,175 | $ | 306,576 | |||||||||
Gross margin (1) | 123,750 | 35.3 | % | 92,288 | 30.1 | % | |||||||
Selling, general and administrative expenses | 48,271 | 13.8 | % | 47,751 | 15.6 | % | |||||||
Research and development (1) | 11,357 | 3.2 | % | 9,907 | 3.2 | % | |||||||
Restructuring charges | 1,718 | 0.5 | % | 3,530 | 1.2 | % | |||||||
(Gain) loss on write down and disposal of long-lived assets | 788 | 0.2 | % | (902 | ) | (0.3 | )% | ||||||
Operating income (loss) (1) | 61,616 | 17.6 | % | 32,002 | 10.4 | % | |||||||
Interest income | (572 | ) | (0.2 | )% | (252 | ) | (0.1 | )% | |||||
Interest expense | 4,480 | 1.3 | % | 7,407 | 2.4 | % | |||||||
Acquisition (gain) loss | — | n.m. | (310 | ) | (0.1 | )% | |||||||
Other (income) expense, net | 14,006 | 4.0 | % | 4,769 | 1.6 | % | |||||||
Income (loss) before income taxes and equity income (loss) from equity method investments (1) | 43,702 | 12.5 | % | 20,388 | 6.7 | % | |||||||
Income tax expense (benefit) (1) | 2,600 | 0.7 | % | 2,037 | 0.7 | % | |||||||
Income (loss) before equity income (loss) from equity method investments (1) | 41,102 | 11.7 | % | 18,351 | 6.0 | % | |||||||
Equity income (loss) from equity method investments | (296 | ) | (0.1 | )% | 238 | 0.1 | % | ||||||
Net income (loss) (1) | $ | 40,806 | 11.7 | % | $ | 18,589 | 6.1 | % |
Three Months Ended December 31, | |||||
2018 | 2017 | ||||
APAC | 38.0 | % | 40.5 | % | |
EMEA | 22.0 | % | 22.5 | % | |
Americas | 26.1 | % | 21.2 | % | |
JPKO | 13.9 | % | 15.8 | % | |
100.0 | % | 100.0 | % |
Three Months Ended December 31, | |||||
2018 | 2017 | ||||
OEM | 42.0 | % | 47.7 | % | |
Distributor | 43.4 | % | 38.9 | % | |
EMS | 14.6 | % | 13.4 | % | |
100.0 | % | 100.0 | % |
Three Months Ended December 31, | |||||||
2018 | 2017 | ||||||
Net sales: | |||||||
Solid Capacitors | $ | 238,683 | $ | 195,049 | |||
Film and Electrolytic (1) | 50,171 | 51,468 | |||||
MSA | 61,321 | 60,059 | |||||
Total | $ | 350,175 | $ | 306,576 | |||
Operating income (loss): | |||||||
Solid Capacitors | $ | 95,105 | $ | 60,991 | |||
Film and Electrolytic (1) | 3,383 | 499 | |||||
MSA | 5,774 | 9,932 | |||||
Corporate | (42,646 | ) | (39,420 | ) | |||
Total | $ | 61,616 | $ | 32,002 |
Three Months Ended December 31, | |||||||||||
2018 | 2017 | ||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | ||||||||
Tantalum product line net sales | $ | 143,680 | $ | 126,625 | |||||||
Ceramic product line net sales | 95,003 | 68,424 | |||||||||
Solid Capacitors net sales | $ | 238,683 | $ | 195,049 | |||||||
Solid Capacitors operating income (loss) | $ | 95,105 | 39.8% | $ | 60,991 | 31.3% |
Three Months Ended December 31, | |||||||||||||
2018 | 2017 | ||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | ||||||||||
Net sales (1) | $ | 50,171 | $ | 51,468 | |||||||||
Operating income (loss) (1) | 3,383 | 6.7 | % | 499 | 1.0 | % |
Three Months Ended December 31, | |||||||||||||
2018 | 2017 | ||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | ||||||||||
Net sales | $ | 61,321 | $ | 60,059 | |||||||||
Operating income (loss) | 5,774 | 9.4 | % | 9,932 | 16.5 | % |
Nine Months Ended December 31, | |||||||||||||
2018 | % to Total Sales | 2017 | % to Total Sales | ||||||||||
Net sales (1) | $ | 1,027,024 | $ | 882,090 | |||||||||
Gross margin (1) | 332,136 | 32.3 | % | 251,309 | 28.5 | % | |||||||
Selling, general and administrative expenses | 149,071 | 14.5 | % | 125,799 | 14.3 | % | |||||||
Research and development (1) | 33,040 | 3.2 | % | 28,690 | 3.3 | % | |||||||
Restructuring charges | 1,622 | 0.2 | % | 6,536 | 0.7 | % | |||||||
(Gain) loss on write down and disposal of long-lived assets | 1,611 | 0.2 | % | (922 | ) | (0.1 | )% | ||||||
Operating income (loss) (1) | 146,792 | 14.3 | % | 91,206 | 10.3 | % | |||||||
Interest income | (1,325 | ) | (0.1 | )% | (413 | ) | n.m. | ||||||
Interest expense | 18,803 | 1.8 | % | 25,732 | 2.9 | % | |||||||
Acquisition (gain) loss | — | n.m. | (137,183 | ) | (15.6 | )% | |||||||
Other (income) expense, net | 6,646 | 0.6 | % | 21,061 | 2.4 | % | |||||||
Income (loss) before income taxes and equity income (loss) from equity method investments (1) | 122,668 | 11.9 | % | 182,009 | 20.6 | % | |||||||
Income tax expense (benefit) (1) | 9,200 | 0.9 | % | 6,041 | 0.7 | % | |||||||
Income (loss) before equity income (loss) from equity method investments (1) | 113,468 | 11.0 | % | 175,968 | 19.9 | % | |||||||
Equity income (loss) from equity method investments | (301 | ) | n.m. | 75,879 | 8.6 | % | |||||||
Net income (loss) (1) | $ | 113,167 | 11.0 | % | $ | 251,847 | 28.6 | % |
Nine Months Ended December 31, | |||||
2018 | 2017 | ||||
APAC | 39.4 | % | 40.8 | % | |
EMEA | 22.3 | % | 22.9 | % | |
Americas | 23.9 | % | 21.7 | % | |
JPKO | 14.4 | % | 14.6 | % | |
100.0 | % | 100.0 | % |
Nine Months Ended December 31, | |||||
2018 | 2017 | ||||
OEM | 43.8 | % | 46.8 | % | |
Distributor | 42.2 | % | 38.7 | % | |
EMS | 14.0 | % | 14.5 | % | |
100.0 | % | 100.0 | % |
Nine Months Ended December 31, | |||||||
2018 | 2017 | ||||||
Net sales: | |||||||
Solid Capacitors | $ | 687,977 | $ | 568,435 | |||
Film and Electrolytic (1) | 155,754 | 146,949 | |||||
MSA | 183,293 | 166,706 | |||||
Total | $ | 1,027,024 | $ | 882,090 | |||
Operating income (loss): | |||||||
Solid Capacitors | $ | 249,456 | $ | 170,417 | |||
Film and Electrolytic (1) | 8,686 | 3,890 | |||||
MSA | 18,961 | 18,055 | |||||
Corporate | (130,311 | ) | (101,156 | ) | |||
Total | $ | 146,792 | $ | 91,206 |
Nine Months Ended December 31, | |||||||||||||
2018 | 2017 | ||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | ||||||||||
Tantalum product line net sales | $ | 426,047 | $ | 368,479 | |||||||||
Ceramic product line net sales | 261,930 | 199,956 | |||||||||||
Solid Capacitors net sales | $ | 687,977 | $ | 568,435 | |||||||||
Solid Capacitors operating income (loss) | $ | 249,456 | 36.3 | % | $ | 170,417 | 30.0 | % |
Nine Months Ended December 31, | |||||||||||||
2018 | 2017 | ||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | ||||||||||
Net sales | $ | 155,754 | $ | 146,949 | |||||||||
Operating income (loss) | 8,686 | 5.6 | % | 3,890 | 2.6 | % |
Nine Months Ended December 31, | |||||||||||||
2018 | 2017 | ||||||||||||
Amount | % to Net Sales | Amount | % to Net Sales | ||||||||||
Net sales | $ | 183,293 | $ | 166,706 | |||||||||
Operating income (loss) | 18,961 | 10.3 | % | 18,055 | 10.8 | % |
• | An amortizing cross-currency swap with an initial notional value JPY 16.5 billion. The notional amount is amortized by approximately JPY 1.4 billion every six months and matures on September 30, 2024. The Company receives interest in JPY on March 31 and September 30 of each year based on the JPY notional value and JPY Libor plus 2.00%. Interest payments are made by the Company in USD on March 31 and September 30 of each year based on the USD equivalent of the JPY notional value and USD Libor plus 2.70%. |
• | A non-amortizing cross-currency swap contract with a notional value of JPY 16.5 billion maturing on September 30, 2024. The Company receives interest in JPY on March 31 and September 30 of each year based on the JPY notional value and JPY Libor plus 2.25%. Interest payments are made by the Company in USD on March 31 and September 30 of each year based on the USD equivalent of the JPY notional value and USD Libor plus 3.15%. |
• | An amortizing cross-currency swap with an initial notional value of JPY 33.0 billion. The notional amount is amortized by approximately JPY 1.4 billion every six months and matures on September 30, 2024. Interest payments are made by the Company in JPY on March 31 and September 30 of each year based on the JPY notional value and a fixed rate of 2.61%. The Company receives interest in USD on March 31 and September 30 of each year based on the USD equivalent of the JPY notional value and a fixed rate of 6.25%. |
Nine months ended December 31, | |||||||
2018 | 2017 | ||||||
Net cash provided by (used in) operating activities | $ | 82,727 | $ | 82,783 | |||
Net cash provided by (used in) investing activities | (78,705 | ) | 140,162 | ||||
Net cash provided by (used in) financing activities | (46,139 | ) | (51,570 | ) | |||
Effect of foreign currency fluctuations on cash, cash equivalents, and restricted cash | (7,236 | ) | 3,017 | ||||
Net increase (decrease) in cash, cash equivalents, and restricted cash | $ | (49,353 | ) | $ | 174,392 |
• | In the nine months ended December 31, 2018, we had net income of $113.2 million, and adjustments to cash flows from operations for non-cash income statement items were a net $73.2 million increase. Included in the non-cash income statement items are depreciation and amortization, (income) loss from equity-method investments, loss on early extinguishment of debt, non-cash debt and financing costs, stock-based compensation expense, write down of receivables, write down and disposals of long-lived assets, pension and other post-retirement benefits, and deferred income taxes. |
• | In the nine months ended December 31, 2017, we had net income of $251.8 million, and adjustments to cash flows for operations for non-cash income statement items were a net $168.6 million decrease, primarily driven by acquisition gain and income from equity-method investments of $137.2 million and $75.9 million, respectively. Also included in the non-cash income statement items are depreciation and amortization, loss on early extinguishment of debt, non-cash debt and financing costs, stock-based compensation expense, write down of receivables, write down and disposals of long-lived assets, pension and other post-retirement benefits, and deferred income taxes. |
• | In the nine months ended December 31, 2018, an increase in accounts receivable used $4.0 million in cash, compared to the nine months ended December 31, 2017, during which a decrease in accounts receivable generated $32.9 million in cash. The primary reason for the change in accounts receivable is due to the timing of customer receipts. |
• | In the nine months ended December 31, 2018, an increase in inventory used $35.3 million in cash, compared to the nine months ended December 31, 2017, during which an increase in inventory used $13.3 million in cash. |
• | In the nine months ended December 31, 2018, an increase in prepaid expenses and other assets used $2.9 million in cash, compared to the nine months ended December 31, 2017, during which a decrease in prepaid expenses and other assets generated $1.0 million in cash. |
• | In the nine months ended December 31, 2018, a decrease in accrued expenses used $66.3 million in cash, compared to the nine months ended December 31, 2017, during which a decrease in accrued expenses used $20.1 million in cash. The primary reason for the change in accrued expenses is due to the payment of TOKIN anti-trust fines. |
• | Partially offsetting the unfavorable changes, in the nine months ended December 31, 2018, an increase in accounts payable generated $2.4 million in cash, compared to the nine months ended December 31, 2017, during which a decrease in accounts payable used $14.5 million in cash. The primary reason for the change in accounts payable is due to the timing of supplier payments. |
• | Also offsetting the unfavorable changes, in the nine months ended December 31, 2018, an increase in accrued income taxes generated $1.7 million in cash, compared to the nine months ended December 31, 2017, during which a decrease in accrued expenses used $0.1 million in cash. |
Payment Due by Period | ||||||||||||||||||||
Contractual obligations | Total | Year 1 | Years 2 - 3 | Years 4 - 5 | More than 5 years | |||||||||||||||
Debt obligations | $ | 315,777 | $ | 28,416 | $ | 57,483 | $ | 54,017 | $ | 175,861 | ||||||||||
Interest obligations | 31,106 | 5,956 | 11,656 | 9,528 | 3,966 | |||||||||||||||
Anti-trust fines and settlements (1) | 45,353 | 28,861 | 12,527 | 3,965 | — |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net sales (1) | $ | 350,175 | $ | 306,576 | $ | 1,027,024 | $ | 882,090 | |||||||
Cost of sales (1) | 226,425 | 214,288 | 694,888 | 630,781 | |||||||||||
Gross margin (U.S. GAAP) (1) | $ | 123,750 | $ | 92,288 | $ | 332,136 | $ | 251,309 | |||||||
Gross margin as a % of net sales | 35.3 | % | 30.1 | % | 32.3 | % | 28.5 | % | |||||||
Non-GAAP adjustments: | |||||||||||||||
Plant start-up costs | 305 | — | 2,419 | — | |||||||||||
Stock-based compensation expense | 666 | 402 | 1,941 | 1,054 | |||||||||||
Adjusted gross margin (non-GAAP) (1) | $ | 124,721 | $ | 92,690 | $ | 336,496 | $ | 252,363 | |||||||
Adjusted gross margin as a % of net sales | 35.6 | % | 30.2 | % | 32.8 | % | 28.6 | % |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Operating income (loss) (U.S. GAAP) (1) | $ | 61,616 | $ | 32,002 | $ | 146,792 | $ | 91,206 | |||||||
Non-GAAP adjustments: | |||||||||||||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||||||||
ERP integration/IT transition costs | 2,453 | — | 5,696 | — | |||||||||||
Stock-based compensation expense | 1,534 | 2,206 | 10,011 | 4,837 | |||||||||||
Legal expenses/fines related to antitrust class actions | 1,268 | 1,482 | 4,294 | 4,998 | |||||||||||
Plant start-up costs | 305 | — | 2,419 | — | |||||||||||
(Gain) loss on write down and disposal of long-lived assets | 788 | (902 | ) | 1,611 | (922 | ) | |||||||||
Adjusted operating income (loss) (non-GAAP) (1) | $ | 69,682 | $ | 38,318 | $ | 172,445 | $ | 106,655 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net income (loss) (U.S. GAAP) (1) | $ | 40,806 | $ | 18,589 | $ | 113,167 | $ | 251,847 | |||||||
Non-GAAP adjustments: | |||||||||||||||
Acquisition (gain) loss | — | (310 | ) | — | (137,183 | ) | |||||||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||||||||
Research and development grant reimbursement | (470 | ) | — | (4,557 | ) | — | |||||||||
ERP integration/IT transition costs | 2,453 | — | 5,696 | — | |||||||||||
Stock-based compensation expense | 1,534 | 2,206 | 10,011 | 4,837 | |||||||||||
Legal expenses/fines related to antitrust class actions | 1,549 | 4,073 | 8,857 | 15,541 | |||||||||||
(Gain) loss on early extinguishment of debt | 15,988 | — | 15,988 | 486 | |||||||||||
Net foreign exchange (gain) loss | (2,218 | ) | 2,239 | (9,546 | ) | 9,173 | |||||||||
Amortization included in interest expense | 450 | 696 | 1,085 | 1,820 | |||||||||||
Equity (income) loss from equity method investments | 296 | (238 | ) | 301 | (75,879 | ) | |||||||||
Plant start-up costs | 305 | — | 2,419 | — | |||||||||||
(Gain) loss on write down and disposal of long-lived assets | 788 | (902 | ) | 1,611 | (922 | ) | |||||||||
Income tax effect of non-GAAP adjustments | (91 | ) | 667 | 196 | (186 | ) | |||||||||
Adjusted net income (loss) (non-GAAP) | $ | 63,108 | $ | 30,550 | $ | 146,850 | $ | 76,070 |
Three Months Ended December 31, | Nine Months Ended December 31, | ||||||||||||||
2018 | 2017 | 2018 | 2017 | ||||||||||||
Net income (loss) (U.S. GAAP) (1) | $ | 40,806 | $ | 18,589 | $ | 113,167 | $ | 251,847 | |||||||
Non-GAAP adjustments: | |||||||||||||||
Interest expense (income), net | 3,908 | 7,155 | 17,478 | 25,319 | |||||||||||
Income tax expense (benefit) (1) | 2,600 | 2,037 | 9,200 | 6,041 | |||||||||||
Depreciation and amortization (1) | 12,763 | 11,353 | 38,405 | 37,366 | |||||||||||
EBITDA (non-GAAP)(1) | 60,077 | 39,134 | 178,250 | 320,573 | |||||||||||
Excluding the following items: | |||||||||||||||
Acquisition (gain) loss | — | (310 | ) | — | (137,183 | ) | |||||||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||||||||
Research and development grant reimbursement | (470 | ) | — | (4,557 | ) | — | |||||||||
ERP integration/IT transition costs | 2,453 | — | 5,696 | — | |||||||||||
Stock-based compensation expense | 1,534 | 2,206 | 10,011 | 4,837 | |||||||||||
Legal expenses/fines related to antitrust class actions | 1,549 | 4,073 | 8,857 | 15,541 | |||||||||||
Net foreign exchange (gain) loss | (2,218 | ) | 2,239 | (9,546 | ) | 9,173 | |||||||||
Equity (income) loss from equity method investments | 296 | (238 | ) | 301 | (75,879 | ) | |||||||||
(Gain) loss on early extinguishment of debt | 15,988 | — | 15,988 | 486 | |||||||||||
Plant start-up costs | 305 | — | 2,419 | — | |||||||||||
(Gain) loss on write down and disposal of long-lived assets | 788 | (902 | ) | 1,611 | (922 | ) | |||||||||
Adjusted EBITDA (non-GAAP) (1) | $ | 82,020 | $ | 49,732 | $ | 210,652 | $ | 143,162 |
• | it does not reflect our cash expenditures, future requirements for capital expenditures, or contractual commitments; |
• | it does not reflect changes in, or cash requirements for, our working capital needs; |
• | it does not reflect any income tax expense or benefit, including any changes to income taxes resulting from the Tax Cuts and Jobs Act enacted December 22, 2017; |
• | it does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt; |
• | although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and our Adjusted EBITDA measure does not reflect any cash requirements for such replacements; |
• | it is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows; |
• | it does not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations; |
• | it does not reflect limitations on or costs related to transferring earnings from our subsidiaries to us; and |
• | other companies in our industry may calculate this measure differently than we do, limiting its usefulness as a comparative measure. |
Periods | (a) Total Number of Shares Purchased (1) | (b) Average Price Paid per Share | (c) Total Number of Shares Purchased as Part of Publicly Announced Programs | (d) Maximum Number of Shares That May Yet be Purchased Under the Programs | |||||
October 1 to October 31, 2018 | 5,107 | $ | 18.97 | — | — | ||||
November 1 to November 30, 2018 | 4,366 | 21.59 | — | — | |||||
December 1 to December 31, 2018 | 192,206 | 20.46 | — | — | |||||
Total for Quarter Ended December 31, 2018 | 201,679 | $ | 20.45 | — | — |
Second Restated Certificate of Incorporation of the Company, as amended to date (incorporated by reference to Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (File No. 1-15491) for the quarter ended June 30, 2011) | |
Amended and Restated By-laws of KEMET Corporation, effective June 5, 2008 (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K (File No. 1-15491) filed on June 5, 2008) | |
English Translation of the Term Loan Agreement, dated October 29, 2018, by and among TOKIN Corporation, the Lenders party thereto and Sumitomo Mitsui Trust Bank Limited, in its capacity as agent (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K File No. 1-15491) filed on October 29, 2018) | |
Form of Guaranty Agreement, dated October 29, 2018, by and between KEMET Corporation and Sumitomo Mitsui Trust Bank Limited, in its capacity as agent (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K File No. 1-15491) filed on October 29, 2018) | |
Amendment No. 10 to Loan and Security Agreement, Waiver and Consent, dated as of October 29, 2018, by and among KEMET, the other borrowers named therein, the financial institutions party thereto as lenders and Bank of America, N.A., a national banking association, as agent for the lenders (incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K File No. 1-15491) filed on October 29, 2018) | |
Rule 13a-14(a)/15d-14(a) Certification - Principal Executive Officer | |
Rule 13a-14(a)/15d-14(a) Certification - Principal Financial Officer | |
Section 1350 Certification - Principal Executive Officer | |
Section 1350 Certification - Principal Financial Officer | |
Exhibit 101 | The following financial information from KEMET Corporation’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2018, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2018 and 2017, (ii) Condensed Consolidated Balance Sheets at December 31, 2018 and March 31, 2018, (iii) Condensed Consolidated Statements of Cash Flows for the nine months ended December 31, 2018, and 2017, and (iv) the Notes to Condensed Consolidated Financial Statements. |
Date: | February 1, 2019 | |
KEMET Corporation | ||
By: | /s/ GREGORY C. THOMPSON | |
Gregory C. Thompson | ||
Executive Vice President and Chief Financial Officer | ||
(Principal Financial and Accounting Officer) | ||
(Duly Authorized Officer) |
1. | I have reviewed this quarterly report on Form 10-Q of KEMET Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: February 1, 2019 | |
/s/ WILLIAM M. LOWE, JR. | |
William M. Lowe, Jr. | |
Chief Executive Officer and Director |
1. | I have reviewed this quarterly report on Form 10-Q of KEMET Corporation; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: February 1, 2019 | |
/s/ GREGORY C. THOMPSON | |
Gregory C. Thompson | |
Executive Vice President and Chief Financial Officer |
/s/ WILLIAM M. LOWE, JR. | |
William M. Lowe, Jr. | |
Chief Executive Officer and Director |
/s/ GREGORY C. THOMPSON | |
Gregory C. Thompson | |
Executive Vice President and Chief Financial Officer |
Document and Entity Information - shares |
9 Months Ended | |
---|---|---|
Dec. 31, 2018 |
Jan. 30, 2019 |
|
Document and Entity Information | ||
Entity Registrant Name | KEMET CORP | |
Entity Central Index Key | 0000887730 | |
Document Type | 10-Q | |
Document Period End Date | Dec. 31, 2018 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --03-31 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 57,786,812 | |
Document Fiscal Year Focus | 2019 | |
Document Fiscal Period Focus | Q3 |
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
||
---|---|---|---|---|
Statement of Financial Position [Abstract] | ||||
Accrued expenses | [1] | $ 98,279 | $ 125,119 | |
Property, Plant and Equipment, Net [Abstract] | ||||
Property and equipment, accumulated depreciation | $ 867,313 | $ 866,614 | ||
Preferred Stock, Number of Shares, Par Value and Other Disclosures [Abstract] | ||||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Preferred stock, authorized shares | 10,000,000 | 10,000,000 | ||
Preferred stock, issued shares | 0 | 0 | ||
Common Stock, Number of Shares, Par Value and Other Disclosures [Abstract] | ||||
Common stock, par value (in dollars per share) | $ 0.009996718205 | $ 0.009992761427 | ||
Common stock, authorized shares | 175,000,000 | 175,000,000 | ||
Common stock, issued shares | 57,818,975 | 56,641,000 | ||
|
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
||||||
Revenues [Abstract] | |||||||||
Net sales | [1] | $ 350,175 | $ 306,576 | $ 1,027,024 | $ 882,090 | ||||
Operating costs and expenses: | |||||||||
Cost of sales | [1] | 226,425 | 214,288 | 694,888 | 630,781 | ||||
Selling, general and administrative expenses | 48,271 | 47,751 | 149,071 | 125,799 | |||||
Research and development | 11,357 | 9,907 | 33,040 | 28,690 | |||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||
(Gain) loss on write down and disposal of long-lived assets | 788 | (902) | 1,611 | (922) | |||||
Total operating costs and expenses | [1] | 288,559 | 274,574 | 880,232 | 790,884 | ||||
Operating income (loss) | [1] | 61,616 | 32,002 | 146,792 | 91,206 | ||||
Non-operating (income) expense: | |||||||||
Interest income | (572) | (252) | (1,325) | (413) | |||||
Interest expense | 4,480 | 7,407 | 18,803 | 25,732 | |||||
Acquisition (gain) loss | 0 | (310) | 0 | (137,183) | |||||
Other (income) expense, net | 14,006 | 4,769 | 6,646 | 21,061 | |||||
Income (loss) before income taxes and equity income (loss) from equity method investments | [1] | 43,702 | 20,388 | 122,668 | 182,009 | ||||
Income tax expense (benefit) | [1] | 2,600 | 2,037 | 9,200 | 6,041 | ||||
Income (loss) before equity income (loss) from equity method investments | [1] | 41,102 | 18,351 | 113,468 | 175,968 | ||||
Equity income (loss) from equity method investments | (296) | 238 | (301) | 75,879 | |||||
Net income (loss) | [1],[2] | $ 40,806 | $ 18,589 | $ 113,167 | $ 251,847 | ||||
Net income (loss) per basic share: | |||||||||
Net income (loss) per basic share (in usd per share) | $ 0.70 | $ 0.33 | $ 1.96 | $ 4.91 | |||||
Net income (loss) per diluted share (in usd per share) | 0.69 | 0.32 | 1.91 | 4.31 | |||||
Dividends declared per share | $ 0.05 | $ 0.00 | $ 0.05 | $ 0.00 | |||||
Weighted-average shares outstanding: | |||||||||
Basic (in shares) | 58,010 | 56,778 | 57,717 | 51,340 | |||||
Diluted (in shares) | 59,111 | 58,937 | 59,116 | 58,431 | |||||
|
Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
||||||
Statement of Comprehensive Income [Abstract] | |||||||||
Net income (loss) | [1],[2] | $ 40,806 | $ 18,589 | $ 113,167 | $ 251,847 | ||||
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] | |||||||||
Foreign currency translation gains (losses) | [2] | (5,152) | 6,516 | (32,504) | 20,481 | ||||
Defined benefit pension plans, net of tax | 139 | 147 | 426 | (6) | |||||
Defined benefit post-retirement plan adjustments | (38) | (47) | (116) | (141) | |||||
Equity interest in investee's other comprehensive income (loss) | 8 | (5) | (9) | 5,568 | |||||
Foreign exchange contracts | (2,605) | (5,330) | (1,855) | (6,807) | |||||
Other Comprehensive Income (Loss), Net of Tax | (1,835) | 0 | (1,835) | 0 | |||||
Other comprehensive income (loss) | [2] | (9,483) | 1,281 | (35,893) | 19,095 | ||||
Total comprehensive income (loss) | [2] | $ 31,323 | $ 19,870 | $ 77,274 | $ 270,942 | ||||
|
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
||||||||||
Statement of Cash Flows [Abstract] | |||||||||||||
Restricted Cash | $ 3,134 | $ 0 | $ 3,134 | $ 0 | |||||||||
Net income (loss) | [1],[2] | 40,806 | 18,589 | 113,167 | 251,847 | ||||||||
Operating Activities: | |||||||||||||
Depreciation and amortization (1) | 12,763 | 11,353 | 38,405 | [3] | 37,366 | [3] | |||||||
Equity (income) loss from equity method investments | 296 | (238) | 301 | (75,879) | |||||||||
Acquisition (gain) loss | 0 | (310) | 0 | (137,183) | |||||||||
Non-cash debt and financing costs | 1,085 | 1,820 | |||||||||||
(Gain) loss on early extinguishment of debt | 15,988 | 486 | |||||||||||
Stock-based compensation expense | 10,011 | 4,837 | |||||||||||
Provision for Doubtful Accounts | 84 | 162 | |||||||||||
(Gain) loss on write down and disposal of long-lived assets | 788 | (902) | 1,611 | (922) | |||||||||
Pension and other post-retirement benefits | 3,823 | 3,897 | |||||||||||
Change in deferred income taxes (1) | [3] | 1,395 | (3,792) | ||||||||||
Change in operating assets (1) | [3] | (42,130) | 25,820 | ||||||||||
Change in operating liabilities (1) | [3] | (61,485) | (26,258) | ||||||||||
Other (1) | 472 | 582 | |||||||||||
Net cash provided by (used in) operating activities (1) | [3] | 82,727 | 82,783 | ||||||||||
Investing activities: | |||||||||||||
Capital expenditures | (77,650) | (30,925) | |||||||||||
Acquisitions, net of cash received | 0 | 167,129 | |||||||||||
Proceeds from Sale of Productive Assets | 169 | 1,227 | |||||||||||
Payments to Acquire Interest in Joint Venture | (2,000) | 0 | |||||||||||
Net cash provided by (used in) investing activities | (78,705) | 140,162 | |||||||||||
Financing activities: | |||||||||||||
Payments of revolving line of credit | 0 | (33,881) | |||||||||||
Proceeds from Issuance of Secured Debt | 293,348 | 334,978 | |||||||||||
Payment for Debt Extinguishment or Debt Prepayment Cost | (3,234) | 0 | |||||||||||
Payments of Debt Issuance Costs | (1,797) | (5,002) | |||||||||||
Payments of long-term debt | (332,063) | (361,625) | |||||||||||
Proceeds from exercise of stock options | 480 | 5,122 | |||||||||||
Payments of Ordinary Dividends, Common Stock | (2,873) | 0 | |||||||||||
Proceeds from Equity Method Investment, Distribution | 776 | 2,731 | |||||||||||
Proceeds from Warrant Exercises | 0 | 8,838 | |||||||||||
Net cash provided by (used in) financing activities | (46,139) | (51,570) | |||||||||||
Net increase (decrease) in cash, cash equivalents and restricted cash | (42,117) | 171,375 | |||||||||||
Effect of foreign currency fluctuations on cash, cash equivalents and restricted cash (1) | [3] | (7,236) | 3,017 | ||||||||||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 237,493 | 284,166 | 237,493 | 284,166 | |||||||||
Cash, cash equivalents, and restricted cash, at end of fiscal period | $ 234,359 | $ 284,166 | $ 234,359 | $ 284,166 | |||||||||
|
Basis of Financial Statement Presentation |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basis of Financial Statement Presentation | Basis of Financial Statement Presentation The Condensed Consolidated Financial Statements contained herein are unaudited and have been prepared from the books and records of KEMET Corporation and its subsidiaries (“KEMET” or the “Company”). In the opinion of management, the Condensed Consolidated Financial Statements reflect all adjustments, consisting only of normal recurring adjustments unless otherwise disclosed, necessary for a fair presentation of the results for the interim periods. The Condensed Consolidated Financial Statements have been prepared in accordance with the instructions to Form 10-Q, and therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, and cash flows in conformity with U.S. generally accepted accounting principles (“U.S. GAAP”). Although the Company believes the disclosures are adequate to make the information presented not misleading, it is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the audited financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended March 31, 2018 (the “Company’s 2018 Annual Report”). The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its wholly-owned subsidiaries. In consolidation, all intercompany amounts and transactions have been eliminated. Net sales and operating results for the three and nine months ended December 31, 2018 are not necessarily indicative of the results to be expected for the full year. The Company’s significant accounting policies are presented in the Company’s 2018 Annual Report. Refer to the “Change in accounting policies” section below for changes in accounting policies since the issuance of the Company's 2018 Annual Report. Use of Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and judgments based on historical data and other assumptions that management believes are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period. The Company’s judgments are based on management’s assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in the unaudited condensed consolidated financial statements. It is important that readers of these unaudited financial statements understand that actual results could differ from these estimates, assumptions, and judgments. Change in Accounting Policies The Company implemented ASC 606, Revenue from Contracts with Customers (“ASC 606”) as of April 1, 2018. As a result, the Company changed its accounting policy for revenue recognition. Except as discussed below, there have not been any other changes to the Company's significant accounting policies since the issuance of the Company's 2018 Annual Report. Research & development The Company previously recognized all research and development (“R&D”) expenses when they were incurred. Under ASC 606, the Company capitalizes a portion of research and development expenses which directly relate to an existing or anticipated contract or specific business opportunity and amortizes them consistently with the pattern of transfer of the goods to which the asset relates. If the expected amortization period is one year or less, the research and development activities are expensed when incurred. Specialized equipment At times, the Company enters into contracts with customers that contain capital arrangements for specialized equipment obtained in order to manufacture products in accordance with customer specifications. The Company may agree to purchase and assemble specific tooling equipment on behalf of the customer and ultimately resell the equipment (and transfer title and control) to the customer. Previously, the Company accumulated such costs on the balance sheet and subsequently applied the receipt of payment from the customer against the asset, thus resulting in no impact to the statement of operations. Under ASC 606, the Company recognizes a distinct performance obligation for the capital arrangement and records the selling price of the equipment as a component of revenue and cost of goods sold at a point in time when the customer obtains control over the asset. Material up-front fees At times, the Company enters into contracts with customers whereby the customer agrees to reimburse the Company for certain manufacturing equipment, capacity expansion, and fulfillment costs required to manufacture product which meets the customer’s required specifications. Previously, the Company recognized the reimbursement revenue in accordance with the contractual reimbursement schedule. Under ASC 606, the Company recognizes material up-front fees as options that provide the customer with a material right to acquire future goods. The Company applies the practical expedient in paragraph 606-10-55-45 and does not estimate the standalone selling price of the option, but instead allocates the transaction price to the optional goods by reference to the goods expected to be provided and the corresponding expected consideration. Accordingly, the revenue is recognized over the longer of the contract period or the estimated length of the product life cycle, which approximates the period during which the customer is expected to benefit. Significant Accounting Policies Revenue Recognition The Company recognizes revenue under the guidance provided in ASC 606. Consistent with the terms of ASC 606, the Company records revenue on product sales in the period in which the Company satisfies its performance obligation by transferring control over a product to a customer. The amount of revenue recognized reflects the consideration the Company expects to receive in exchange for transferring products to a customer. The Company has elected the practical expedient under ASC 606-10-32-18 and does not consider the effects of a financing component on the promised amount of consideration because the period between when the Company transfers a product to a customer and when the customer pays for that product is one year or less. As performance obligations are expected to be fulfilled in one year or less, the Company has elected the practical expedient under ASC 606-10-50-14 and has not disclosed information relating to remaining performance obligations. The Company sells its products to distributors, original equipment manufacturers (“OEM”), and electronic manufacturing services providers (“EMS”), and the sales price may include adjustments for sales discounts, price adjustments, and sales allowances. The Company has elected the practical expedient under ASC 606-10-10-4 and evaluates these sales-related adjustments on a portfolio basis. The principle forms of these adjustments include:
The Company's inventory price protection and SFSD programs provide authorized distributors with the flexibility to meet marketplace prices by allowing them, upon a pre-approved case-by-case basis, to adjust their purchased inventory cost to correspond with current market demand. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment quote from their local KEMET sales representative, and apply only to a specific customer, part, specified special price amount, specified quantity, and are only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain accounting assumptions, all of which are reviewed quarterly. Select distributors have the right to return a certain portion of their purchased inventory to KEMET from the previous fiscal quarter. The Company estimates future returns based on historical return patterns and records a corresponding right of return asset and refund liability as a component of the line items, “Inventories, net” and “Accrued expenses,” respectively, on the Condensed Consolidated Balance Sheets. The Company also offers volume based rebates on a case-by-case basis to certain customers in each of the Company’s sales channels. The Company's sales allowances are recognized as a reduction in the line item “Net sales” on the Condensed Consolidated Statements of Operations, while the associated reserves are included in the line item “Accounts receivable, net” on the Condensed Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the effects of technological change, and other variables that might result in changes to the Company’s estimates. The Company provides a limited assurance warranty on products that meet certain specifications to select customers. The warranty coverage period is generally limited to one year for United States based customers and a length of time commensurate with regulatory requirements or industry practice outside the United States. A warranty cannot be purchased by the customer separately and, as a result, product warranties are not considered to be separate performance obligations. The Company’s liability under these warranties is generally limited to a replacement of the product or refund of the purchase price of the product. Warranty costs were not material for the three and nine months ended December 31, 2018 and 2017. Shipping and handling costs are included in cost of sales. Disaggregation of Revenue Refer to Note 8, “Segment and Geographic Information” for revenue disaggregated by primary geographical market, sales channel, and major product line. Contract liabilities Contract liabilities consist of advance payments from certain customers within the OEM channel for the development of additional production capacity. The current and noncurrent portions of these liabilities are included as a component of the line items, “Accrued expenses” and “Other non-current obligations,” respectively, on the Condensed Consolidated Balance Sheets. The balance of net contract liabilities consisted of the following at December 31, 2018 and March 31, 2018 (amounts in thousands):
In the three and nine months ended December 31, 2018, the Company recognized revenue of $0.1 million and $0.2 million related to contract liabilities at March 31, 2018. In the three and nine months ended December 31, 2017, the Company recognized revenue of $0.1 million and $0.2 million related to contract liabilities at March 31, 2017. Revenue related to contract liabilities is recorded on the Condensed Consolidated Statements of Operations line item, "Net sales." Contract assets The Company recognizes an asset from the costs incurred to fulfill a contract if those costs directly relate to an existing or anticipated contract or specific business opportunity, if the costs enhance our own resources that will be used in satisfying performance obligations in the future, and the costs are expected to be recovered through subsequent sale of product to the customer. The Company has determined that certain direct labor, materials, and allocations of overhead incurred within research and development activities meet the requirements to be capitalized. As most of our contracts and customer specific business opportunities do not include a stated term, the Company amortizes these capitalized costs over the expected product life cycle, which is consistent with the estimated transfer of goods to the customer. Capitalized contract costs were $1.7 million and $2.2 million at December 31, 2018 and March 31, 2018, respectively. Capitalized contracts costs are recorded on the Condensed Consolidated Balance Sheets in the line item, “Other assets.” Amortization expense related to the contract costs was $0.2 million and $0.6 million for the three and nine months ended December 31, 2018, respectively, and $0.2 million and $0.7 million for the three and nine months ended December 31, 2017, respectively. There was no impairment loss in relation to the costs capitalized for the three and nine months ended December 31, 2018 and 2017. Amortization expense related to contract assets is recorded on the Condensed Consolidated Statements of Operations line item "Cost of sales." Fair Value Measurement The Company utilizes three levels of inputs to measure the fair value of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s Condensed Consolidated Financial Statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The first two inputs are considered observable and the last is considered unobservable. The levels of inputs are as follows:
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2018 and March 31, 2018 are as follows (amounts in thousands):
(1) Included in the line item “Cash and cash equivalents” on the Condensed Consolidated Balance Sheets. (2) Certificates of Deposit of $35.4 million and $33.9 million that mature in three months of less are included within the balance as of December 31, 2018 and March 31, 2018, respectively. (3) Derivative assets and liabilities fair value was determined by using a third-party matrix-pricing model that uses significant inputs derived from or corroborated by observable market data. Where applicable, these models discount future cash flow amounts using market-based observable inputs, including interest rate yield curves, and forward and spot prices for currencies. For Total debt, the valuation approach used to calculate fair value was a discounted cash flow based on the current market rate. Deferred Income Taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. The Company periodically evaluates its net deferred tax assets based on an assessment of historical performance, ability to forecast future events, and the likelihood that the Company will realize the benefits through future taxable income. Valuation allowances are recorded to reduce the net deferred tax assets to the amount that is more likely than not to be realized. For interim reporting purposes, the Company records income taxes based on the expected annual effective income tax rate, taking into consideration global forecasted tax results and the effect of discrete tax events. The Company makes certain estimates and judgments in the calculation for the provision for income taxes, in the resulting tax liabilities, and in the recoverability of deferred tax assets. All deferred tax assets are reported as noncurrent in the Condensed Consolidated Balance Sheets. Inventories Inventories are stated at the lower of cost or net realizable value. The components of inventories are as follows (amounts in thousands):
Recently Issued Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. This ASU amends the definition of a hosting arrangement and requires a customer in a hosting arrangement that is a service contract to capitalize certain implementation costs as if the arrangement was an internal-use software project. Under this ASU, a customer will apply ASC 350-40 to determine whether to capitalize implementation costs of the cloud computing arrangement that is a service contract or expense them as incurred. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on the Company’s Condensed Consolidated Financial Statements. In March 2018, the FASB issued ASU No. 2018-05, Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (“SAB”) No. 118. The amendments in this update provide guidance on when to record and disclose provisional amounts for certain income tax effects of the Tax Cuts and Jobs Act (the “Act”). The amendments also require any provisional amounts or subsequent adjustments to be included in net income from continuing operations. Additionally, this ASU discusses required disclosures that an entity must make with regard to the Act. This ASU is effective immediately as new information is available to adjust provisional amounts that were previously recorded. The Company has adopted this standard and has finalized its accounting for the Act. See Note 11, “Income Taxes” for additional information on the Act. In August 2017, the FASB issued ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (“ASU 2017-12”). The ASU amends and simplifies existing guidance in order to allow companies to more accurately present the economic effects of risk management activities in the financial statements. For cash flow hedges existing on the date of adoption, an entity is required to eliminate the separate measurement of ineffectiveness in earnings by means of a cumulative-effect adjustment to accumulated other comprehensive income (“AOCI”) with a corresponding adjustment to the opening balance of retained earnings. ASU 2017-12 becomes effective for fiscal years and interim periods beginning after December 15, 2018 and early adoption is permitted. In the third quarter of fiscal year 2019, the Company entered into new derivative contracts and elected to early adopt the ASU effective as of October 1, 2018. The adoption of the standard did not result in a cumulative-effect adjustment since the Company has not previously had any ineffectiveness associated with its cash flows hedges. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments. The update clarifies how cash receipts and cash payments in certain transactions are presented and classified in the statement of cash flows. The effective date of this update is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires retrospective application to all periods presented but may be applied prospectively if retrospective application is impracticable. The Company adopted this guidance as of April 1, 2018. In connection with the adoption of this ASU, the Company elected to account for distributions received from equity method investees using the nature of distributions approach, under which distributions are classified based on the nature of activity that generated them. The other provisions of this ASU did not have an impact on the Company's Condensed Consolidated Cash Flows. In February 2016, the FASB issued ASU No. 2016-02 (“ASU 2016-02”), Leases, as modified by ASU 2017-03, Transition and Open Effective Date Information, requiring lessees to recognize a right-of-use asset and a lease liability for all leases. The ASU also requires expanded disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The standard is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. In July 2018, the FASB issued an update which provides an additional transition method allowing entities to only apply the new lease standard in the year of adoption. The Company will adopt ASU 2016-02 on April 1, 2019. We are currently collecting the necessary information on our lease population, establishing a new lease accounting process, and designing new internal controls for the new process. The Company continues to assess the potential effects of this ASU, which have not yet been quantified. The Company's assessment, which it expects to substantially complete in the fourth quarter of fiscal year 2019, includes a detailed review of the Company's lease contracts and a comparison of its historical accounting policies and practices to ASC 2016-02. Based on the Company's progress in reviewing its leasing arrangements across all of its business units, the Company expects to recognize a material amount of lease assets and liabilities on its Condensed Consolidated Balance Sheet upon adoption of the standard. This ASU is not expected to have a material effect on the amount of expense recognized in connection with the Company's current practice. For information about the Company's future lease commitments as of March 31, 2018, see Note 15, "Commitments and Contingencies," in the Company's 2018 Form 10-K. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which superseded existing accounting standards for revenue recognition and created a single framework. ASU 2014-09 and its amendments were included primarily in ASC 606. The core principle of ASC 606 is that an entity should recognize revenue for the transfer of goods or services equal to an amount that it expects to be entitled to receive for those goods or services. ASC 606 also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. The Company adopted the requirements of ASC 606 effective in the first quarter of fiscal year 2019, using the full retrospective method, which required us to restate each prior reporting period presented. The Company has applied practical expedient ASC 606-10-65-1(f)(3) and notes that all previously reported historical amounts are adjusted for the impact of ASC 606. Adoption of the requirements in ASC 606 impacted our previously reported Condensed Consolidated Balance Sheet as of March 31, 2018, our Condensed Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended December 31, 2017, and the Condensed Consolidated Statement of Cash Flows for the nine months ended December 31, 2017 as follows (amounts in thousands, except per share data): Condensed Consolidated Balance Sheet
Condensed Consolidated Statement of Operations
Condensed Consolidated Statement of Comprehensive Income
Condensed Consolidated Statement of Cash Flows
There are currently no other accounting standards that have been issued that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption. |
Acquisitions (Notes) |
9 Months Ended |
---|---|
Dec. 31, 2018 | |
Acquisitions [Abstract] | |
Business Combination Disclosure [Text Block] | Acquisitions Sale of Electro-Mechanical Business and Acquisition of Remaining Interest in TOKIN Between February 1, 2013 and April 19, 2017, KEMET, through its wholly-owned subsidiary, KEMET Electronics Corporation (“KEC”), held a 34% economic interest in TOKIN Corporation (“TOKIN”) pursuant to a Stock Purchase Agreement (the “Stock Purchase Agreement”) by and among KEC, TOKIN and NEC Corporation (“NEC”), as calculated based on the number of common shares held by KEC, directly and indirectly, in proportion to the aggregate number of common and preferred shares of TOKIN outstanding as of such date. TOKIN was established in Japan in 1938 and is engaged in production and distribution of tantalum capacitors, transmitting communication devices, magnetic devices, piezoelectric devices and sensors. TOKIN has six manufacturing locations throughout Asia and was previously operating as a joint venture with NEC. On April 14, 2017, TOKIN closed on the sale of its electro-mechanical devices (“EMD”) business to NTJ Holdings 1 Ltd. (“NTJ”), a special purpose entity that is owned by funds managed or operated by Japan Industrial Partners, Inc. (“JIP”), pursuant to a master sale and purchase agreement (the “EMD Master Sale and Purchase Agreement”) previously entered into between TOKIN, NTJ and JIP (“Sale of EMD”). The initial selling price for EMD was JPY 48.2 billion, or approximately $431.0 million, using the March 31, 2017 exchange rate of 111.823 Japanese Yen (“JPY”) to 1.00 U.S. Dollar (“USD”), and was subject to certain working capital adjustments. In the third quarter of fiscal year 2018, the selling price was adjusted by JPY 1.1 billion or approximately $10.1 million (using the December 31, 2017 exchange rate of 112.574 Japanese Yen to 1.00 U.S. Dollar) related to working capital and other adjustments in accordance with the EMD Master Sale and Purchase Agreement. At the closing of the Sale of EMD, TOKIN used a portion of the sale proceeds to repay debt related to a shareholder loan from NEC. The TOKIN historical balance sheet was adjusted to reflect the removal of net assets sold and other items directly impacted by the Sale of EMD. Additionally, due to KEMET’s 34% equity interest in TOKIN held as of the closing, adjustments were made to reflect KEMET’s accounting for the Sale of EMD in accordance with the equity method of accounting. On April 19, 2017, pursuant to a stock purchase agreement (the “TOKIN Purchase Agreement”) dated February 23, 2017 between KEC and NEC, KEC completed its acquisition, subject to final purchase price adjustments, of the remaining 66% economic interest in TOKIN, and as a result, TOKIN became a 100% owned indirect subsidiary of KEMET (the “TOKIN Acquisition”). Under the terms of the TOKIN Purchase Agreement, KEC paid NEC JPY 16.2 billion, or approximately $148.6 million (using the April 19, 2017 exchange rate of 109.007 Japanese Yen to 1.00 U.S. Dollar), for all of the outstanding shares of TOKIN it did not already own. The preliminary purchase price was comprised of JPY 6.0 billion, or approximately $55.0 million (using the April 19, 2017 exchange rate of 109.007 Japanese Yen to 1.00 U.S. Dollar) plus JPY 10.2 billion, or approximately $93.6 million, which represented one-half of the estimated excess net cash proceeds (“Excess Cash”) from the Sale of EMD. The acquisition price was subject to working capital adjustments pursuant to the EMD Master Sale and Purchase Agreement. As a result of these working capital adjustments, the acquisition price was increased by JPY 0.3 billion, or approximately $3.0 million (using the September 30, 2017 exchange rate of 112.502 Japanese Yen to 1.00 U.S. Dollar) in the second quarter of fiscal year 2018. The Company believes the acquisition of TOKIN expands KEMET’s geographic presence, combining KEMET’s presence in the western hemisphere and TOKIN’s excellent position in Asia to enhance customer reach and creates an entrance into Japan for KEMET. The Company believes TOKIN’s product portfolio is a strong complement to KEMET’s existing product portfolio. KEMET believes the combination creates a leader in the combined polymer and tantalum capacitors market. The acquisition also enhances KEMET’s product diversification with entry into Electro-Magnetic Compatible ("EMC") devices, as well as sensors and actuators. With the increased scale, the Company anticipates optimizing costs through competitive raw materials sourcing and maximizing operating efficiencies. Consistent with expectations, the acquisition has been accretive to earnings with improvement in Net income, Adjusted EBITDA and cash flows. TOKIN’s tantalum capacitor business is included within KEMET’s Solid Capacitor segment (“Solid Capacitors”) and the remainder of TOKIN’s business formed a new reportable segment for KEMET in fiscal year 2018, Electro-Magnetic, Sensors, and Actuators (“MSA”). |
Debt |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt | Debt A summary of debt is as follows (amounts in thousands):
(1) Amount shown is net of discount, bank issuance costs, and other indirect issuance costs of $13.3 million as of March 31, 2018 . (2) Amount shown is net of discount, bank issuance costs, and other indirect issuance costs of $9.1 million as of December 31, 2018. (3) Amount shown is net of discount of $0.6 million at December 31, 2018. (4) Amounts are shown net of discounts of $0.4 million and $0.5 million at December 31, 2018 and March 31, 2018, respectively. The line item “Interest expense” on the Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2018 and 2017, consists of the following (amounts in thousands):
Term Loan Credit Agreement On November 7, 2018, the Company repaid the full outstanding balance under the Company's prior Term Loan Credit Agreement dated April 28, 2017 (“Term Loan Credit Agreement”) with Bank of America, N.A.. The Company incurred a $16.0 million loss on the debt extinguishment and the loss is included in the line item “Other (income) expense, net” in the Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2018. Interest payable related to the Term Loan Credit Agreement included in the line item “Accrued expenses” on the Condensed Consolidated Balance Sheets was $0.2 million as of March 31, 2018. TOKIN Term Loan Facility On October 29, 2018, the Company entered into a JPY 33.0 billion Term Loan Agreement (the “TOKIN Term Loan Facility”) by and among TOKIN, the lenders party thereto (the “Lenders”) and Sumitomo Mitsui Trust Bank, Limited in its capacity as agent (the “Agent”), arranger and Lender. Funding for the Term Loan facility occurred on November 7, 2018. The proceeds, which were net of an arrangement fee withheld from the funding amount, were JPY 32.1 billion, or approximately $283.9 million using the exchange rate as of November 7, 2018. The proceeds from the TOKIN Term Loan Facility were used by TOKIN to make intercompany loans (the “Intercompany Loans”) to the Company. The proceeds, along with other cash on hand, were used to prepay in full the outstanding amounts under the Term Loan Credit Agreement of $323.4 million and a prepayment premium of 1.0%. The TOKIN Term Loan Facility consists of (i) a JPY 16.5 billion (approximately $146.0 million using the exchange rate as of November 7, 2018) Term Loan A tranche (the “Term Loan A”) and (ii) a JPY 16.5 billion (approximately $146.0 million using the exchange rate as of November 7, 2018) Term Loan B tranche (the “Term Loan B” and, together with the Term Loan A, collectively, the “Term Loans”). Principal payments under Term Loan A are required semi-annually, in the amount of JPY 1.4 billion (approximately $12.5 million using the exchange rate as of December 31, 2018), while the principal of Term Loan B is due in one payment at maturity. At each reporting period, the carrying value of the loan is translated from Japanese Yen to U.S. Dollars using the spot exchange rate as of the end of the reporting period. Interest payments are due semi-annually on the Term Loans, with the interest rate based on a margin over the six-month Japanese TIBOR. The applicable margin for Term Loan A is 2.00% and for Term Loan B is 2.25%. Japanese TIBOR at December 31, 2018 was 0.13%. Interest payable related to the TOKIN Term Loan Facility included in the line item “Accrued expenses” on the Condensed Consolidated Balance Sheets was $1.0 million as of December 31, 2018. The Term Loans mature on September 30, 2024. KEMET and certain subsidiaries of TOKIN provided guarantees of the obligations under the Term Loans, which will also be secured by certain assets, properties and equity interests of TOKIN and its material subsidiaries. The TOKIN Term Loan Facility contains customary covenants applicable to both the Company and to TOKIN, including maintenance of a consolidated leverage ratio, the absence of two consecutive years of consolidated operating losses and the maintenance of certain required levels of consolidated net assets. The TOKIN Term Loan Facility Agreement also contains customary events of default. The Company may prepay the Term Loans at any time, subject to certain notice requirements and reimbursement of loan breakage costs. Revolving Line of Credit In connection with the closing of the TOKIN Term Loan Facility on October 29 2018, the Company entered into Amendment No. 10 to the Loan and Security Agreement, Waiver and Consent (the “Revolver Amendment”), by and among KEMET, KEC, the other borrowers named therein, the financial institutions party thereto as lenders and Bank of America, N.A., a national banking association, as agent for the lenders. The Revolver Amendment provides the Company with, among other things, increased flexibility for certain restricted payments (including dividends), and also released certain pledges that allowed the Company to obtain the TOKIN Term Loan Facility in order to pay down the Term Loan Credit Agreement. The revolving line of credit has a facility amount of up to $75.0 million, which is based on factors including outstanding eligible accounts receivable, inventory, and equipment collateral. As of December 31, 2018, there were no borrowings under the revolving line of credit, and the Company’s available borrowing capacity, which is based on factors including outstanding eligible accounts receivable, inventory, and equipment collateral, under the Revolver Amendment was $62.4 million. Customer Advances In September and November 2018, the Company entered into two agreements with different customers (the “Customers”) pursuant to which the Customers agreed to make advances (collectively, the “Advances”) to the Company in an aggregate amount of up to $66.0 million (collectively, the “Customer Capacity Agreements”). The Company is using these Advances to fund the purchase of production equipment and to make other investments and improvements in its business and operations (the “Investments”) in order to increase overall capacity to produce various electronic components of the type and part as may be sold by the Company to the Customers from time to time. The Company retains all rights to the production equipment purchased with the funds from the Advances. The Advances from the Customers are being made in quarterly installments (“Installments”) over an expected period of 18 to 24 months from the effective date of the Customer Capacity Agreements, with the amount of each of the Installments based on the costs and expenses that have been incurred, or are reasonably expected to be incurred or committed to be incurred, by the Company in connection with the Investments during the quarter applicable to such Installments. The Advances will be repaid beginning on the date that production from the Investments is sufficient to meet the Company's obligations under the agreements with the Customers. Repayments will be made on a quarterly basis as determined by calculations that generally take into account the number of components purchased by the Customers during the quarter. Repayments based on the calculations will continue until either the Advances are repaid in full, or December 31, 2038 for both Customers. The Company has a quarterly repayment cap in the agreement with each of the Customers and is not required to make any quarterly repayments to the Customers that in the aggregate exceed $1.7 million. If the Customers do not purchase a number of components that would require full repayment of the Advances by December 31, 2038, then the Advances shall be deemed repaid in full. Additionally, if the Customers do not purchase a number of components that would require a payment on the Advances for a period of 16 consecutive quarters, the Advances shall be deemed repaid in full. As of December 31, 2018, the Company has received a total of $9.5 million in Advances from these Customers. Since the debt is non-interest bearing, we have recorded debt discounts on the Advances. These discounts will be amortized over the expected life of the Advances through interest expense. As of December 31, 2018, the Company had $3.1 million in cash that was restricted to be used to fund these Investments. Restricted cash is recorded within “Prepaid expenses and other current assets” in the Condensed Consolidated Balance Sheets. Other Debt In January 2017, KEMET’s wholly-owned subsidiary, KEMET Electronics Portugal, S.A., received the first part of an interest free loan from the Portuguese Government in the amount of EUR 2.2 million (or $2.5 million) to be used for fixed asset purchases. In July 2017, KEMET Electronics Portugal, S.A. received the second part of the loan in the amount of EUR 0.3 million (or $0.3 million). The loan has a total term of eight years ending February 1, 2025. The loan will be repaid through semi-annual payments beginning on August 1, 2019. The first payment will be in the amount of EUR 0.2 million (or $0.2 million) beginning on August 1, 2019 and the remaining payments will be in the amount of EUR 0.2 million (or $0.2 million). Since the debt is non-interest bearing, the Company has recorded a debt discount in the amount of EUR 0.6 million (or $0.7 million) with an offsetting reduction to fixed assets. This discount will be amortized over the life of the loan through interest expense. If certain conditions are met, such as increased headcount, increased revenue, and increased gross value added, a portion of the loan could be forgiven during fiscal year 2020. TOKIN has a a short term borrowing pursuant to an agreement with The 77 Bank Limited, located in Japan, in the amount of 350.0 million Yen (or $3.2 million). This was existing TOKIN debt when the Company purchased TOKIN is fiscal year 2018. The interest rate for the borrowing is the Japanese TIBOR plus 40 basis points. The loan was originally due in September 2018 and was extended to September 2019. The loan agreement automatically renews annually if both parties choose not to terminate or modify it. |
Goodwill and Intangible Assets (Notes) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Text Block] | Goodwill and Intangible Assets The following table highlights the Company’s intangible assets (amounts in thousands):
For each of the three months ended December 31, 2018 and 2017, amortization related to intangibles was $1.1 million, consisting of amortization related to patents of $0.4 million and amortization related to customer relationships of $0.7 million. For each of the nine months ended December 31, 2018 and 2017, amortization related to intangibles was $3.4 million consisting of amortization related to patents of $1.1 million and amortization related to customer relationships of $2.3 million. The weighted-average useful life for patents was 15.8 years as of December 31, 2018 and March 31, 2018, respectively, and 12.3 years for customer relationships as of December 31, 2018 and March 31, 2018, respectively. Estimated amortization of intangible assets for each of the next five fiscal years is $4.5 million, and thereafter, amortization will total $17.5 million. Estimated amortization of patents for each of the next five fiscal years is $1.4 million, and thereafter, amortization will total $7.9 million. Estimated amortization of customer relationships for each of the next five fiscal years is $3.1 million, and thereafter, amortization will total $9.6 million. There were no changes in the carrying amount of goodwill for the nine months ended December 31, 2018. The Company’s goodwill balance was $40.3 million at December 31, 2018 and March 31, 2018. |
(Gain) Loss on Write Down and Disposal of Long-Lived Assets - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Property, Plant and Equipment [Abstract] | ||||
(Gain) loss on write down and disposal of long-lived assets | $ 788 | $ (902) | $ 1,611 | $ (922) |
Restructuring Charges |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring Charges | Restructuring Charges The Company has implemented restructuring plans, which include programs to increase competitiveness by removing excess capacity, relocating production to lower cost locations, relocating corporate functions to the new headquarters, and eliminating unnecessary costs throughout the Company. Significant restructuring plans in progress or recently completed as of December 31, 2018 are summarized below (amounts in thousands):
__________________ (1) Cumulative personnel reduction costs incurred to date are comprised of $3.8 million, $1.2 million, and $0.1 million within the MSA, Corporate, and Solid Capacitors segments, respectively. A summary of the expenses aggregated in the Condensed Consolidated Statements of Operations line item “Restructuring charges” in the three and nine months ended December 31, 2018 and 2017, is as follows (amounts in thousands):
Three Months Ended December 31, 2018 The Company incurred $1.7 million in restructuring charges in the three months ended December 31, 2018 comprised of $1.0 million in personnel reduction costs and $0.8 million in manufacturing relocation and exit costs. The personnel reduction costs of $1.0 million were related to $0.7 million in costs related to headcount reductions in the TOKIN legacy group across various internal and operational functions and $0.3 million in severance charges related to personnel reductions in the Film and Electrolytic segment resulting from a reorganization of the segment's management structure. The manufacturing relocation and exit costs of $0.8 million related to the relocation of axial electrolytic production equipment from the plant in Granna, Sweden to the Company's plant in Evora, Portugal as the Company is in the process of shutting down operations at the Granna plant. Nine Months Ended December 31, 2018 The Company incurred $1.6 million in restructuring charges in the nine months ended December 31, 2018 comprised of $0.9 million in personnel reduction costs and $0.7 million in manufacturing relocation and exit costs. The personnel reduction costs of $0.9 million were primarily related to $0.7 million in costs related to headcount reductions in the TOKIN legacy group across various internal and operational functions and $0.3 million in severance charges related to personnel reductions in the Film and Electrolytic segment resulting from a reorganization of the segment's management structure. The manufacturing relocation and exit costs of $0.7 million were primarily related to the relocation of axial electrolytic production equipment from the plant in Granna, Sweden to the Company's plant in Evora, Portugal. Three Months Ended December 31, 2017 The Company incurred $3.5 million in restructuring charges in the three months ended December 31, 2017 comprised of $3.3 million in personnel reduction costs and $0.3 million in manufacturing relocation and exit costs. The personnel reduction costs of $3.3 million were related to $2.2 million in costs due to a voluntary reduction in force in the Film and Electrolytic segment's Italian operations, $1.0 million in severance charges across various overhead functions in the Simpsonville, South Carolina office as these functions were relocated to the Company's new corporate headquarters in Fort Lauderdale, and $0.1 million in costs related to headcount reductions within the TOKIN legacy group related to a European sales reorganization. The manufacturing relocation and exit costs of $0.3 million primarily consisted of $0.1 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant and $0.1 million in exit costs related to the shut-down of operations for KEMET Foil Manufacturing, LLC (“KFM”) in Knoxville, Tennessee. Nine Months Ended December 31, 2017 The Company incurred $6.5 million in restructuring charges in the nine months ended December 31, 2017 comprised of $4.4 million in personnel reduction costs and $2.1 million in manufacturing relocation and exit costs. The personnel reduction costs of $4.4 million were related to $2.2 million in costs due to a voluntary reduction in force in the Film and Electrolytic segment's Italian operations, $2.1 million in severance charges across various overhead functions in the Simpsonville, South Carolina office as these functions were relocated to the Company's new corporate headquarters in Fort Lauderdale, Florida, and $0.1 million in headcount reductions within the TOKIN legacy group related to a European sales reorganization. The manufacturing relocation and exit costs of $2.1 million primarily consisted of $0.9 million in lease termination penalties related to the relocation of global marketing, finance and accounting, and information technology functions to the Company's Fort Lauderdale, Florida office, $0.8 million in expenses related to the relocation of the K-Salt operations to the existing Matamoros, Mexico plant, $0.4 million in exit costs related to the shut-down of operations for KFM, and $0.1 million related to the transfer of certain Tantalum production from Simpsonville, South Carolina to Victoria, Mexico. Reconciliation of Restructuring Liability A reconciliation of the beginning and ending liability balances for restructuring charges included in the line items “Accrued expenses” and “Other non-current obligations” on the Condensed Consolidated Balance Sheets for the three and nine months ended December 31, 2018 and 2017 is as follows (amounts in thousands):
|
Comprehensive Income (Loss) and Accumulated Other Comprehensive Income |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comprehensive Income (Loss) and Accumulated Other Comprehensive Income | Comprehensive Income (Loss) and Accumulated Other Comprehensive Income Changes in AOCI for the three and nine months ended December 31, 2018 and 2017 include the following components (amounts in thousands):
_________________ (1) Due primarily to the Company’s valuation allowance on deferred tax assets, there were no significant deferred tax effects associated with the cumulative currency translation gains and losses during the three and nine months ended December 31, 2018 and 2017. (2) September 30, 2017, December 31, 2017 and March 31, 2018 were adjusted due to the adoption of ASC 606. (3) Ending balance is net of tax of $2.2 million as of December 31, 2018 and 2017, respectively. (4) Foreign currency translation for both the three and nine months ended December 31, 2018 includes losses of $3.6 million related to a derivative instrument accounted for as a net investment hedge. Refer to Note 13, Derivatives, for further information. (5) Foreign currency translation opening balance adjusted due to fair value adjustments recorded retroactively during the third quarter of fiscal year 2018 related to the TOKIN acquisition. |
Equity Method Investments |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments and Joint Ventures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Investment in NEC TOKIN | The following table provides a reconciliation of equity method investments to the Company's Condensed Consolidated Balance Sheets (amounts in thousands):
TOKIN's Joint Ventures - NYC and NTS NYC was established in 1966 by TOKIN (previously Tohoku Metal Industries Co., Ltd.) and Mitsui Mining and Smelting Co., Ltd (“Mitsui”). NYC was established to commercialize yttrium oxides and the Company owns 30% of NYC's stock. The carrying amount of the Company's equity investment in NYC was $8.1 million at both December 31, 2018 and March 31, 2018. NTS was established in 2004 by TOKIN, however subsequent to its formation, TOKIN sold 67% of its stock. NTS provides world-class electronic devices by utilizing global procurement networks and the Company owns 33% of NTS' stock. During the quarter ended December 31, 2018, a significant portion of NTS' sales were TOKIN’s products. The carrying amount of the Company's equity investment in NTS was $1.1 million and $1.0 million as of December 31, 2018 and March 31, 2018, respectively. Summarized transactions between KEMET and NTS were as follows (amounts in thousands):
Investment in Novasentis In fiscal year 2018, KEMET invested in the Series-D round of funding of Novasentis, a leading developer of film-based haptic actuators. Novasentis produces the world’s thinnest electro mechanical polymer-based actuators that provide rich haptic feedback for a variety of applications, including AR/VR and Wearables. Novasentis supplies its “smart” film and KEMET applies its expertise in manufacturing film capacitors to the development and commercial production of the actuators. The Company's ownership percentage in Novasentis is 25% and has 1 of 3 seats on Novasentis’ board of directors. Additionally, KEMET has an exclusive manufacturing supply agreement, whereby Novasentis will purchase goods exclusively from KEMET and KEMET shall manufacture and sell goods exclusively to Novasentis. While the Company determined that Novasentis is a variable interest entity, the Company concluded that it is not the primary beneficiary of Novasentis. Accordingly, the Company accounts for its investment in Novasentis under the equity method of accounting. The carrying amount of the Company's equity investment in Novasentis was $2.9 million as of both December 31, 2018 and March 31, 2018. As of both December 31, 2018 and March 31, 2018, the Company's maximum exposure to loss in its investment in Novasentis was limited to the carrying amount of its investment. Under the equity method, the Company's share of profits and losses, and impairment charges from equity method investments are included in “Equity income (loss) from equity method investments” in the Condensed Consolidated Statements of Operations. KEMET Jianghai Joint Venture On January 29, 2018, the Company entered into a joint venture agreement with JIANGHAI (Nantong) Film Capacitor Co., Ltd (“Jianghai Film”), a subsidiary of Nantong Jianghai Capacitor Co., Ltd (“Jianghai”) for the formation of KEMET Jianghai, a limited liability company located in Nantong, China. KEMET Jianghai was officially formed on May 16, 2018 to manufacture axial electrolytic capacitors and (H)EV Film DC brick capacitors, for distribution through the KEMET and Jianghai Film sales channels. The Company's ownership percentage is 50% and the Company and Jianghai Film will be equally represented on the joint venture’s board of directors. The Company's initial capital contribution to KEMET Jianghai was made during the second quarter of fiscal year 2019, and the Company accounts for its investment using the equity method due to the related nature of operations and its ability to influence the joint venture's decisions. As of December 31, 2018, the carrying amount of the Company's equity investment in KEMET Jianghai was $0.7 million. |
Segment and Geographic Information |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment and Geographic Information | Segment and Geographic Information The Company is organized into three segments: Solid Capacitors, the Film and Electrolytic segment (“Film and Electrolytic”) and MSA. The segments are responsible for their respective manufacturing sites as well as their research and development efforts. The Company does not allocate corporate indirect selling, general and administrative (“SG&A”) or shared R&D expenses to the segments. Solid Capacitors Solid Capacitors operates in ten manufacturing sites in the United States, Mexico, and Asia, and operates innovation centers in the United States and Japan. Solid Capacitors primarily produces tantalum, aluminum polymer, and ceramic capacitors, which are sold globally. Solid Capacitors also produces tantalum powder used in the production of tantalum capacitors. Film and Electrolytic Film and Electrolytic operates in ten manufacturing sites throughout Europe and Asia, and maintain product innovation centers in Italy, Portugal, and Sweden. Film and Electrolytic primarily produces film, paper, and wet aluminum electrolytic capacitors, which are sold globally. In addition, the Film and Electrolytic segment designs and produces electromagnetic interference filters. MSA MSA operates in four manufacturing sites throughout Asia and operates a product innovation center in Japan. MSA primarily produces electro-magnetically compatible ("EMC") materials and devices, piezo materials and actuators, and various types of sensors, which are sold globally. In the following tables, revenue is disaggregated by primary geographical market, sales channel, and major product lines. The tables also include reconciliations of the disaggregated revenue with the reportable segments for the three and nine months ended December 31, 2018 and 2017 (amounts in thousands):
(1) Three months ended December 31, 2017 adjusted due to the adoption of ASC 606.
(1) Nine months ended December 31, 2017 adjusted due to the adoption of ASC 606. The following table reflects each segment’s operating income (loss), depreciation and amortization expenses, and restructuring charges for the three and nine months ended December 31, 2018 and 2017 (amounts in thousands):
(1) Restructuring charges included in Operating income (loss) are as follows (amounts in thousands). (2) Three and nine months ended December 31, 2017 adjusted due to the adoption of ASC 606.
|
Defined Benefit Pension and Other Postretirement Benefit Plans |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pension and Other Postretirement Benefits Disclosure [Text Block] | Defined Benefit Pension and Other Postretirement Benefit Plans The Company sponsors eleven defined benefit pension plans: six in Europe, one in Singapore, two in Mexico, and two in Japan. The Company funds the pension liabilities in accordance with laws and regulations applicable to those plans. In addition, the Company maintains two frozen post-retirement benefit plans in the United States: health care and life insurance benefits for certain retired United States employees who reached retirement age while working for the Company. The health care plan is contributory, with participants’ contributions adjusted annually. The life insurance plan is non-contributory. Costs recognized for benefit plans are recorded using estimated amounts which may change as actual costs for the fiscal year are determined. The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans for the three months ended December 31, 2018 and 2017 are as follows (amounts in thousands):
The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans for the nine months ended December 31, 2018 and 2017 are as follows (amounts in thousands):
All of the amounts in the tables above, other than service cost, were recorded in the line item "Other (income) expense, net" in our Condensed Consolidated Statements of Operations. In fiscal year 2019, the Company expects to contribute up to $9.0 million to the pension plans, $5.9 million of which has been contributed as of December 31, 2018. For the postretirement benefit plan, the Company’s policy is to pay benefits as costs are incurred. |
Stock-based Compensation |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stock-based Compensation | Stock-Based Compensation As of December 31, 2018, the KEMET Corporation Omnibus Incentive Plan (the “Incentive Plan”), which amended and restated the KEMET Corporation 2014 Amendment and Restatement of the KEMET Corporation 2011 Omnibus Equity Incentive Plan, approved by the Company’s stockholders on August 2, 2017, is the only plan utilized by the Company to issue equity based awards to executives and key employees. Upon adoption of the Incentive Plan, no further awards were permitted to be granted under the Company’s prior plans, including the 1992 Key Employee Stock Option Plan, the 1995 Executive Stock Option Plan, and the 2004 Long-Term Equity Incentive Plan (collectively, the “Prior Plans”). The Incentive Plan has authorized, in the aggregate, the grant of up to 12.2 million shares of the Company’s Common Stock, comprised of 11.4 million shares under the Incentive Plan and 0.8 million shares remaining from the Prior Plans and authorizes the Company to provide equity-based compensation in the form of:
Except as described below, options issued under these plans vest within one to three years and expire ten years from the grant date. Restricted stock and RSUs issued under these plans vest over one to four years, except for RSUs granted to members of the Board of Directors (the “Board”), which vest immediately beginning in fiscal year 2019. The Company grants RSUs to members of the Board, the Chief Executive Officer and key members of management. Once vested and settled, RSUs are converted into restricted stock. For members of the Board and key members of management, such restricted stock cannot be sold until 90 days after termination of service with the Company, or until the individual achieves the targeted ownership under the Company’s stock ownership guidelines, and only to the extent that such ownership level exceeds the target. Compensation expense is recognized over the respective vesting periods. Historically, the Board has approved annual Long Term Incentive Plans (“LTIP”), which cover two year periods and are primarily based upon the achievement of an Adjusted EBITDA range for the two-year period. At the time of the award, the individual plans entitle the participants to receive cash or RSUs, or a combination of both as determined by the Company’s Board. The 2016/2017, 2017/2018, 2018/2019 and 2019/2020 LTIP also awarded RSUs which vest over the course of three years from the anniversary of the establishment of the plan and are not subject to a performance metric. The Company assesses the likelihood of meeting the Adjusted EBITDA financial metric on a quarterly basis and adjusts compensation expense to match expectations. Any related liability is reflected in the line item “Accrued expenses” on the Condensed Consolidated Balance Sheets and any RSU commitment is reflected in the line item “Additional paid-in capital” on the Condensed Consolidated Balance Sheets. During the nine months ended December 31, 2018, 85,956 in non-vested RSUs under the 2017/2018, 2018/2019, and 2019/2020 LTIPs were forfeited by Per-Olof Loof, the Company's prior Chief Executive Officer upon his resignation in December 2018. On May 18, 2018, the Company granted RSUs under the 2019/2020 LTIP with a grant date fair value of $17.86 that vest as follows (amounts in thousands):
(1) RSUs granted include a performance component. Therefore the granted shares shown above are an estimate based upon current performance expectations. The final number of shares granted depends on the achievement of performance metrics. (2) 36,059 in non-vested RSUs under the 2019/2020 LTIP were forfeited by the Company's prior Chief Executive Officer upon his resignation. The following is the vesting schedule of RSUs under each respective LTIP, which vested during the nine months ended December 31, 2018 (shares in thousands):
Restricted stock activity, excluding the LTIP activity discussed above, for the nine months ended December 31, 2018 is as follows (amounts in thousands except fair value):
Vested shares include the acceleration of 275,000 shares related to the April 18, 2018 Amended and Restated Employment Agreement for the former Chief Executive Officer, which amended and restated Mr. Loof's prior employment agreement with the Company dated June 29, 2015. Upon the signing of the Amended and Restated Employment Agreement, certain RSUs previously granted to Mr. Loof on June 29, 2015, totaling 175,000 shares, and on September 6, 2017, totaling 100,000 shares, both of which were scheduled to vest over time, became fully vested. Incremental compensation cost resulting from the modification totaled $1.7 million. The compensation expense associated with stock-based compensation for the three months ended December 31, 2018 and 2017 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
The compensation expense associated with stock-based compensation for the nine months ended December 31, 2018 and 2017 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
In the “Operating activities” section of the Condensed Consolidated Statements of Cash Flows, stock-based compensation expense was treated as an adjustment to Net income (loss) for the nine months ended December 31, 2018, and 2017. There were 72,800 stock options exercised in the nine months ended December 31, 2018 and 705,000 stock options were exercised in the nine months ended December 31, 2017. |
Income Taxes |
9 Months Ended |
---|---|
Dec. 31, 2018 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes During the quarter ended December 31, 2018, the Company recognized $2.6 million of income tax expense, comprised of $2.9 million of income tax expense related to foreign operations, $0.2 million of federal income tax benefit, and $0.1 million of state income tax benefit. During the nine months ended December 31, 2018, the Company recognized $9.2 million of income tax expense, comprised of $9.6 million of income tax expense related to foreign operations and $0.4 million of state income tax benefit. The $9.6 million of income tax expense related to foreign operations includes a $0.6 million benefit related to the settlement of uncertain tax positions. During the quarter ended December 31, 2017, the Company recognized $2.0 million of income tax expense comprised of $2.7 million of income tax expense related to foreign operations and $0.7 million of federal income tax benefit. During the nine months ended December 31, 2017, the Company recognized $6.0 million of income tax expense, comprised of $6.4 million of income tax expense related to foreign operations, $0.5 million of federal income tax benefit, and $0.1 million of state income tax expense. The effective tax rates differ from income taxes recorded using a statutory rate largely due to the relative mix in earnings and losses in various tax jurisdictions and the usage of the net operating losses and reversal of associated valuation allowances previously recorded on the deferred tax assets. Tax Cuts and Jobs Act The Tax Cuts and Jobs Act (the “Act”) was enacted on December 22, 2017. The Act reduced the US federal corporate tax rate from 35% to 21%, required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously tax deferred, and created new taxes on certain foreign-sourced earnings. During the 2018 fiscal year and in the first six months of fiscal year 2019, the Company recorded provisional amounts for certain enactment-date effects of the Act by applying the guidance in SAB 118, because the Company had not yet completed its accounting for all of the tax effects of the Act. Certain provisions of the Act did not impact the Company until the current fiscal year. These provisions include, but are not limited to, the base erosion anti-abuse tax (“BEAT”), the provision designed to tax global intangible low-taxed income (“GILTI”), the foreign-derived intangible income (“FDII”) provision, and the provision designed to limit interest expense deductions. During the quarter ended December 31, 2018, the Company completed its accounting for the enactment-date income tax effects of the Act as the remeasurement period per SAB 118 ended on December 22, 2018. The Company has completed the analysis based on legislative updates relating to the Act currently available. These tax effects related to the one-time transition tax and the reduced corporate tax rate. The Company recognized the below adjustments as a component of income tax expense. One-time Transition Tax The one-time transition tax is based on the Company’s total post-1986 earnings and profits which were previously deferred from U.S. income taxes under U.S. law. In previous periods, the Company recorded provisional amounts for its one-time transition tax liability for each of its foreign subsidiaries, and the amounts were offset by utilizing net operating losses that had been carried forward from prior years. Upon further analysis of the Act and notices and regulations issued and proposed under Internal Revenue Code (“IRC”) Section 965 by the U.S. Department of Treasury and the Internal Revenue Service, the Company finalized its calculations of the transition tax liability during the current reporting period. The final net taxable income the Company reported on its 2018 federal income tax return under IRC Section 965, after allowable deductions under IRC Section 965(c), was $34.3 million. The amount was included as a component of income tax expense and offset by federal net operating loss carryover utilizations, resulting in a net income tax expense of zero. There is no impact to foreign locations. Deferred tax assets and liabilities The Company had initially determined a $0.8 million tax benefit related to the US federal corporate tax rate change to its existing deferred tax balances, which was included as a component of income tax expense for fiscal year 2018. Upon further analysis of certain aspects of the Act and refinement of our calculations, the $0.8 million tax benefit remains unchanged. Global intangible low-taxed income (“GILTI”) The Act subjects a U.S. shareholder to tax on GILTI earned by certain foreign subsidiaries. The Financial Accounting Standards Board (“FASB”) Staff Q&A, Topic 740, No. 5, Accounting for Global Intangible Low-Taxed income, states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years, or to provide for the tax expense related to GILTI in the year the tax is incurred as a period expense. The Company has elected to account for GILTI as a period cost in the year the tax is incurred. At December 31, 2018, the Company has sufficient U.S. net operating loss carryovers to offset the additional taxable income related to the GILTI inclusion during the nine months ended December 31, 2018, resulting in a net income tax expense of zero. Foreign-Derived Intangible Income (“FDII”) The Act provides tax incentives to U.S. companies to earn income from the sale, lease, or license of goods and services abroad in the form of a deduction for foreign-derived intangible income. The tax law limits the amount of the FDII deductions to the U.S. shareholder’s taxable income. At December 31, 2018, the Company estimates to utilize net operating loss carryovers to absorb its taxable income for the fiscal year 2019. As a result, the Company is not estimating any taxable income deduction related to FDII. Base Erosion Anti-Abuse Tax (“BEAT”) Under the Act, an entity must pay a BEAT tax, if the BEAT is greater than its regular tax liability. The BEAT calculation eliminates the deduction of certain payments made to foreign affiliates, referred to as base erosion payments, but applies a lower tax rate on the resulting BEAT income. During the nine months ended December 31, 2018, the Company estimates a tax expense of $0.8 million related to BEAT. The annual BEAT inclusion increased the Company’s annual effective tax rate by 0.7% for the 2019 fiscal year. Interest Expense Deduction Limits The Act limits the deduction for net interest expense incurred by U.S. corporations for amounts that exceed 30% of the corporation’s adjusted taxable income for the year. The adjusted taxable income is computed initially excluding depreciation, amortization, or depletion and includes these items beginning in the year 2022. The Act permits an indefinite carryforward of any disallowed business interest expense. At December 31, 2018, the Company estimates that its net interest expense deduction for the fiscal year 2019 will not be limited. Valuation Allowance of U.S. Group Companies At December 31, 2018, the Company has a valuation allowance against the net deferred tax assets of its U.S. group entities. The Company intends to continue maintaining a full valuation allowance on these deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. However, given its current earnings and anticipated future earnings, the Company believes that there is a reasonable possibility that the U.S. valuation allowance could be released within the next 12 months, as sufficient positive evidence may become available to allow it to reach a conclusion that a significant portion of the valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period in which the release is recorded. However, the exact timing and amount of the valuation allowance release is subject to change on the basis of the level of profitability that that Company is actually able to achieve. |
Basic and Diluted Net Income (Loss) Per Common Share |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Basic and Diluted Net Income (Loss) Per Common Share | Basic and Diluted Net Income (Loss) Per Common Share The following table presents basic earnings per share (“EPS”) and diluted EPS (amounts in thousands, except per share data):
(1) Three and nine months ended December 31, 2017 adjusted due to the adoption of ASC 606. Common stock equivalents that could potentially dilute net income (loss) per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive, are as follows (amounts in thousands):
During the three and nine months ended December 31, 2018 the Company paid cash dividends of 2.9 million to its shareholders. |
Derivatives |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivatives | Derivatives Certain of the Company’s foreign operations expose the Company to fluctuations in currency exchange rates. These fluctuations may impact the value of the Company’s cash payments, assets, and liabilities in terms of the Company’s functional currency. The Company enters into derivative financial instruments to protect the value of certain obligations and its net investment in its TOKIN subsidiary in terms of its functional currency, the U.S. dollar. The Company’s primary exposure to foreign currency exchange rate risk relates to (i) intercompany financings with TOKIN, (ii) its net investment in TOKIN, and (iii) certain operating expenses at the Company’s Mexican facilities. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not utilize derivatives for speculative or other purposes other than currency risk management. The use of derivative financial instruments carries certain risks, including the risk that any counterparty to a contractual arrangement may not be able to perform under the agreement. To mitigate this risk, the Company only enters into derivative financial instruments with a counterparty that is a major financial institution with a high credit rating. The Company does not anticipate that the counterparty will fail to meet its obligations. Each derivative instrument that qualifies for hedge accounting is expected to be highly effective at reducing the risk associated with the exposure being hedged, and the Company monitors each instrument for effectiveness on a quarterly basis. The Company formally documents all relationships between hedging instruments and hedged items, as well as risk management objectives and strategies for undertaking various hedge transactions. Changes in fair value of all its derivative instruments are reported in earnings or in AOCI, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction. The Company records all derivative financial instruments on its Condensed Consolidated Balance Sheets at fair value. Certain of the derivative instruments are subject to master netting agreements and are presented in the Condensed Consolidated Balance Sheets on a net basis. If the Company were to account for the asset and liability balances of those derivative contracts on a gross basis, the amounts presented in the Condensed Consolidated Balance Sheets would be adjusted from the current net presentation to the gross amounts as detailed in the table below. The balance sheet classifications and fair value of derivative instruments designated as hedges as of December 31, 2018 and March 31, 2018 are as follows (amounts in thousands):
Fair Value Hedging Strategy The Company entered into two cross-currency swaps designated as fair value hedges on November 7, 2018 to hedge the foreign currency risk on the Intercompany Loans. These agreements are contracts to exchange floating-rate payments in one currency with floating-rate payments in another currency. These swaps are intended to offset in the same period the remeasurement of the carrying value of the underlying foreign currency Intercompany Loans. Changes in the fair value of these cross-currency swaps due to changes in foreign currency exchange rates are recognized in earnings upon the recognition of the change in the fair value of the hedged intercompany financings. The Company excludes the change in the fair value of these cross-currency swaps due to changes in interest rates from the assessment of hedge effectiveness. Changes in fair value of the swaps associated with changes in interest rates are initially recorded as a component of AOCI and recognized into other (income) expense, net in the Condensed Consolidated Statement of Operations using a systematic and rational method over the instrument’s term. The terms of the two cross-currency swaps designated as fair value hedges are as follows:
The notional value of these contracts were JPY 33.0 billion or $291.9 million at December 31, 2018. Hedges of Net Investments in Foreign Operations Strategy The Company entered into a cross-currency swap designated as a net investment hedge on November 7, 2018 to hedge the JPY currency exposure of the Company’s net investment in TOKIN. This agreement is a contract to exchange fixed-rate payments in one currency for fixed-rate payments in another currency. Changes in the fair value of this swap are recorded in equity as a component of AOCI in the same manner as foreign currency translation adjustments. In assessing the effectiveness of this hedge, the Company uses a method based on changes in spot rates to measure the impact of the foreign currency exchange rate fluctuations on both its foreign subsidiary net investment and the related swap. Under this method, changes in the fair value of the hedging instrument other than those due to changes in the spot rate are initially recorded in AOCI as a translation adjustment, and then are amortized into other (income) expense, net in the Condensed Consolidated Statement of Operations using a systematic and rational method over the instrument’s term. Changes in the fair value associated with the effective portion (i.e. those changes due to the spot rate) are recorded in AOCI as a translation adjustment and are released and recognized in earnings only upon the sale or liquidation of the hedged net investment. The terms of this cross-currency swap are as follows:
The notional value of this contract was JPY 33.0 billion or $291.9 million at December 31, 2018. Cash Flow Hedging Strategy Certain operating expenses at the Company’s Mexican facilities are paid in Mexican Pesos. In order to hedge a portion of these forecasted cash flows, the Company purchases foreign exchange contracts, with terms generally less than twelve months, to buy Mexican Pesos for periods and amounts consistent with underlying cash flow exposures. These contracts are designated as cash flow hedges at inception. Unrealized gains and losses associated with the change in fair value of the foreign exchange contracts are recorded in AOCI. Changes in the derivatives’ fair values are deferred and recorded as a component of AOCI until the underlying transaction is settled and recorded to the Condensed Consolidated Statement of Operations. When the hedged item affects income, gains or losses are reclassified from AOCI to the Condensed Consolidated Statement of Operations as Cost of Sales for foreign exchange contracts to purchase such foreign currency. The notional value of outstanding Peso contracts was $72.2 million and $70.6 million as of December 31, 2018 and March 31, 2018, respectively. Hedging Strategy Impact on Statements of Operations The following tables present gain and loss activity for the three and nine months ended December 31, 2018 and 2017 for derivative instruments designated as hedges (amounts in thousands):
_________________ (1) Amounts recognized in AOCI represent the change in the fair value of the derivative instruments related to the excluded components. Amounts reclassified from AOCI to income represent amortization of excluded components based upon the instruments' periodic coupons. Amounts recorded directly to income represent the change in the fair value of the derivative instruments related to the effective portion of the qualifying hedge. (2) Amounts recognized in AOCI represent the total change in the fair value of the derivative instrument. Amounts recorded to AOCI are recorded within foreign currency translation. Amounts reclassified from AOCI to income represent amortization of excluded components based on the instrument's periodic coupon.. (3) Amounts recognized in AOCI represent the total change in the fair value of the derivative instruments. Amounts reclassified from AOCI to income represent the change in the fair value of the derivative instruments pertaining to the settlement of the qualifying hedged item (effective portion). The following tables present the total amount of each income and expense line item presented in the Statements of Operations in which the results of fair value and cash flow hedges are recorded and the effects of those hedging strategies on income (amounts in thousands):
_________________ (1) Amounts recognized in income includes the change in the fair value of the derivative instruments related to the effective portion of the qualifying hedges and amortization of the excluded components. (2) Net losses of $1.2 million are expected to be reclassified from AOCI into income within the next 12 months. (3) Three and nine months ended December 31, 2017 adjusted due to the adoption of ASC 606. |
Concentrations of Risks |
9 Months Ended |
---|---|
Dec. 31, 2018 | |
Risks and Uncertainties [Abstract] | |
Concentrations of Risks | Concentrations of Risks The Company sells to customers globally. Credit evaluations of its customers’ financial condition are performed periodically, and the Company generally does not require collateral from its customers. One of the Company's customers, TTI, Inc., an electronics distributor, accounted for over 10% of the Company’s net sales for the three and nine months ended December 31, 2018 and 2017. There were no accounts receivable balances from any customer exceeding 10% of gross accounts receivable as of December 31, 2018 and March 31, 2018. Electronics distributors are an important channel in the electronics industry and accounted for 43.4% and 38.9% of the Company's net sales for the three months ended December 31, 2018 and 2017, respectively, and 42.2% and 38.7% for the nine months ended December 31, 2018 and 2017, respectively. As a result of the Company’s concentration of sales to electronics distributors, the Company may experience fluctuations in the Company’s operating results as electronics distributors experience fluctuations in end-market demand and/or adjust their inventory stocking levels. Legal Update In July 2013, TOKIN was named as one of eight defendants in two purported U.S. class action antitrust lawsuits (In Re: Lithium Ion Batteries Antitrust Litigation, 13-MD-02420-YGR, United States District Court, Northern District of California) (the “Battery Class Action Suits”) regarding the sale of lithium ion batteries brought on behalf of direct product purchasers and indirect product purchasers. On March 2, 2018, TOKIN entered into a settlement agreement, which, subject to court approval, provides for the release of TOKIN and its subsidiaries from claims asserted in the Battery Class Action Suits, in consideration of which, TOKIN agreed to pay $2.0 million to the settlement class of indirect product purchasers. TOKIN paid the settlement amount into an escrow account on January 25, 2019. On May 16, 2018, the Court granted final approval to a settlement agreement by which, in consideration of the release of TOKIN and its subsidiaries from claims asserted in the Battery Class Action Suits, TOKIN agreed to pay $4.95 million to the settlement class of direct product purchasers. TOKIN had paid the settlement amount for the settlement class of direct product purchasers on January 18, 2018, prior to receiving the final court approval. Beginning in March 2014, TOKIN and certain of its subsidiaries received inquiries, requests for information and other communications from government authorities in China, the United States, the European Commission, Japan, South Korea, Taiwan, Singapore and Brazil concerning alleged anti-competitive activities within the capacitor industry. On September 2, 2015, the United States Department of Justice announced a plea agreement with TOKIN in which TOKIN agreed to plead guilty to a one-count felony charge of unreasonable restraint of interstate and foreign trade and commerce in violation of Section 1 of the Sherman Act, and to pay a criminal fine of $13.8 million. The plea agreement was approved by the United States District Court, Northern District of California, on January 21, 2016. The fine is payable over five years in six installments of $2.3 million each, plus accrued interest. The first four payments were made in February 2016, January 2017, January 2018, and January 2019, while the next payment is due in January 2020. On December 9, 2015, the Taiwan Fair Trade Commission (“TFTC”) publicly announced that TOKIN would be fined 1.2 billion New Taiwan dollars (“NTD”) (approximately USD $39.6 million) for violations of the Taiwan Fair Trade Act. Subsequently, the TFTC has reduced the fine to NTD 609.1 million (approximately USD $19.8 million). In February 2016, TOKIN commenced an administrative suit in Taiwan, challenging the validity of the amount of the fine. On August 23, 2018, the Taipei High Administrative Court revoked the TFTC decision, finding that the decision had been time-barred by applicable statute. On September 21, 2018, the TFTC filed an appeal against the High Administrative Court's decision. On March 29, 2016, the Japan Fair Trade Commission published an order by which TOKIN was fined JPY 127.2 million (approximately USD $1.1 million) for violation of the Japanese Antimonopoly Act. Payment of the fine was made on October 31, 2016. On July 15, 2016, TOKIN entered into definitive settlement agreements in two antitrust suits filed with the United States District Court, Northern District of California as In re: Capacitors Antitrust Litigation, No. 3:14-cv-03264-JD (the “Capacitor Class Action Suits”). Pursuant to the terms of the settlement, in consideration of the release of TOKIN and its subsidiaries (including TOKIN America, Inc.) from claims asserted in the Capacitor Class Action Suits, TOKIN will pay an aggregate $37.3 million to a settlement class of direct purchasers of capacitors and a settlement class of indirect purchasers of capacitors. Each of the respective class payments is payable in five installments, three of which have been paid on or before their respective due dates of July 29, 2016, May 15, 2017, and May 15, 2018. The fourth payment is due May 15, 2019 and the final payment is due by December 31, 2019. On July 27, 2016, Brazil’s Administrative Council for Economic Defense approved a cease and desist agreement with TOKIN in which TOKIN made a financial contribution of Brazilian Real 0.6 million (approximately USD $0.2 million) to Brazil’s Fund for Defense of Diffuse Rights. On March 21, 2018, the European Commission announced a decision by which TOKIN was fined EUR 8.8 million directly (approximately USD $10.3 million) and EUR 5.0 million (approximately USD $5.9 million) jointly and severally with NEC Corporation, for violation of the competition laws of the European Union. Payment of the fines were made on June 28, 2018. On June 4, 2018, TOKIN filed an appeal with the General Court of the European Union, seeking annulment and/or reduction of the fines. On November 30, 2018, the Korean Fair Trade Commission (“KFTC”) notified TOKIN of its decision to impose an administrative fine on TOKIN of KRW 8.1 billion (approximately USD $7.2 million) for violation of South Korea's Monopoly Regulation and Fair Trade Law. TOKIN filed its appeal of the KFTC's decision with the Seoul High Court on December 28, 2018. TOKIN is required to pay the fine by February 1, 2019, even though an appeal of the decision is currently pending. On December 6, 2018, the Ontario Superior Court of Justice approved a May 30, 2018 definitive settlement agreement with the plaintiffs in the Canadian Complaints (as defined in “Item 3. Legal Proceedings” of the Company's 2018 Form 10-K). Pursuant to the terms of the settlement, in consideration of the release of TOKIN and its subsidiaries (including TOKIN America, Inc.) from claims asserted in the Canadian Complaints, TOKIN paid CAD 2.9 million (approximately USD $2.2 million) to a settlement class of purchasers of aluminum and tantalum electrolytic capacitors and purchasers of products containing such capacitors. The settlement payment was made on June 27, 2018. On July 2, 2018, TOKIN and TOKIN America Inc. were named as two of 20 defendants in a purported U.S. class action antitrust lawsuit, In re: Inductors Antitrust Litigation, No. 5:18-cv-00198-EJD-NC, filed in the United States District Court, Northern District of California, regarding the sale of inductors brought on behalf of direct product purchasers and indirect product purchasers. The complaint alleges violations of Sections 1 and 3 of the Sherman Act, for which it seeks injunctive and equitable relief and money damages. The remaining governmental investigations are continuing at various stages. As of December 31, 2018, TOKIN’s accrual for antitrust and civil litigation claims totaled $48.2 million which is stated in the following line items, “Account payable” ($15.0 million), “Accrued expenses” ($16.7 million) and “Other non-current obligations” ($16.5 million) on the Condensed Consolidated Balance Sheets. This amount includes the best estimate of losses which may result from the ongoing antitrust investigations, civil litigation and claims. However, the actual outcomes could differ from what has been accrued. Additionally, under the terms of the TOKIN Purchase Agreement, KEMET will be responsible for defending all suits brought against TOKIN, paying all expenses and satisfying all judgments to the extent incurred by or rendered against TOKIN arising out of or related to the capacitor antitrust investigations and related litigation described above. |
Subsequent Events (Notes) |
9 Months Ended |
---|---|
Dec. 31, 2018 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events The Company has evaluated events from December 31, 2018 through the date the financial statements were issued and there have not been any subsequent events that require disclosure. |
Basis of Financial Statement Presentation (Policies) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Use of Estimates and Assumptions | Use of Estimates and Assumptions The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, assumptions, and judgments based on historical data and other assumptions that management believes are reasonable. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. In addition, they affect the reported amounts of revenues and expenses during the reporting period. The Company’s judgments are based on management’s assessment as to the effect certain estimates, assumptions, or future trends or events may have on the financial condition and results of operations reported in the unaudited condensed consolidated financial statements. It is important that readers of these unaudited financial statements understand that actual results could differ from these estimates, assumptions, and judgments. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Change in Accounting Policies | Change in Accounting Policies The Company implemented ASC 606, Revenue from Contracts with Customers (“ASC 606”) as of April 1, 2018. As a result, the Company changed its accounting policy for revenue recognition. Except as discussed below, there have not been any other changes to the Company's significant accounting policies since the issuance of the Company's 2018 Annual Report. Research & development The Company previously recognized all research and development (“R&D”) expenses when they were incurred. Under ASC 606, the Company capitalizes a portion of research and development expenses which directly relate to an existing or anticipated contract or specific business opportunity and amortizes them consistently with the pattern of transfer of the goods to which the asset relates. If the expected amortization period is one year or less, the research and development activities are expensed when incurred. Specialized equipment At times, the Company enters into contracts with customers that contain capital arrangements for specialized equipment obtained in order to manufacture products in accordance with customer specifications. The Company may agree to purchase and assemble specific tooling equipment on behalf of the customer and ultimately resell the equipment (and transfer title and control) to the customer. Previously, the Company accumulated such costs on the balance sheet and subsequently applied the receipt of payment from the customer against the asset, thus resulting in no impact to the statement of operations. Under ASC 606, the Company recognizes a distinct performance obligation for the capital arrangement and records the selling price of the equipment as a component of revenue and cost of goods sold at a point in time when the customer obtains control over the asset. Material up-front fees At times, the Company enters into contracts with customers whereby the customer agrees to reimburse the Company for certain manufacturing equipment, capacity expansion, and fulfillment costs required to manufacture product which meets the customer’s required specifications. Previously, the Company recognized the reimbursement revenue in accordance with the contractual reimbursement schedule. Under ASC 606, the Company recognizes material up-front fees as options that provide the customer with a material right to acquire future goods. The Company applies the practical expedient in paragraph 606-10-55-45 and does not estimate the standalone selling price of the option, but instead allocates the transaction price to the optional goods by reference to the goods expected to be provided and the corresponding expected consideration. Accordingly, the revenue is recognized over the longer of the contract period or the estimated length of the product life cycle, which approximates the period during which the customer is expected to benefit. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred Income Taxes | Deferred Income Taxes The Company accounts for income taxes under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. The Company periodically evaluates its net deferred tax assets based on an assessment of historical performance, ability to forecast future events, and the likelihood that the Company will realize the benefits through future taxable income. Valuation allowances are recorded to reduce the net deferred tax assets to the amount that is more likely than not to be realized. For interim reporting purposes, the Company records income taxes based on the expected annual effective income tax rate, taking into consideration global forecasted tax results and the effect of discrete tax events. The Company makes certain estimates and judgments in the calculation for the provision for income taxes, in the resulting tax liabilities, and in the recoverability of deferred tax assets. All deferred tax assets are reported as noncurrent in the Condensed Consolidated Balance Sheets. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Recently Issued Accounting Pronouncements | Recently Issued Accounting Pronouncements In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. This ASU amends the definition of a hosting arrangement and requires a customer in a hosting arrangement that is a service contract to capitalize certain implementation costs as if the arrangement was an internal-use software project. Under this ASU, a customer will apply ASC 350-40 to determine whether to capitalize implementation costs of the cloud computing arrangement that is a service contract or expense them as incurred. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this guidance on the Company’s Condensed Consolidated Financial Statements. In March 2018, the FASB issued ASU No. 2018-05, Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (“SAB”) No. 118. The amendments in this update provide guidance on when to record and disclose provisional amounts for certain income tax effects of the Tax Cuts and Jobs Act (the “Act”). The amendments also require any provisional amounts or subsequent adjustments to be included in net income from continuing operations. Additionally, this ASU discusses required disclosures that an entity must make with regard to the Act. This ASU is effective immediately as new information is available to adjust provisional amounts that were previously recorded. The Company has adopted this standard and has finalized its accounting for the Act. See Note 11, “Income Taxes” for additional information on the Act. In August 2017, the FASB issued ASU No. 2017-12, Targeted Improvements to Accounting for Hedging Activities (“ASU 2017-12”). The ASU amends and simplifies existing guidance in order to allow companies to more accurately present the economic effects of risk management activities in the financial statements. For cash flow hedges existing on the date of adoption, an entity is required to eliminate the separate measurement of ineffectiveness in earnings by means of a cumulative-effect adjustment to accumulated other comprehensive income (“AOCI”) with a corresponding adjustment to the opening balance of retained earnings. ASU 2017-12 becomes effective for fiscal years and interim periods beginning after December 15, 2018 and early adoption is permitted. In the third quarter of fiscal year 2019, the Company entered into new derivative contracts and elected to early adopt the ASU effective as of October 1, 2018. The adoption of the standard did not result in a cumulative-effect adjustment since the Company has not previously had any ineffectiveness associated with its cash flows hedges. In August 2016, the FASB issued ASU No. 2016-15, Statement of Cash Flows (Topic 230) Classification of Certain Cash Receipts and Cash Payments. The update clarifies how cash receipts and cash payments in certain transactions are presented and classified in the statement of cash flows. The effective date of this update is for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2017, with early adoption permitted. The update requires retrospective application to all periods presented but may be applied prospectively if retrospective application is impracticable. The Company adopted this guidance as of April 1, 2018. In connection with the adoption of this ASU, the Company elected to account for distributions received from equity method investees using the nature of distributions approach, under which distributions are classified based on the nature of activity that generated them. The other provisions of this ASU did not have an impact on the Company's Condensed Consolidated Cash Flows. In February 2016, the FASB issued ASU No. 2016-02 (“ASU 2016-02”), Leases, as modified by ASU 2017-03, Transition and Open Effective Date Information, requiring lessees to recognize a right-of-use asset and a lease liability for all leases. The ASU also requires expanded disclosures to help financial statement users better understand the amount, timing, and uncertainty of cash flows arising from leases. The standard is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. In July 2018, the FASB issued an update which provides an additional transition method allowing entities to only apply the new lease standard in the year of adoption. The Company will adopt ASU 2016-02 on April 1, 2019. We are currently collecting the necessary information on our lease population, establishing a new lease accounting process, and designing new internal controls for the new process. The Company continues to assess the potential effects of this ASU, which have not yet been quantified. The Company's assessment, which it expects to substantially complete in the fourth quarter of fiscal year 2019, includes a detailed review of the Company's lease contracts and a comparison of its historical accounting policies and practices to ASC 2016-02. Based on the Company's progress in reviewing its leasing arrangements across all of its business units, the Company expects to recognize a material amount of lease assets and liabilities on its Condensed Consolidated Balance Sheet upon adoption of the standard. This ASU is not expected to have a material effect on the amount of expense recognized in connection with the Company's current practice. For information about the Company's future lease commitments as of March 31, 2018, see Note 15, "Commitments and Contingencies," in the Company's 2018 Form 10-K. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers, which superseded existing accounting standards for revenue recognition and created a single framework. ASU 2014-09 and its amendments were included primarily in ASC 606. The core principle of ASC 606 is that an entity should recognize revenue for the transfer of goods or services equal to an amount that it expects to be entitled to receive for those goods or services. ASC 606 also requires additional disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments. The Company adopted the requirements of ASC 606 effective in the first quarter of fiscal year 2019, using the full retrospective method, which required us to restate each prior reporting period presented. The Company has applied practical expedient ASC 606-10-65-1(f)(3) and notes that all previously reported historical amounts are adjusted for the impact of ASC 606. Adoption of the requirements in ASC 606 impacted our previously reported Condensed Consolidated Balance Sheet as of March 31, 2018, our Condensed Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended December 31, 2017, and the Condensed Consolidated Statement of Cash Flows for the nine months ended December 31, 2017 as follows (amounts in thousands, except per share data): Condensed Consolidated Balance Sheet
Condensed Consolidated Statement of Operations
Condensed Consolidated Statement of Comprehensive Income
Condensed Consolidated Statement of Cash Flows
There are currently no other accounting standards that have been issued that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Measurement | Fair Value Measurement The Company utilizes three levels of inputs to measure the fair value of (a) nonfinancial assets and liabilities that are recognized or disclosed at fair value in the Company’s Condensed Consolidated Financial Statements on a recurring basis (at least annually) and (b) all financial assets and liabilities. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The first two inputs are considered observable and the last is considered unobservable. The levels of inputs are as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inventories | Inventories Inventories are stated at the lower of cost or net realizable value. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | Revenue Recognition The Company recognizes revenue under the guidance provided in ASC 606. Consistent with the terms of ASC 606, the Company records revenue on product sales in the period in which the Company satisfies its performance obligation by transferring control over a product to a customer. The amount of revenue recognized reflects the consideration the Company expects to receive in exchange for transferring products to a customer. The Company has elected the practical expedient under ASC 606-10-32-18 and does not consider the effects of a financing component on the promised amount of consideration because the period between when the Company transfers a product to a customer and when the customer pays for that product is one year or less. As performance obligations are expected to be fulfilled in one year or less, the Company has elected the practical expedient under ASC 606-10-50-14 and has not disclosed information relating to remaining performance obligations. The Company sells its products to distributors, original equipment manufacturers (“OEM”), and electronic manufacturing services providers (“EMS”), and the sales price may include adjustments for sales discounts, price adjustments, and sales allowances. The Company has elected the practical expedient under ASC 606-10-10-4 and evaluates these sales-related adjustments on a portfolio basis. The principle forms of these adjustments include:
The Company's inventory price protection and SFSD programs provide authorized distributors with the flexibility to meet marketplace prices by allowing them, upon a pre-approved case-by-case basis, to adjust their purchased inventory cost to correspond with current market demand. Requests for SFSD adjustments are considered on an individual basis, require a pre-approved cost adjustment quote from their local KEMET sales representative, and apply only to a specific customer, part, specified special price amount, specified quantity, and are only valid for a specific period of time. To estimate potential SFSD adjustments corresponding with current period sales, KEMET records a sales reserve based on historical SFSD credits, distributor inventory levels, and certain accounting assumptions, all of which are reviewed quarterly. Select distributors have the right to return a certain portion of their purchased inventory to KEMET from the previous fiscal quarter. The Company estimates future returns based on historical return patterns and records a corresponding right of return asset and refund liability as a component of the line items, “Inventories, net” and “Accrued expenses,” respectively, on the Condensed Consolidated Balance Sheets. The Company also offers volume based rebates on a case-by-case basis to certain customers in each of the Company’s sales channels. The Company's sales allowances are recognized as a reduction in the line item “Net sales” on the Condensed Consolidated Statements of Operations, while the associated reserves are included in the line item “Accounts receivable, net” on the Condensed Consolidated Balance Sheets. Estimates used in determining sales allowances are subject to various factors. This includes, but is not limited to, changes in economic conditions, pricing changes, product demand, inventory levels in the supply chain, the effects of technological change, and other variables that might result in changes to the Company’s estimates. The Company provides a limited assurance warranty on products that meet certain specifications to select customers. The warranty coverage period is generally limited to one year for United States based customers and a length of time commensurate with regulatory requirements or industry practice outside the United States. A warranty cannot be purchased by the customer separately and, as a result, product warranties are not considered to be separate performance obligations. The Company’s liability under these warranties is generally limited to a replacement of the product or refund of the purchase price of the product. Warranty costs were not material for the three and nine months ended December 31, 2018 and 2017. Shipping and handling costs are included in cost of sales. Disaggregation of Revenue Refer to Note 8, “Segment and Geographic Information” for revenue disaggregated by primary geographical market, sales channel, and major product line. Contract liabilities Contract liabilities consist of advance payments from certain customers within the OEM channel for the development of additional production capacity. The current and noncurrent portions of these liabilities are included as a component of the line items, “Accrued expenses” and “Other non-current obligations,” respectively, on the Condensed Consolidated Balance Sheets. The balance of net contract liabilities consisted of the following at December 31, 2018 and March 31, 2018 (amounts in thousands):
In the three and nine months ended December 31, 2018, the Company recognized revenue of $0.1 million and $0.2 million related to contract liabilities at March 31, 2018. In the three and nine months ended December 31, 2017, the Company recognized revenue of $0.1 million and $0.2 million related to contract liabilities at March 31, 2017. Revenue related to contract liabilities is recorded on the Condensed Consolidated Statements of Operations line item, "Net sales." Contract assets The Company recognizes an asset from the costs incurred to fulfill a contract if those costs directly relate to an existing or anticipated contract or specific business opportunity, if the costs enhance our own resources that will be used in satisfying performance obligations in the future, and the costs are expected to be recovered through subsequent sale of product to the customer. The Company has determined that certain direct labor, materials, and allocations of overhead incurred within research and development activities meet the requirements to be capitalized. As most of our contracts and customer specific business opportunities do not include a stated term, the Company amortizes these capitalized costs over the expected product life cycle, which is consistent with the estimated transfer of goods to the customer. Capitalized contract costs were $1.7 million and $2.2 million at December 31, 2018 and March 31, 2018, respectively. Capitalized contracts costs are recorded on the Condensed Consolidated Balance Sheets in the line item, “Other assets.” Amortization expense related to the contract costs was $0.2 million and $0.6 million for the three and nine months ended December 31, 2018, respectively, and $0.2 million and $0.7 million for the three and nine months ended December 31, 2017, respectively. There was no impairment loss in relation to the costs capitalized for the three and nine months ended December 31, 2018 and 2017. Amortization expense related to contract assets is recorded on the Condensed Consolidated Statements of Operations line item "Cost of sales." |
Basis of Financial Statement Presentation (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Contract with customer, asset and liability | The balance of net contract liabilities consisted of the following at December 31, 2018 and March 31, 2018 (amounts in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of assets and liabilities measured at fair value on a recurring basis | Assets and liabilities measured at fair value on a recurring basis as of December 31, 2018 and March 31, 2018 are as follows (amounts in thousands):
(1) Included in the line item “Cash and cash equivalents” on the Condensed Consolidated Balance Sheets. (2) Certificates of Deposit of $35.4 million and $33.9 million that mature in three months of less are included within the balance as of December 31, 2018 and March 31, 2018, respectively. (3) Derivative assets and liabilities fair value was determined by using a third-party matrix-pricing model that uses significant inputs derived from or corroborated by observable market data. Where applicable, these models discount future cash flow amounts using market-based observable inputs, including interest rate yield curves, and forward and spot prices for currencies. For Total debt, the valuation approach used to calculate fair value was a discounted cash flow based on the current market rate. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of inventories | Inventories are stated at the lower of cost or net realizable value. The components of inventories are as follows (amounts in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of new accounting pronouncements and changes in accounting principles | Adoption of the requirements in ASC 606 impacted our previously reported Condensed Consolidated Balance Sheet as of March 31, 2018, our Condensed Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended December 31, 2017, and the Condensed Consolidated Statement of Cash Flows for the nine months ended December 31, 2017 as follows (amounts in thousands, except per share data): Condensed Consolidated Balance Sheet
Condensed Consolidated Statement of Operations
Condensed Consolidated Statement of Comprehensive Income
Condensed Consolidated Statement of Cash Flows
|
Debt (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Debt | A summary of debt is as follows (amounts in thousands):
(1) Amount shown is net of discount, bank issuance costs, and other indirect issuance costs of $13.3 million as of March 31, 2018 . (2) Amount shown is net of discount, bank issuance costs, and other indirect issuance costs of $9.1 million as of December 31, 2018. (3) Amount shown is net of discount of $0.6 million at December 31, 2018. (4) Amounts are shown net of discounts of $0.4 million and $0.5 million at December 31, 2018 and March 31, 2018, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of line item Interest expense on the Condensed Consolidated Statements of Operations | The line item “Interest expense” on the Condensed Consolidated Statements of Operations for the three and nine months ended December 31, 2018 and 2017, consists of the following (amounts in thousands):
|
Goodwill and Intangible Assets (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Intangible Assets and Goodwill [Table Text Block] | The following table highlights the Company’s intangible assets (amounts in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Goodwill [Table Text Block] | There were no changes in the carrying amount of goodwill for the nine months ended December 31, 2018. |
Restructuring Charges (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restructuring and Related Activities [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of the expenses aggregated on the Condensed Consolidated Statements of Operations line item "Restructuring charges" | A summary of the expenses aggregated in the Condensed Consolidated Statements of Operations line item “Restructuring charges” in the three and nine months ended December 31, 2018 and 2017, is as follows (amounts in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation of the beginning and ending liability balances for restructuring charges included in the line items Accrued expenses and Other non-current obligations on the Condensed Consolidated Balance Sheets | A reconciliation of the beginning and ending liability balances for restructuring charges included in the line items “Accrued expenses” and “Other non-current obligations” on the Condensed Consolidated Balance Sheets for the three and nine months ended December 31, 2018 and 2017 is as follows (amounts in thousands):
|
Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of changes in Accumulated Other Comprehensive Income (Loss) | Changes in AOCI for the three and nine months ended December 31, 2018 and 2017 include the following components (amounts in thousands):
_________________ (1) Due primarily to the Company’s valuation allowance on deferred tax assets, there were no significant deferred tax effects associated with the cumulative currency translation gains and losses during the three and nine months ended December 31, 2018 and 2017. (2) September 30, 2017, December 31, 2017 and March 31, 2018 were adjusted due to the adoption of ASC 606. (3) Ending balance is net of tax of $2.2 million as of December 31, 2018 and 2017, respectively. (4) Foreign currency translation for both the three and nine months ended December 31, 2018 includes losses of $3.6 million related to a derivative instrument accounted for as a net investment hedge. Refer to Note 13, Derivatives, for further information. (5) Foreign currency translation opening balance adjusted due to fair value adjustments recorded retroactively during the third quarter of fiscal year 2018 related to the TOKIN acquisition. |
Equity Method Investments (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation between NEC TOKIN's net loss and KEMET's equity investment loss | The following table provides a reconciliation of equity method investments to the Company's Condensed Consolidated Balance Sheets (amounts in thousands):
|
Segment and Geographic Information (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of business group's net sales, operating income (loss), depreciation and amortization expenses and sales by region | in four manufacturing sites throughout Asia and operates a product innovation center in Japan. MSA primarily produces electro-magnetically compatible ("EMC") materials and devices, piezo materials and actuators, and various types of sensors, which are sold globally. In the following tables, revenue is disaggregated by primary geographical market, sales channel, and major product lines. The tables also include reconciliations of the disaggregated revenue with the reportable segments for the three and nine months ended December 31, 2018 and 2017 (amounts in thousands):
(1) Three months ended December 31, 2017 adjusted due to the adoption of ASC 606.
(1) Nine months ended December 31, 2017 adjusted due to the adoption of ASC 606. The following table reflects each segment’s operating income (loss), depreciation and amortization expenses, and restructuring charges for the three and nine months ended December 31, 2018 and 2017 (amounts in thousands):
(1) Restructuring charges included in Operating income (loss) are as follows (amounts in thousands). (2) Three and nine months ended December 31, 2017 adjusted due to the adoption of ASC 606.
|
Defined Benefit Pension and Other Postretirement Benefit Plans (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement Benefits [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of components of net periodic benefit (income) costs relating to pension and other postretirement benefit plans | The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans for the three months ended December 31, 2018 and 2017 are as follows (amounts in thousands):
The components of net periodic benefit (income) costs relating to the Company’s pension and other postretirement benefit plans for the nine months ended December 31, 2018 and 2017 are as follows (amounts in thousands):
All of the amounts in the tables above, other than service cost, were recorded in the line item "Other (income) expense, net" in our Condensed Consolidated Statements of Operations. |
Stock-based Compensation (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity | On May 18, 2018, the Company granted RSUs under the 2019/2020 LTIP with a grant date fair value of $17.86 that vest as follows (amounts in thousands):
(1) RSUs granted include a performance component. Therefore the granted shares shown above are an estimate based upon current performance expectations. The final number of shares granted depends on the achievement of performance metrics. (2) 36,059 in non-vested RSUs under the 2019/2020 LTIP were forfeited by the Company's prior Chief Executive Officer upon his resignation. The following is the vesting schedule of RSUs under each respective LTIP, which vested during the nine months ended December 31, 2018 (shares in thousands):
Restricted stock activity, excluding the LTIP activity discussed above, for the nine months ended December 31, 2018 is as follows (amounts in thousands except fair value):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of the compensation expense (recovery) associated with stock-based compensation | The compensation expense associated with stock-based compensation for the three months ended December 31, 2018 and 2017 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
The compensation expense associated with stock-based compensation for the nine months ended December 31, 2018 and 2017 is recorded on the Condensed Consolidated Statements of Operations as follows (amounts in thousands):
|
Basic and Diluted Net Income (Loss) Per Common Share (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of basic EPS and diluted EPS | The following table presents basic earnings per share (“EPS”) and diluted EPS (amounts in thousands, except per share data):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of common stock equivalents that could potentially dilute net income (loss) per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been antidilutive | Common stock equivalents that could potentially dilute net income (loss) per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been anti-dilutive, are as follows (amounts in thousands):
|
Derivatives (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The balance sheet classifications and fair value of derivative instruments designated as hedges as of December 31, 2018 and March 31, 2018 are as follows (amounts in thousands):
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gain (Loss) for Derivative Instruments Designated as Hedges | The following tables present gain and loss activity for the three and nine months ended December 31, 2018 and 2017 for derivative instruments designated as hedges (amounts in thousands):
_________________ (1) Amounts recognized in AOCI represent the change in the fair value of the derivative instruments related to the excluded components. Amounts reclassified from AOCI to income represent amortization of excluded components based upon the instruments' periodic coupons. Amounts recorded directly to income represent the change in the fair value of the derivative instruments related to the effective portion of the qualifying hedge. (2) Amounts recognized in AOCI represent the total change in the fair value of the derivative instrument. Amounts recorded to AOCI are recorded within foreign currency translation. Amounts reclassified from AOCI to income represent amortization of excluded components based on the instrument's periodic coupon.. (3) Amounts recognized in AOCI represent the total change in the fair value of the derivative instruments. Amounts reclassified from AOCI to income represent the change in the fair value of the derivative instruments pertaining to the settlement of the qualifying hedged item (effective portion). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value and Cash Flow Hedges Included in Earnings | The following tables present the total amount of each income and expense line item presented in the Statements of Operations in which the results of fair value and cash flow hedges are recorded and the effects of those hedging strategies on income (amounts in thousands):
_________________ (1) Amounts recognized in income includes the change in the fair value of the derivative instruments related to the effective portion of the qualifying hedges and amortization of the excluded components. (2) Net losses of $1.2 million are expected to be reclassified from AOCI into income within the next 12 months. (3) Three and nine months ended December 31, 2017 adjusted due to the adoption of ASC 606. |
Basis of Financial Statement Presentation - Revenue Recognition Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||
Period of product warranty | 1 year | ||||
Contracts with customers, revenues recognized | $ 0.1 | $ 0.1 | $ 0.2 | $ 0.2 | |
Capitalized contract costs | 1.7 | 1.7 | $ 2.2 | ||
Capitalized contract cost, amortization | $ 0.2 | $ 0.2 | $ 0.6 | $ 0.7 |
Basis of Financial Statement Presentation - Disaggregation of Revenue (Details) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Contract liabilities - current (Accrued expenses) | $ 256 | $ 256 |
Contract liabilities - noncurrent (Other non-current obligations) | 320 | 513 |
Total contract liabilities | $ 576 | $ 769 |
Basis of Financial Statement Presentation - Contract Liabilities (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | |||
---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||
Contracts with customers, revenues recognized | $ 0.1 | $ 0.1 | $ 0.2 | $ 0.2 | |
Capitalized contract costs | 1.7 | 1.7 | $ 2.2 | ||
Capitalized contract cost, amortization | $ 0.2 | $ 0.2 | $ 0.6 | $ 0.7 |
Basis of Financial Statement Presentation - Fair Value Measurements (Details) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
---|---|---|
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money markets, Carrying Value | $ 63,701 | $ 83,891 |
Total debt, Carrying Value | (305,676) | (324,623) |
Certificates of Deposit, at carrying value | 35,400 | 33,900 |
Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Total debt, Fair Value | (315,905) | (343,125) |
Level 1 | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Instruments in Hedges, Assets, at Fair Value | 0 | 0 |
Derivative Liability | 0 | 0 |
Total debt, Fair Value | 0 | 0 |
Level 2 | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Instruments in Hedges, Assets, at Fair Value | 4,951 | |
Derivative Liability | (4,273) | 0 |
Total debt, Fair Value | (315,905) | (343,125) |
Level 3 | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Derivative Instruments in Hedges, Assets, at Fair Value | 0 | 0 |
Derivative Liability | 0 | 0 |
Total debt, Fair Value | 0 | 0 |
Money markets | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money markets, Fair Value Measurement | 63,701 | 83,891 |
Money markets | Level 1 | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money markets, Fair Value Measurement | 63,701 | 83,891 |
Money markets | Level 2 | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money markets, Fair Value Measurement | 0 | 0 |
Money markets | Level 3 | Recurring | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Money markets, Fair Value Measurement | $ 0 | $ 0 |
Basis of Financial Statement Presentation - Inventory (Details) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
---|---|---|
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Raw materials and supplies | $ 95,023 | $ 88,408 |
Work in process | 68,464 | 65,417 |
Finished goods | 86,556 | 66,907 |
Subtotal | 250,043 | 220,732 |
Inventory reserves | (16,706) | (16,346) |
Inventories, net | $ 233,337 | $ 204,386 |
Basis of Financial Statement Presentation - ASC 606 Adjustments Balance Sheets (Details) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
|||
---|---|---|---|---|---|
Assets | |||||
Account receivable, net | [1] | $ 147,848 | $ 146,561 | ||
Total current assets | [1] | 655,838 | 678,953 | ||
Other assets | [1] | 17,107 | 12,600 | ||
Total assets | [1] | 1,231,257 | 1,222,923 | ||
Liabilities and Stockholders' Equity | |||||
Accrued expenses | [1] | 98,279 | 125,119 | ||
Total current liabilities | [1] | 274,797 | 287,658 | ||
Deferred Tax Liabilities, Net, Noncurrent | [1] | 14,911 | 15,058 | ||
Other non-current obligations | [1] | 125,856 | 152,249 | ||
Total liabilities | [1] | 692,824 | 759,048 | ||
Retained earnings (deficit) | [1] | 113,664 | 3,370 | ||
Accumulated other comprehensive income (loss) | [1] | (38,691) | (2,798) | ||
Total stockholders’ equity | [1] | 538,433 | 463,875 | ||
Total liabilities and stockholders’ equity | [1] | $ 1,231,257 | 1,222,923 | ||
As Previously Reported | |||||
Assets | |||||
Account receivable, net | 144,076 | ||||
Total current assets | 676,468 | ||||
Other assets | 10,431 | ||||
Total assets | 1,218,269 | ||||
Liabilities and Stockholders' Equity | |||||
Accrued expenses | 122,377 | ||||
Total current liabilities | 284,916 | ||||
Deferred income taxes | 14,571 | ||||
Other non-current obligations | 151,736 | ||||
Total liabilities | 755,306 | ||||
Retained earnings (deficit) | 2,675 | ||||
Accumulated other comprehensive income (loss) | (3,015) | ||||
Total stockholders’ equity | 462,963 | ||||
Total liabilities and stockholders’ equity | 1,218,269 | ||||
ASC 606 Adjustments | ASC 606 Adjustments | |||||
Assets | |||||
Account receivable, net | 2,485 | ||||
Total current assets | 2,485 | ||||
Other assets | 2,169 | ||||
Total assets | 4,654 | ||||
Liabilities and Stockholders' Equity | |||||
Accrued expenses | 2,742 | ||||
Total current liabilities | 2,742 | ||||
Deferred income taxes | 487 | ||||
Other non-current obligations | 513 | ||||
Total liabilities | 3,742 | ||||
Retained earnings (deficit) | 695 | ||||
Accumulated other comprehensive income (loss) | 217 | ||||
Total stockholders’ equity | 912 | ||||
Total liabilities and stockholders’ equity | $ 4,654 | ||||
|
Basis of Financial Statement Presentation - ASC 606 Adjustment Statement of Operations (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||
Net sales | [1] | $ 350,175 | $ 306,576 | $ 1,027,024 | $ 882,090 | ||||
Operating costs and expenses: | |||||||||
Cost of sales | [1] | 226,425 | 214,288 | 694,888 | 630,781 | ||||
Research and development | 11,357 | 9,907 | 33,040 | 28,690 | |||||
Operating Income (Loss) | [1] | 61,616 | 32,002 | 146,792 | 91,206 | ||||
Income tax expense | [1] | 2,600 | 2,037 | 9,200 | 6,041 | ||||
Net income (loss) | [1],[2] | $ 40,806 | $ 18,589 | $ 113,167 | $ 251,847 | ||||
Net income (loss) per basic share (in usd per share) | $ 0.70 | $ 0.33 | $ 1.96 | $ 4.91 | |||||
Earnings Per Share, Diluted | $ 0.69 | $ 0.32 | $ 1.91 | $ 4.31 | |||||
As Previously Reported | |||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||
Net sales | $ 306,408 | $ 881,879 | |||||||
Operating costs and expenses: | |||||||||
Cost of sales | 213,947 | 629,905 | |||||||
Research and development | 10,005 | 29,057 | |||||||
Operating Income (Loss) | 32,077 | 91,504 | |||||||
Income tax expense | 2,060 | 6,090 | |||||||
Net income (loss) | 18,641 | 252,096 | |||||||
ASC 606 Adjustments | ASC 606 Adjustments | |||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||
Net sales | 168 | 211 | |||||||
Operating costs and expenses: | |||||||||
Cost of sales | 341 | 876 | |||||||
Research and development | (98) | (367) | |||||||
Operating Income (Loss) | (75) | (298) | |||||||
Income tax expense | (23) | (49) | |||||||
Net income (loss) | $ (52) | $ (249) | |||||||
|
Basis of Financial Statement Presentation - ASC 606 Adjustment Other Comprehensive Income (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||
Net income (loss) | [1],[2] | $ 40,806 | $ 18,589 | $ 113,167 | $ 251,847 | ||||
Foreign currency translation gains (losses) | [2] | (5,152) | 6,516 | (32,504) | 20,481 | ||||
Other comprehensive income (loss) | [2] | (9,483) | 1,281 | (35,893) | 19,095 | ||||
Total comprehensive income (loss) | [2] | $ 31,323 | 19,870 | $ 77,274 | 270,942 | ||||
As Previously Reported | |||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||
Net income (loss) | 18,641 | 252,096 | |||||||
Foreign currency translation gains (losses) | 6,503 | 20,301 | |||||||
Other comprehensive income (loss) | 1,268 | 18,915 | |||||||
Total comprehensive income (loss) | 19,909 | 271,011 | |||||||
ASC 606 Adjustments | ASC 606 Adjustments | |||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||
Net income (loss) | (52) | (249) | |||||||
Foreign currency translation gains (losses) | 13 | 180 | |||||||
Other comprehensive income (loss) | 13 | 180 | |||||||
Total comprehensive income (loss) | $ (39) | $ (69) | |||||||
|
Basis of Financial Statement Presentation - ASC 606 Adjustment Cash Flow (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
||||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||||||
Net income (loss) | [1],[2] | $ 40,806 | $ 18,589 | $ 113,167 | $ 251,847 | ||||||||
Depreciation and amortization | $ 12,763 | 11,353 | 38,405 | [3] | 37,366 | [3] | |||||||
Change in deferred income taxes | [3] | 1,395 | (3,792) | ||||||||||
Change in operating assets | [3] | (42,130) | 25,820 | ||||||||||
Change in operating liabilities | [3] | (61,485) | (26,258) | ||||||||||
Other | 472 | 582 | |||||||||||
Net cash provided by (used in) operating activities | [3] | 82,727 | 82,783 | ||||||||||
Effect of foreign currency fluctuations on cash | [3] | $ (7,236) | 3,017 | ||||||||||
As Previously Reported | |||||||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||||||
Net income (loss) | 18,641 | 252,096 | |||||||||||
Depreciation and amortization | 36,694 | ||||||||||||
Change in deferred income taxes | (3,792) | ||||||||||||
Change in operating assets | 26,296 | ||||||||||||
Change in operating liabilities | (26,316) | ||||||||||||
Other | 499 | ||||||||||||
Net cash provided by (used in) operating activities | 82,695 | ||||||||||||
Effect of foreign currency fluctuations on cash | 3,105 | ||||||||||||
ASC 606 Adjustments | ASC 606 Adjustments | |||||||||||||
Revenue, Initial Application Period Cumulative Effect Transition [Line Items] | |||||||||||||
Net income (loss) | $ (52) | (249) | |||||||||||
Depreciation and amortization | 672 | ||||||||||||
Change in deferred income taxes | 0 | ||||||||||||
Change in operating assets | (476) | ||||||||||||
Change in operating liabilities | 58 | ||||||||||||
Other | 83 | ||||||||||||
Net cash provided by (used in) operating activities | 88 | ||||||||||||
Effect of foreign currency fluctuations on cash | $ (88) | ||||||||||||
|
Acquisitions (Details) $ in Thousands, ¥ in Billions |
3 Months Ended | 9 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 19, 2017
USD ($)
Rate
|
Apr. 19, 2017
JPY (¥)
Rate
|
Dec. 31, 2018
USD ($)
manufacturing_site
|
Dec. 31, 2017
USD ($)
Rate
|
Dec. 31, 2018
USD ($)
manufacturing_site
|
Dec. 31, 2017
USD ($)
Rate
|
Dec. 31, 2017
JPY (¥)
Rate
|
Sep. 30, 2017
Rate
|
Apr. 14, 2017
USD ($)
|
Apr. 14, 2017
JPY (¥)
|
Mar. 31, 2017
Rate
|
|
Business Acquisition [Line Items] | |||||||||||
Foreign Currency Exchange Rate, Translation | Rate | 10900.70% | 10900.70% | 11257.40% | 11257.40% | 11257.40% | 11250.20% | 11182.30% | ||||
Equity income (loss) from equity method investments | $ (296) | $ 238 | $ (301) | $ 75,879 | |||||||
Acquisition (gain) loss | $ 0 | (310) | $ 0 | (137,183) | |||||||
Business Acquisition Cost of Acquired Entity Working Capital Adjustment | 0 | 0 | ¥ 0.3 | ||||||||
KEC [Member] | TOKIN [Member] | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Equity Method Investment, Ownership Percentage | 100.00% | 100.00% | |||||||||
Business Acquisition, Percentage of Voting Interests Acquired | 66.00% | 66.00% | |||||||||
Payments to Acquire Businesses, Gross | $ 148,600 | ¥ 16.2 | |||||||||
TOKIN [Member] | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Number of Manufacturing Sites | manufacturing_site | 6 | 6 | |||||||||
Disposal Group, Including Discontinued Operation, Consideration | $ 10,100 | $ 10,100 | ¥ 1.1 | $ 431,000 | ¥ 48.2 | ||||||
Stock Purchase Agreement [Member] | NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member] | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Equity Method Investment, Ownership Percentage | 34.00% | 34.00% | |||||||||
Excess cash [Member] | KEC [Member] | TOKIN [Member] | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Payments to Acquire Businesses, Gross | 93,600 | 10.2 | |||||||||
Cash Distribution [Member] | KEC [Member] | TOKIN [Member] | |||||||||||
Business Acquisition [Line Items] | |||||||||||
Payments to Acquire Businesses, Gross | $ 55,000 | ¥ 6.0 |
Debt (Details) € in Thousands, $ in Thousands, ¥ in Millions |
1 Months Ended | 3 Months Ended | 9 Months Ended | 96 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 07, 2018
USD ($)
|
Sep. 01, 2017
USD ($)
|
Sep. 01, 2017
JPY (¥)
|
Jul. 31, 2017
EUR (€)
|
Jul. 31, 2017
USD ($)
|
Jan. 31, 2017
EUR (€)
|
Jan. 31, 2017
USD ($)
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
Rate
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
Rate
|
Feb. 01, 2025
EUR (€)
|
Feb. 01, 2025
USD ($)
|
Nov. 07, 2018
USD ($)
|
Mar. 31, 2018
USD ($)
|
Jul. 01, 2017
EUR (€)
|
Jul. 01, 2017
USD ($)
|
May 02, 2016
USD ($)
|
|
Debt | ||||||||||||||||||
Gain (Loss) on Extinguishment of Debt | $ (15,988) | $ (486) | ||||||||||||||||
Long-term Debt | $ 305,676 | 305,676 | $ 324,623 | |||||||||||||||
Debt, Long-term and Short-term, Combined Amount [Abstract] | ||||||||||||||||||
Revolving line of credit | 0 | 0 | ||||||||||||||||
Current maturities | (28,416) | (28,416) | (20,540) | |||||||||||||||
Total long-term debt | 277,260 | 277,260 | 304,083 | |||||||||||||||
Interest expense | ||||||||||||||||||
Contractual interest expense | 4,034 | $ 6,680 | 17,775 | 23,762 | ||||||||||||||
Capitalized interest | (41) | (41) | (161) | (80) | ||||||||||||||
Amortization of debt issuance costs | 53 | 98 | 262 | 410 | ||||||||||||||
Amortization of debt (premium) discount | 383 | 570 | 780 | 1,326 | ||||||||||||||
Imputed interest on acquisition-related obligations | 14 | 28 | 43 | 84 | ||||||||||||||
Interest expense on capital lease | 37 | 72 | 104 | 230 | ||||||||||||||
Total interest expense | 4,480 | 7,407 | 18,803 | 25,732 | ||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Restricted Cash | 3,134 | $ 0 | 3,134 | $ 0 | ||||||||||||||
Second part of loan | € 300 | $ 300 | ||||||||||||||||
Term Loan Facility | ||||||||||||||||||
Debt | ||||||||||||||||||
Long-term Debt | 291,152 | 291,152 | 0 | |||||||||||||||
Debt Issuance Costs, Net | (9,100) | (9,100) | ||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Interest payable | 1,000 | 1,000 | ||||||||||||||||
Advanced Payment from Original Equipment Manufacturer [Member] | ||||||||||||||||||
Debt | ||||||||||||||||||
Long-term Debt | 8,870 | 8,870 | 0 | |||||||||||||||
Debt Issuance Costs, Net | (600) | (600) | ||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Proceeds from Issuance of Debt | $ 9,500 | |||||||||||||||||
Advanced Payment from Original Equipment Manufacturer [Member] | Line of Credit [Member] | ||||||||||||||||||
Debt | ||||||||||||||||||
Line of Credit Facility, Maximum Borrowing Capacity | 66,000 | 66,000 | ||||||||||||||||
Term Loan Credit Agreement | ||||||||||||||||||
Debt | ||||||||||||||||||
Gain (Loss) on Extinguishment of Debt | 16,000 | |||||||||||||||||
Long-term Debt | 0 | 0 | $ 323,400 | 318,782 | ||||||||||||||
Debt Issuance Costs, Net | (13,300) | |||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Interest payable | 200 | |||||||||||||||||
Revolving Credit Facility [Member] | ||||||||||||||||||
Line of Credit Facility [Abstract] | ||||||||||||||||||
Current borrowing capacity | $ 75,000 | |||||||||||||||||
Remaining borrowing capacity | 62,400 | 62,400 | ||||||||||||||||
Other Debt Obligations [Member] | ||||||||||||||||||
Debt | ||||||||||||||||||
Long-term Debt | 5,654 | 5,654 | 5,841 | |||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Proceeds from Issuance of Debt | € 2,200 | $ 2,500 | ||||||||||||||||
Debt Instrument, Unamortized Discount | (400) | (400) | $ (500) | € (600) | $ (700) | |||||||||||||
Scenario, Forecast [Member] | Other Debt Obligations [Member] | ||||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Long-term Debt, Maturities, Repayment Terms | P8Y | P8Y | ||||||||||||||||
TOKIN [Member] | Other Debt Obligations [Member] | ||||||||||||||||||
Debt | ||||||||||||||||||
Line of Credit, Debt Issue Discount Percent | Rate | 0.04% | 0.04% | ||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Proceeds from Issuance of Debt | $ 3,200 | ¥ 350.0 | ||||||||||||||||
Initial Repayment [Member] [Member] | Scenario, Forecast [Member] | Other Debt Obligations [Member] | ||||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Repayments of Other Debt | € 200 | $ 200 | ||||||||||||||||
Remaining Repayment [Member] | Scenario, Forecast [Member] | Other Debt Obligations [Member] | ||||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Repayments of Other Debt | € 210 | $ 248 | ||||||||||||||||
Prepaid Expenses and Other Current Assets | ||||||||||||||||||
Long-term Debt, Unclassified [Abstract] | ||||||||||||||||||
Restricted Cash | $ 3,100 | $ 3,100 |
Debt Term Loan Facility (JPY) (Details) $ in Thousands, ¥ in Millions |
9 Months Ended | ||||||
---|---|---|---|---|---|---|---|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2018
JPY (¥)
|
Dec. 31, 2017
USD ($)
|
Nov. 07, 2018
USD ($)
|
Nov. 07, 2018
JPY (¥)
|
Mar. 31, 2018
USD ($)
|
|
Debt Instrument [Line Items] | |||||||
Long-term Debt | $ 305,676 | $ 305,676 | $ 324,623 | ||||
Proceeds from Issuance of Secured Debt | 293,348 | $ 334,978 | |||||
Term Loan Credit Agreement | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | 0 | 0 | $ 323,400 | 318,782 | |||
Debt, Prepayment Premium, Percent | 1.00% | 1.00% | |||||
Interest Payable, Current | 200 | ||||||
Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | 291,152 | 291,152 | $ 0 | ||||
Interest Payable, Current | $ 1,000 | 1,000 | |||||
Term Loan A Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.00% | 2.00% | |||||
Term Loan B Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Debt Instrument, Interest Rate, Stated Percentage | 2.25% | 2.25% | |||||
Japan, Yen | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | ¥ | ¥ 33,000.0 | ||||||
Proceeds from Issuance of Secured Debt | ¥ | ¥ 32,100.0 | ||||||
Japan, Yen | Term Loan A Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | ¥ | 16,500.0 | ||||||
Debt Instrument, Periodic Payment, Principal | ¥ | 1,400.0 | ||||||
Japan, Yen | Term Loan B Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | ¥ | ¥ 16,500.0 | ||||||
United States of America, Dollars | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Proceeds from Issuance of Secured Debt | $ 283,900 | ||||||
United States of America, Dollars | Term Loan A Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | $ 146,000 | ||||||
Debt Instrument, Periodic Payment, Principal | ¥ | ¥ 12.5 | ||||||
United States of America, Dollars | Term Loan B Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Long-term Debt | $ 146,000 | ||||||
TIBOR | Term Loan B Tranche | Term Loan Facility | |||||||
Debt Instrument [Line Items] | |||||||
Basis spread on variable rate | 0.13% |
Goodwill and Intangible Assets (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||
---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
|
Finite-Lived Intangible Assets [Line Items] | |||||
Finite-Lived Intangible Assets, Accumulated Amortization | $ (25,223) | $ (25,223) | $ (22,598) | ||
Intangible Assets, Net (Including Goodwill) | 55,170 | 55,170 | 59,907 | ||
Finite-Lived Intangible Assets, Net | 39,957 | 39,957 | 44,433 | ||
Finite-Lived Intangible Assets, Gross | 65,180 | 65,180 | 67,031 | ||
Intangible Assets, Gross (Excluding Goodwill) | 80,393 | 80,393 | 82,505 | ||
Indefinite-Lived Trademarks | 15,213 | 15,213 | 15,474 | ||
Intangible Assets, Net (Excluding Goodwill) | 55,170 | 55,170 | 59,907 | ||
Goodwill | 40,294 | 40,294 | $ 40,294 | ||
Amortization of Intangible Assets | 1,100 | $ 1,100 | 3,400 | $ 3,400 | |
Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months | 4,500 | 4,500 | |||
Finite-Lived Intangible Assets, Amortization Expense, after Year Five | 17,500 | $ 17,500 | |||
Purchased Technology Customer Relationships And Patents [Member] | Weighted Average [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Finite-Lived Intangible Asset, Useful Life | 15 years 9 months 12 days | 15 years 9 months 12 days | |||
Patents [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Finite-Lived Intangible Assets, Accumulated Amortization | (11,691) | $ (11,691) | $ (10,625) | ||
Finite-Lived Intangible Assets, Net | 14,971 | 14,971 | 16,037 | ||
Finite-Lived Patents, Gross | 26,662 | 26,662 | 26,662 | ||
Amortization of Intangible Assets | 400 | 400 | 1,100 | 1,100 | |
Finite-Lived Intangible Assets, Amortization Expense, after Year Five | 7,900 | 7,900 | |||
Finite-Lived Intangible Assets, Amortization Expense, Year Four | 1,400 | 1,400 | |||
Customer Relationships [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Finite-Lived Intangible Assets, Accumulated Amortization | (13,310) | (13,310) | (11,735) | ||
Finite-Lived Intangible Assets, Net | 24,986 | 24,986 | 28,396 | ||
Finite-Lived Customer Relationships, Gross | 38,296 | 38,296 | $ 40,131 | ||
Amortization of Intangible Assets | 700 | $ 700 | $ 2,300 | $ 2,300 | |
Finite-Lived Intangible Asset, Useful Life | 12 years 3 months 12 days | 12 years 3 months 12 days | |||
Finite-Lived Intangible Assets, Amortization Expense, after Year Five | 9,600 | $ 9,600 | |||
Finite-Lived Intangible Assets, Amortization Expense, Year Four | 3,100 | 3,100 | |||
Other Intangible Assets [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Finite-Lived Intangible Assets, Accumulated Amortization | (222) | (222) | $ (238) | ||
Finite-Lived Intangible Assets, Net | 0 | 0 | 0 | ||
Other Finite-Lived Intangible Assets, Gross | 222 | 222 | 238 | ||
Trademarks [Member] | |||||
Finite-Lived Intangible Assets [Line Items] | |||||
Intangible Assets, Net (Excluding Goodwill) | $ 15,213 | $ 15,213 | $ 15,474 |
(Gain) Loss on Write Down and Disposal of Long-Lived Assets (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Property, Plant and Equipment [Line Items] | ||||
Disposal Group, Not (Gain) loss on write down and disposal of long-lived assetsDiscontinued Operation, Loss (Gain) on Write-down | $ 788 | $ (902) | $ 1,611 | $ (922) |
Restructuring Charges (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Restructuring Charges | ||||
Restructuring charges | $ 1,718 | $ 3,530 | $ 1,622 | $ 6,536 |
Reconciliation of restructuring liability | ||||
Costs charged to expense | 1,718 | 3,530 | $ 1,622 | 6,536 |
Film and Electrolytic [Member] | ||||
Restructuring Charges | ||||
Headcount reduction | 2,200 | $ 2,200 | ||
Employee Severance | ||||
Restructuring Charges | ||||
Business Acquisition, Planned Restructuring Activities, Description | 0 | 0 | ||
Restructuring charges | 961 | 3,278 | $ 877 | $ 4,389 |
Reconciliation of restructuring liability | ||||
Beginning of period | 2,837 | 1,494 | 9,629 | 999 |
Costs charged to expense | 961 | 3,278 | 877 | 4,389 |
Costs paid or settled | (1,258) | (444) | (7,702) | (1,080) |
Change in foreign exchange | 16 | 49 | (248) | 69 |
End of period | 2,556 | 4,377 | 2,556 | 4,377 |
Employee Severance | Corporate, Non-Segment [Member] | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 0 | |||
Restructuring and Related Cost, Cost Incurred to Date | 2,655 | 2,655 | ||
Restructuring and Related Cost, Expected Cost | 2,655 | 2,655 | ||
Employee Severance | Solid Capacitors | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 0 | |||
Restructuring and Related Cost, Cost Incurred to Date | 0 | 0 | ||
Restructuring and Related Cost, Expected Cost | 897 | 897 | ||
Employee Severance | Film and Electrolytic [Member] | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 0 | |||
Restructuring and Related Cost, Cost Incurred to Date | 0 | 0 | ||
Restructuring and Related Cost, Expected Cost | 1,200 | 1,200 | ||
Restructuring charges | 300 | 300 | ||
Reconciliation of restructuring liability | ||||
Costs charged to expense | 300 | 300 | ||
Employee Severance | FLORIDA | ||||
Restructuring Charges | ||||
Restructuring charges | 1,000 | 2,100 | ||
Reconciliation of restructuring liability | ||||
Costs charged to expense | 1,000 | $ 2,100 | ||
Manufacturing Relocation 1 [Member] | ||||
Reconciliation of restructuring liability | ||||
Costs paid or settled | (757) | (745) | ||
Facility Closing [Member] | Corporate, Non-Segment [Member] | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 0 | |||
Restructuring and Related Cost, Cost Incurred to Date | 909 | 909 | ||
Restructuring and Related Cost, Expected Cost | 909 | 909 | ||
Facility Closing [Member] | Solid Capacitors | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 0 | |||
Restructuring and Related Cost, Cost Incurred to Date | 0 | 0 | ||
Restructuring and Related Cost, Expected Cost | 2,098 | 2,098 | ||
Facility Closing [Member] | Film and Electrolytic [Member] | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 778 | |||
Restructuring and Related Cost, Cost Incurred to Date | 778 | 778 | ||
Restructuring and Related Cost, Expected Cost | 2,600 | $ 2,600 | ||
Manufacturing Relocation | ||||
Restructuring Charges | ||||
Business Acquisition, Planned Restructuring Activities, Description | 0 | 314 | ||
Restructuring charges | 757 | 252 | $ 745 | $ 2,147 |
Reconciliation of restructuring liability | ||||
Beginning of period | 310 | 312 | 330 | 406 |
Costs charged to expense | 757 | 252 | 745 | 2,147 |
Costs paid or settled | (252) | (2,553) | ||
Change in foreign exchange | 9 | (1) | (11) | (3) |
End of period | 319 | 311 | 319 | 311 |
Manufacturing Relocation | FLORIDA | ||||
Restructuring Charges | ||||
Restructuring charges | 900 | |||
Reconciliation of restructuring liability | ||||
Costs charged to expense | 900 | |||
Manufacturing Relocation | Tennessee | ||||
Restructuring Charges | ||||
Restructuring charges | 100 | 400 | ||
Reconciliation of restructuring liability | ||||
Costs charged to expense | 100 | 400 | ||
Manufacturing Relocation | Mexico | K-Salt | ||||
Restructuring Charges | ||||
Restructuring charges | 100 | 800 | ||
Reconciliation of restructuring liability | ||||
Costs charged to expense | 100 | 800 | ||
Manufacturing Relocation | Victoria Mexico [Member] | Solid Capacitors | ||||
Restructuring Charges | ||||
Restructuring accrual adjustment | 100 | |||
TOKIN [Member] | Employee Severance | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 696 | |||
Restructuring and Related Cost, Cost Incurred to Date | 5,093 | 5,093 | ||
Restructuring and Related Cost, Expected Cost | 5,293 | 5,293 | ||
Restructuring charges | 700 | 100 | 700 | 100 |
Reconciliation of restructuring liability | ||||
Costs charged to expense | 700 | $ 100 | 700 | $ 100 |
TOKIN [Member] | Employee Severance | Electro-magnetic, Sensors & Actuators [Member] | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Cost Incurred to Date | 3,800 | 3,800 | ||
TOKIN [Member] | Employee Severance | Solid Capacitors | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Cost Incurred to Date | 100 | 100 | ||
TOKIN [Member] | Facility Closing [Member] | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Incurred Cost | 0 | |||
Restructuring and Related Cost, Cost Incurred to Date | 0 | 0 | ||
Restructuring and Related Cost, Expected Cost | 0 | 0 | ||
Corporate, Non-Segment [Member] | TOKIN [Member] | Employee Severance | ||||
Restructuring Charges | ||||
Restructuring and Related Cost, Cost Incurred to Date | $ 1,200 | $ 1,200 |
Comprehensive Income (Loss) and Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Foreign Currency Translation | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | $ (17,637) | $ (11,591) | $ 9,715 | $ (25,556) |
Other comprehensive income (loss) before reclassifications | (3,543) | 6,516 | (30,895) | 20,481 |
Amounts reclassified out of AOCI | (1,609) | 0 | (1,609) | 0 |
Other comprehensive income (loss) | (5,152) | 6,516 | (32,504) | 20,481 |
Balance at the end of the period | (22,789) | (5,075) | (22,789) | (5,075) |
Post-Retirement Benefit Plan Adjustments | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | 801 | 1,040 | 879 | 1,134 |
Amounts reclassified out of AOCI | (38) | (47) | (116) | (141) |
Other comprehensive income (loss) | (38) | (47) | (116) | (141) |
Balance at the end of the period | 763 | 993 | 763 | 993 |
Defined Benefit Pension Plans, Net of Tax | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | (14,544) | (15,151) | (14,831) | (14,998) |
Other comprehensive income (loss) before reclassifications | 0 | 0 | ||
Amounts reclassified out of AOCI | 139 | 147 | 426 | (6) |
Other comprehensive income (loss) | 139 | 147 | 426 | (6) |
Balance at the end of the period | (14,405) | (15,004) | (14,405) | (15,004) |
Accumulated tax expense (benefit) | 2,200 | 2,200 | ||
Ownership Share of Equity Method Investees’ Other Comprehensive Income (Loss) | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | 268 | 274 | 285 | (5,299) |
Other comprehensive income (loss) before reclassifications | 8 | (5) | (9) | 5,568 |
Other comprehensive income (loss) | 8 | (5) | (9) | 5,568 |
Balance at the end of the period | 276 | 269 | 276 | 269 |
Foreign Exchange Contracts | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | 1,904 | 1,430 | 1,154 | 2,907 |
Other comprehensive income (loss) before reclassifications | (2,435) | (7,130) | (2,130) | (9,711) |
Amounts reclassified out of AOCI | (170) | 1,800 | 275 | 2,904 |
Other comprehensive income (loss) | (2,605) | (5,330) | (1,855) | (6,807) |
Balance at the end of the period | (701) | (3,900) | (701) | (3,900) |
Accumulated Gain (Loss) from Components Excluded from Assessment of Fair Value Hedge Effectiveness, net [Member] | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | 0 | 0 | 0 | 0 |
Other comprehensive income (loss) before reclassifications | (3,407) | 0 | (3,407) | 0 |
Amounts reclassified out of AOCI | 1,572 | 0 | 1,572 | 0 |
Other comprehensive income (loss) | (1,835) | 0 | (1,835) | 0 |
Balance at the end of the period | (1,835) | 0 | (1,835) | 0 |
Net Accumulated Other Comprehensive Income (Loss) | ||||
Changes in accumulated other comprehensive income (loss) | ||||
Balance at the beginning of the period | (29,208) | (23,998) | (2,798) | (41,812) |
Other comprehensive income (loss) before reclassifications | (9,377) | (619) | (36,441) | 16,338 |
Amounts reclassified out of AOCI | (106) | 1,900 | 548 | 2,757 |
Other comprehensive income (loss) | (9,483) | 1,281 | (35,893) | 19,095 |
Balance at the end of the period | $ (38,691) | $ (22,717) | $ (38,691) | $ (22,717) |
Equity Method Investments - Stock Purchase Agreement (Details) |
Dec. 31, 2018 |
---|---|
NEC TOKIN Corporation [Member] | KEMET Electronics Corporation [Member] | Stock Purchase Agreement [Member] | |
Schedule of Equity Method Investments [Line Items] | |
Equity Method Investment, Ownership Percentage | 34.00% |
Equity Method Investments - Equity Method Investment Income (Loss) Reconciliation (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Schedule of Equity Method Investments [Line Items] | ||||
Income (Loss) from Equity Method Investments | $ (296) | $ 238 | $ (301) | $ 75,879 |
Equity Method Investments - Equity Method Investment Reconciliation (Details) $ in Thousands, $ in Millions |
3 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Jul. 26, 2016
USD ($)
|
May 02, 2016
installment
suit
|
Dec. 09, 2015
USD ($)
|
Dec. 09, 2015
TWD ($)
|
Sep. 02, 2015
installment
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
Mar. 31, 2018
USD ($)
|
|
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity [Abstract] | ||||||||||
Equity method investments | $ 12,861 | $ 12,861 | $ 12,016 | |||||||
Indemnification Agreement [Member] | Equity Method Investments [Member] | NEC TOKIN Corporation [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Litigation Settlement, Number of Payment Installments | installment | 5 | |||||||||
Settled Litigation [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Litigation Settlement, Payment Period | 5 years | |||||||||
Litigation Settlement, Number of Payment Installments | installment | 6 | |||||||||
Preliminary Settlement [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member] | NEC TOKIN Corporation [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Loss Contingency, Pending Claims, Number | suit | 2 | |||||||||
TAIWAN, PROVINCE OF CHINA | Taiwan, New Dollars | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Loss Contingency, Damages Sought, Value | $ 1,200.0 | |||||||||
TAIWAN, PROVINCE OF CHINA | Taiwan, New Dollars | Minimum [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Loss Contingency, Damages Sought, Value | $ 609.1 | |||||||||
TAIWAN, PROVINCE OF CHINA | United States of America, Dollars | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Loss Contingency, Damages Sought, Value | $ 39,600 | |||||||||
TAIWAN, PROVINCE OF CHINA | United States of America, Dollars | Minimum [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Loss Contingency, Damages Sought, Value | $ 19,800 | |||||||||
BRAZIL | United States of America, Dollars | Settled Litigation [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Loss Contingency, Damages Paid, Value | $ 200 | |||||||||
NT Sales Co., Ltd (NTS) [Member] | ||||||||||
Related Party Transactions [Abstract] | ||||||||||
Sales to NEC TOKIN | 12,805 | $ 12,837 | 37,402 | $ 38,802 | ||||||
NEC TOKIN's sales to KEMET | $ 495 | $ 278 | $ 1,266 | $ 1,002 |
Equity Method Investments - Equity Method Investments Summary (Details) - USD ($) $ in Thousands |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Mar. 31, 2018 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | $ 12,861 | $ 12,016 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | The following table provides a reconciliation of equity method investments to the Company's Condensed Consolidated Balance Sheets (amounts in thousands):
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Nippon Yttrium Co., Ltd (NYC) [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | $ 8,095 | 8,148 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NT Sales Co., Ltd (NTS) [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | 1,110 | 998 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Novasentis [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | 2,938 | 2,870 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
KEMET Jianghai [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity Method Investments | $ 718 | $ 0 |
Equity Method Investments Narrative (Details) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
---|---|---|
Schedule of Equity Method Investments [Line Items] | ||
Equity method investments | $ 12,861 | $ 12,016 |
Novasentis [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity Method Investment, Ownership Percentage | 25.00% | |
Equity method investments | $ 2,938 | 2,870 |
Nippon Yttrium Co., Ltd (NYC) [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity Method Investment, Ownership Percentage | 30.00% | |
Equity method investments | $ 8,095 | 8,148 |
NT Sales Co., Ltd (NTS) [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity Method Investment, Ownership Percentage | 33.00% | |
Equity method investments | $ 1,110 | 998 |
KEMET Jianghai [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity Method Investment, Ownership Percentage | 50.00% | |
Equity method investments | $ 718 | $ 0 |
NT Sales Co., Ltd (NTS) [Member] | TOKIN [Member] | Discontinued Operations, Disposed of by Sale [Member] | ||
Schedule of Equity Method Investments [Line Items] | ||
Equity Method Investment, Ownership Percentage | 67.00% |
Segment and Geographic Information (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2018
USD ($)
manufacturing_site
|
Dec. 31, 2017
USD ($)
|
Dec. 31, 2018
USD ($)
manufacturing_site
business_group
|
Dec. 31, 2017
USD ($)
|
||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | $ 882,090 | ||||||||||
Net sales | [1] | $ 350,175 | $ 306,576 | $ 1,027,024 | 882,090 | ||||||
Number of business groups | business_group | 3 | ||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Operating income (loss) | [1] | 61,616 | 32,002 | $ 146,792 | 91,206 | ||||||
Depreciation and amortization expense | 12,763 | 11,353 | 38,405 | [2] | 37,366 | [2] | |||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||||
North and South America (“Americas”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 191,429 | ||||||||||
Net sales | 91,385 | 65,097 | 245,825 | ||||||||
Europe, Middle East, Africa (“EMEA”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 201,922 | ||||||||||
Net sales | 77,098 | 68,844 | 229,478 | ||||||||
Japan and Korea (“JPKO”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 128,514 | ||||||||||
Net sales | 48,700 | 48,395 | 147,382 | ||||||||
Asia and Pacific Rim (“APAC”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 360,225 | ||||||||||
Net sales | 132,992 | 124,240 | 404,339 | ||||||||
Operating Income (Loss) [Member] | |||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Restructuring charges | 1,718 | 3,530 | 1,622 | 6,536 | |||||||
Corporate, Non-Segment [Member] | |||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Operating income (loss) | (42,646) | (39,420) | (130,311) | (101,156) | |||||||
Depreciation and amortization expense | 2,319 | 2,203 | 5,951 | 6,569 | |||||||
Corporate, Non-Segment [Member] | Operating Income (Loss) [Member] | |||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Restructuring charges | 241 | 1,100 | 162 | 3,121 | |||||||
Solid Capacitors | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 568,435 | ||||||||||
Net sales | $ 238,683 | 195,049 | $ 687,977 | ||||||||
Number of Manufacturing Sites | manufacturing_site | 10 | 10 | |||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Operating income (loss) | $ 95,105 | 60,991 | $ 249,456 | 170,417 | |||||||
Depreciation and amortization expense | 6,866 | 6,900 | 21,401 | 21,490 | |||||||
Solid Capacitors | North and South America (“Americas”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 25,459 | ||||||||||
Net sales | 79,782 | 56,574 | 27,872 | ||||||||
Solid Capacitors | Europe, Middle East, Africa (“EMEA”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 112,139 | ||||||||||
Net sales | 47,863 | 37,174 | 135,401 | ||||||||
Solid Capacitors | Japan and Korea (“JPKO”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 261,520 | ||||||||||
Net sales | 9,472 | 7,752 | 308,473 | ||||||||
Solid Capacitors | Asia and Pacific Rim (“APAC”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 169,317 | ||||||||||
Net sales | 101,566 | 93,549 | 216,231 | ||||||||
Solid Capacitors | Operating Income (Loss) [Member] | |||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Restructuring charges | 0 | 121 | (18) | 841 | |||||||
Film and Electrolytic [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 146,949 | ||||||||||
Net sales | $ 50,171 | 51,468 | $ 155,754 | ||||||||
Number of Manufacturing Sites | manufacturing_site | 10 | 10 | |||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Operating income (loss) | $ 3,383 | 499 | $ 8,686 | 3,890 | |||||||
Depreciation and amortization expense | 2,434 | 2,728 | 7,252 | 8,281 | |||||||
Film and Electrolytic [Member] | North and South America (“Americas”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 0 | ||||||||||
Net sales | 9,053 | 6,349 | 561 | ||||||||
Film and Electrolytic [Member] | Europe, Middle East, Africa (“EMEA”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 88,289 | ||||||||||
Net sales | 28,718 | 31,122 | 92,157 | ||||||||
Film and Electrolytic [Member] | Japan and Korea (“JPKO”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 42,460 | ||||||||||
Net sales | 207 | 0 | 40,490 | ||||||||
Film and Electrolytic [Member] | Asia and Pacific Rim (“APAC”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 16,200 | ||||||||||
Net sales | 12,193 | 13,997 | 22,546 | ||||||||
Film and Electrolytic [Member] | Operating Income (Loss) [Member] | |||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Restructuring charges | 1,025 | 2,309 | 1,026 | 2,574 | |||||||
Electro-magnetic, Sensors & Actuators [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 166,706 | ||||||||||
Net sales | $ 61,321 | 60,059 | $ 183,293 | ||||||||
Number of Manufacturing Sites | manufacturing_site | 4 | 4 | |||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Operating income (loss) | $ 5,774 | 9,932 | $ 18,961 | 18,055 | |||||||
Depreciation and amortization expense | 1,144 | (478) | 3,801 | 1,026 | |||||||
Electro-magnetic, Sensors & Actuators [Member] | North and South America (“Americas”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 103,055 | ||||||||||
Net sales | 2,550 | 2,174 | 118,949 | ||||||||
Electro-magnetic, Sensors & Actuators [Member] | Europe, Middle East, Africa (“EMEA”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 1,494 | ||||||||||
Net sales | 517 | 548 | 1,920 | ||||||||
Electro-magnetic, Sensors & Actuators [Member] | Japan and Korea (“JPKO”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 56,245 | ||||||||||
Net sales | 39,021 | 40,643 | 55,376 | ||||||||
Electro-magnetic, Sensors & Actuators [Member] | Asia and Pacific Rim (“APAC”) | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 5,912 | ||||||||||
Net sales | 19,233 | 16,694 | 7,048 | ||||||||
Electro-magnetic, Sensors & Actuators [Member] | Operating Income (Loss) [Member] | |||||||||||
Segment Reporting Information, Profit (Loss) [Abstract] | |||||||||||
Restructuring charges | 452 | 0 | 452 | 0 | |||||||
OEM [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 412,975 | ||||||||||
Net sales | 147,123 | 146,165 | 450,084 | ||||||||
OEM [Member] | Solid Capacitors | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 193,182 | ||||||||||
Net sales | 70,426 | 67,267 | 215,365 | ||||||||
OEM [Member] | Film and Electrolytic [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 63,539 | ||||||||||
Net sales | 18,768 | 20,804 | 61,303 | ||||||||
OEM [Member] | Electro-magnetic, Sensors & Actuators [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 156,254 | ||||||||||
Net sales | 57,929 | 58,094 | 173,416 | ||||||||
Distributor [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 341,592 | ||||||||||
Net sales | 151,766 | 119,386 | 432,868 | ||||||||
Distributor [Member] | Solid Capacitors | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 265,290 | ||||||||||
Net sales | 124,467 | 92,898 | 349,046 | ||||||||
Distributor [Member] | Film and Electrolytic [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 66,278 | ||||||||||
Net sales | 25,277 | 24,651 | 76,607 | ||||||||
Distributor [Member] | Electro-magnetic, Sensors & Actuators [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 10,024 | ||||||||||
Net sales | 2,022 | 1,837 | 7,215 | ||||||||
EMS [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 127,523 | ||||||||||
Net sales | 51,286 | 41,025 | 144,072 | ||||||||
EMS [Member] | Solid Capacitors | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 109,963 | ||||||||||
Net sales | 43,790 | 34,884 | 123,566 | ||||||||
EMS [Member] | Film and Electrolytic [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 17,132 | ||||||||||
Net sales | 6,126 | 6,013 | 17,844 | ||||||||
EMS [Member] | Electro-magnetic, Sensors & Actuators [Member] | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 428 | ||||||||||
Net sales | 1,370 | 128 | 2,662 | ||||||||
Tantalum [Member] | Solid Capacitors | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | 368,479 | ||||||||||
Net sales | 143,680 | 126,625 | 426,047 | ||||||||
Ceramics [Member] | Solid Capacitors | |||||||||||
Segment and geographic information | |||||||||||
Sales Revenue, Goods, Net | $ 199,956 | ||||||||||
Net sales | $ 95,003 | $ 68,424 | $ 261,930 | ||||||||
|
Defined Benefit Pension and Other Postretirement Benefit Plans (Details) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017
USD ($)
|
|
Defined Benefit Plan Disclosure | ||||
Defined Benefit Plan, Number of Plans | 11 | |||
Pension | ||||
Defined Benefit Plan Disclosure | ||||
Contribution by employer | $ 5,900 | |||
Net periodic benefit (income) costs | ||||
Net service cost | $ 1,233 | $ 1,307 | 3,699 | $ 3,926 |
Interest cost | 478 | 425 | 1,434 | 1,274 |
Expected return on net assets | (531) | (501) | (1,594) | (1,502) |
Amortization: | ||||
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) | 107 | 91 | 322 | 271 |
Prior service cost | 23 | 20 | 69 | 60 |
Total net periodic benefit (income) costs | 1,310 | 1,342 | 3,930 | 4,029 |
Pension | Maximum | ||||
Defined Benefit Plan Disclosure | ||||
Estimated employer contribution in current fiscal year | 9,000 | $ 9,000 | ||
Pension | Europe | ||||
Defined Benefit Plan Disclosure | ||||
Defined Benefit Plan, Number of Plans | 6 | |||
Pension | Singapore | ||||
Defined Benefit Plan Disclosure | ||||
Defined Benefit Plan, Number of Plans | 1 | |||
Pension | Mexico | ||||
Defined Benefit Plan Disclosure | ||||
Defined Benefit Plan, Number of Plans | 2 | |||
Pension | JAPAN | ||||
Defined Benefit Plan Disclosure | ||||
Defined Benefit Plan, Number of Plans | 2 | |||
Other Benefits | ||||
Net periodic benefit (income) costs | ||||
Net service cost | 0 | 0 | $ 0 | 0 |
Interest cost | 3 | 3 | 9 | 9 |
Expected return on net assets | 0 | 0 | 0 | 0 |
Amortization: | ||||
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) | (39) | (47) | (116) | (141) |
Prior service cost | 0 | 0 | 0 | 0 |
Total net periodic benefit (income) costs | $ (36) | $ (44) | $ (107) | $ (132) |
Stock-based Compensation - Narrative (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Apr. 18, 2018 |
Dec. 31, 2018 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of shares authorized | 12,200,000 | 12,200,000 | ||
Stock options exercised | 72,800 | 705,000 | ||
Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Expiration period | 10 years | |||
Employee Stock Option [Member] | Minimum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Employee Stock Option [Member] | Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Restricted Stock Units (RSUs) [Member] | Director [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Period of restriction for sale of shares | 90 days | |||
Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award Accelerated Compensation Cost | $ 1.7 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 85,956 | |||
Restricted Stock Units (RSUs) [Member] | Minimum [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Restricted Stock Units (RSUs) [Member] | Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 4 years | |||
Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 1,066,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 21,000 | |||
Restricted Stock [Member] | Chief Executive Officer [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 275,000 | |||
Omnibus Equity Incentive Plan 2011 [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of shares authorized | 11,400,000 | 11,400,000 | ||
Prior Plans [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of shares authorized | 800,000 | 800,000 | ||
Long Term Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Performance period | P2Y | |||
Long Term Incentive Plan 2019 2020 [Member] | Restricted Stock Units (RSUs) [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Long Term Incentive Plan 2019 2020 [Member] | Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | 36,059 | |||
Long Term Incentive Plan 2016 2017 [Member] | Restricted Stock Units, Performance-Based Award [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 173,000 | |||
Long Term Incentive Plan 2016 2017 [Member] | Restricted Stock Units, Time-Based Award [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 191,000 | |||
Long Term Incentive Plan 2016 2017 [Member] | Restricted Stock Units (RSUs) [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
June 29, 2015 [Member] | Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 175,000 | |||
September 6, 2017 [Member] | Restricted Stock Units (RSUs) [Member] | Chief Executive Officer [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | 100,000 |
Stock-based Compensation - Schedule of Award Activity (Details) - $ / shares shares in Thousands |
9 Months Ended | |
---|---|---|
May 18, 2018 |
Dec. 31, 2018 |
|
Restricted Stock Units (RSUs) [Member] | Long Term Incentive Plan 2019 2020 [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |
Shares | ||
Granted | 298 | |
Weighted- average Fair Value on Grant Date | ||
Granted | $ 17.86 | |
Restricted Stock Units (RSUs) [Member] | Long Term Incentive Plan 2016 2017 [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |
Restricted Stock Units (RSUs) [Member] | Long Term Incentive Plan 2018 2019 [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |
Restricted Stock Units (RSUs) [Member] | Long Term Incentive Plan 2017 2018 [Member] | ||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | 3 years | |
Restricted Stock Units (RSUs) [Member] | May 18, 2019 | Long Term Incentive Plan 2019 2020 [Member] | ||
Shares | ||
Granted | 56 | |
Restricted Stock Units (RSUs) [Member] | May 18, 2020 | Long Term Incentive Plan 2019 2020 [Member] | ||
Shares | ||
Granted | 120 | |
Restricted Stock Units (RSUs) [Member] | May 18, 2021 | Long Term Incentive Plan 2019 2020 [Member] | ||
Shares | ||
Granted | 122 | |
Restricted Stock Units, Performance-Based Award [Member] | Long Term Incentive Plan 2016 2017 [Member] | ||
Shares | ||
Vested | (173) | |
Restricted Stock Units, Performance-Based Award [Member] | Long Term Incentive Plan 2018 2019 [Member] | ||
Shares | ||
Vested | 0 | |
Restricted Stock Units, Performance-Based Award [Member] | Long Term Incentive Plan 2017 2018 [Member] | ||
Shares | ||
Vested | 0 | |
Restricted Stock Units, Time-Based Award [Member] | Long Term Incentive Plan 2016 2017 [Member] | ||
Shares | ||
Vested | (191) | |
Restricted Stock Units, Time-Based Award [Member] | Long Term Incentive Plan 2018 2019 [Member] | ||
Shares | ||
Vested | (63) | |
Restricted Stock Units, Time-Based Award [Member] | Long Term Incentive Plan 2017 2018 [Member] | ||
Shares | ||
Vested | (198) | |
Restricted Stock | ||
Shares | ||
Beginning balance | 1,405 | |
Granted | 292 | |
Vested | (1,066) | |
Forfeited | (21) | |
Ending balance | 610 | |
Weighted- average Fair Value on Grant Date | ||
Beginning balance | $ 9.82 | |
Granted | 21.81 | |
Vested | 9.49 | |
Forfeited | 7.78 | |
Ending balance | $ 16.21 |
Stock-based Compensation - Allocation of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Long Term Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | $ 644 | $ 722 | $ 2,699 | $ 1,912 |
Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 0 | 0 | 0 | 0 |
Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 890 | 1,484 | 7,312 | 2,925 |
Cost of sales | Long Term Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 345 | 192 | 919 | 505 |
Cost of sales | Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 0 | 0 | 0 | 0 |
Cost of sales | Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 321 | 210 | 1,022 | 549 |
Selling, General and Administrative Expenses [Member] | Long Term Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 220 | 490 | 1,580 | 1,294 |
Selling, General and Administrative Expenses [Member] | Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 0 | 0 | 0 | 0 |
Selling, General and Administrative Expenses [Member] | Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 547 | 1,262 | 6,236 | 2,345 |
Research and Development Expense [Member] | Long Term Incentive Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 79 | 40 | 200 | 113 |
Research and Development Expense [Member] | Employee Stock Option [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | 0 | 0 | 0 | 0 |
Research and Development Expense [Member] | Restricted Stock [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total | $ 22 | $ 12 | $ 54 | $ 31 |
Income Taxes (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
Mar. 31, 2018 |
|||
Income Tax Contingency [Line Items] | |||||||
Current Income Tax Expense (Benefit) | $ 2,600,000 | $ 9,200,000 | |||||
Income tax expense (benefit) | [1] | 2,600,000 | $ 2,037,000 | 9,200,000 | $ 6,041,000 | ||
Current State and Local Tax Expense (Benefit) | 400,000 | ||||||
Current Federal Tax Expense (Benefit) | 200,000 | (700,000) | (500,000) | ||||
Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | 0.007 | ||||||
Foreign Tax Authority [Member] | |||||||
Income Tax Contingency [Line Items] | |||||||
Income tax expense (benefit) | $ 2,700,000 | 6,400,000 | |||||
Foreign Income Tax Expense (Benefit), Continuing Operations | 2,900,000 | 9,600,000 | |||||
Tax Adjustments, Settlements, and Unusual Provisions | 600,000 | ||||||
State and Local Jurisdiction [Member] | |||||||
Income Tax Contingency [Line Items] | |||||||
Income tax expense (benefit) | $ 100,000 | $ 100,000 | |||||
Reduction in Taxes [Member] | |||||||
Income Tax Contingency [Line Items] | |||||||
Income tax expense (benefit) | $ 800,000 | ||||||
BEAT Tax [Member] | |||||||
Income Tax Contingency [Line Items] | |||||||
Income tax expense (benefit) | $ 800,000 | ||||||
|
Basic and Diluted Net Income (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|||||
Numerator: | ||||||||
Net income (loss) | [1],[2] | $ 40,806 | $ 18,589 | $ 113,167 | $ 251,847 | |||
Weighted-average shares outstanding: | ||||||||
Basic (in shares) | 58,010 | 56,778 | 57,717 | 51,340 | ||||
Assumed conversion of employee stock grants (in shares) | 1,101 | 2,159 | 1,399 | 2,384 | ||||
Assumed conversion of warrants (in shares) | 0 | 0 | 0 | 4,707 | ||||
Diluted (in shares) | 59,111 | 58,937 | 59,116 | 58,431 | ||||
Net income (loss) per basic share (in usd per share) | $ 0.70 | $ 0.33 | $ 1.96 | $ 4.91 | ||||
Net income (loss) per diluted share (in usd per share) | $ 0.69 | $ 0.32 | $ 1.91 | $ 4.31 | ||||
Common stock equivalents that could potentially dilute net income per basic share in the future, but were not included in the computation of diluted earnings per share because the impact would have been antidilutive | ||||||||
Payments of Ordinary Dividends, Common Stock | $ 2,873 | $ 0 | ||||||
Common stock equivalents (in shares) | 76 | 164 | 0 | 134 | ||||
|
Derivatives - Balance Sheet Classification and Fair Value of Derivative Instruments (Details) - USD ($) $ in Thousands |
Dec. 31, 2018 |
Mar. 31, 2018 |
---|---|---|
Prepaid Expenses and Other Current Assets | Foreign Exchange Forward | ||
Derivative [Line Items] | ||
Derivative Asset | $ 0 | $ 1,154 |
Derivative Asset, Fair Value, Gross Liability | 434 | 0 |
Derivative Asset, Fair Value, Gross Asset | 434 | 1,154 |
Accrued Liabilities | Foreign Exchange Forward | ||
Derivative [Line Items] | ||
Derivative Liability | 702 | 0 |
Derivative Liability, Fair Value, Gross Liability | 1,136 | 0 |
Derivative Liability, Fair Value, Gross Asset | 434 | 0 |
Fair Value Hedging | Other Noncurrent Assets | Currency Swap | ||
Derivative [Line Items] | ||
Derivative Asset, Fair Value, Gross Liability | 0 | 0 |
Derivative Asset, Fair Value, Gross Asset | 4,951 | 0 |
Net Investment Hedging | Other Noncurrent Liabilities | Currency Swap | ||
Derivative [Line Items] | ||
Derivative Liability | 0 | |
Derivative Liability, Fair Value, Gross Liability | 3,571 | 0 |
Derivative Liability, Fair Value, Gross Asset | $ 0 | $ 0 |
Derivatives - Gain (Loss) for Derivative Instruments Designated as Hedges (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
Currency Swap | Other income/expense, net | Fair Value Hedging | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gain (Loss) Recognized in AOCI | $ (3,407) | $ 0 | $ (3,407) | $ 0 |
Gain (Loss) Reclassified from AOCI to Income | (1,572) | 0 | (1,572) | 0 |
Gain (Loss) Recorded Directly to Income | 8,358 | 0 | 8,358 | 0 |
Currency Swap | Other income/expense, net | Net Investment Hedging | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gain (Loss) Recognized in AOCI | (3,571) | 0 | (3,571) | 0 |
Gain (Loss) Reclassified from AOCI to Income | 1,609 | 0 | 1,609 | 0 |
Gain (Loss) Recorded Directly to Income | 0 | 0 | 0 | 0 |
Foreign Exchange Forward | Cost of sales | Cash Flow Hedging | ||||
Derivative Instruments, Gain (Loss) [Line Items] | ||||
Gain (Loss) Recognized in AOCI | (2,435) | (7,130) | (2,130) | (9,711) |
Gain (Loss) Reclassified from AOCI to Income | 170 | (1,800) | (275) | (2,904) |
Gain (Loss) Recorded Directly to Income | $ 0 | $ 0 | $ 0 | $ 0 |
Derivatives - Narrative (Details) - USD ($) $ in Millions |
9 Months Ended | ||
---|---|---|---|
Dec. 31, 2018 |
Nov. 07, 2018 |
Mar. 31, 2018 |
|
Mexico, Pesos | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 72.2 | $ 70.6 | |
Fair Value Hedging | Currency Swap One | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Basis Spread on Variable Rate | 2.70% | ||
Fair Value Hedging | Currency Swap Two | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Basis Spread on Variable Rate | 3.20% | ||
Fair Value Hedging | Japan, Yen | Currency Swap One | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 16,500.0 | ||
Amortization | $ 1,400.0 | ||
Derivative, Basis Spread on Variable Rate | 2.00% | ||
Fair Value Hedging | Japan, Yen | Currency Swap Two | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | 16,500.0 | ||
Derivative, Basis Spread on Variable Rate | 2.30% | ||
Fair Value Hedging | Japan, Yen | Currency Swap | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 33,000.0 | ||
Fair Value Hedging | United States of America, Dollars | Currency Swap | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 291.9 | ||
Net Investment Hedging | Currency Swap | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Basis Spread on Variable Rate | 6.30% | ||
Net Investment Hedging | Japan, Yen | Currency Swap Two | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 33,000.0 | ||
Net Investment Hedging | Japan, Yen | Currency Swap | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 33,000.0 | ||
Amortization | $ 1,400.0 | ||
Derivative, Basis Spread on Variable Rate | 2.60% | ||
Net Investment Hedging | United States of America, Dollars | Currency Swap | |||
Derivatives, Fair Value [Line Items] | |||
Derivative, Notional Amount | $ 291.9 |
Derivatives - Schedule of Fair Value and Cash Flow Hedges Included in Earnings (Details) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||||
---|---|---|---|---|---|---|
Dec. 31, 2018 |
Dec. 31, 2017 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|||
Derivative [Line Items] | ||||||
Cost of sales | [1] | $ 226,425 | $ 214,288 | $ 694,888 | $ 630,781 | |
Other (income) expense, net | (14,006) | (4,769) | (6,646) | (21,061) | ||
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | 1,200 | |||||
Other income/expense, net | ||||||
Derivative [Line Items] | ||||||
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge | (8,358) | (8,358) | ||||
Gain (Loss) on Fair Value Hedges Recognized in Earnings | 6,786 | 6,786 | ||||
Cost of sales | ||||||
Derivative [Line Items] | ||||||
Foreign Currency Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net | $ 170 | $ (1,800) | $ (275) | $ (2,904) | ||
|
Concentrations of Risks (Details) $ in Thousands, € in Millions, ¥ in Millions, R$ in Millions, $ in Millions, $ in Millions, ₩ in Billions |
3 Months Ended | 9 Months Ended | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nov. 30, 2018
USD ($)
|
Nov. 30, 2018
KRW (₩)
|
Jun. 27, 2018
USD ($)
|
Jun. 27, 2018
CAD ($)
|
Mar. 21, 2018
EUR (€)
|
Mar. 21, 2018
USD ($)
|
Jul. 26, 2016
USD ($)
|
Jul. 26, 2016
BRL (R$)
|
May 02, 2016
USD ($)
installment
suit
|
Mar. 29, 2016
USD ($)
|
Mar. 29, 2016
JPY (¥)
|
Dec. 09, 2015
USD ($)
|
Dec. 09, 2015
TWD ($)
|
Sep. 02, 2015
USD ($)
installment
|
Jul. 31, 2013
defendant
suit
|
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017 |
Dec. 31, 2018
USD ($)
|
Dec. 31, 2017 |
Mar. 31, 2018
USD ($)
|
||||
Concentration of Risk | |||||||||||||||||||||||
Accounts Payable, Trade, Current | $ 144,418 | $ 144,418 | $ 139,989 | ||||||||||||||||||||
Accrued expenses | [1] | 98,279 | 98,279 | 125,119 | |||||||||||||||||||
Other non-current obligations | [1] | $ 125,856 | $ 125,856 | $ 152,249 | |||||||||||||||||||
Revenue from Contract with Customer [Member] | Sales risk | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration Risk, Customer | 1 | ||||||||||||||||||||||
Revenue from Contract with Customer [Member] | Sales risk | Minimum [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration risk, percentage | 10.00% | ||||||||||||||||||||||
Revenue from Contract with Customer [Member] | Electronics distributor risk | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration risk, percentage | 42.20% | 38.70% | |||||||||||||||||||||
Accounts receivable | Sales risk | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration Risk, Customer | 0 | 0 | 0 | 0 | |||||||||||||||||||
Accounts receivable | Credit Concentration Risk [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration Risk, Customer | 0 | ||||||||||||||||||||||
Accounts receivable | Credit Concentration Risk [Member] | Maximum | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration risk, percentage | 10.00% | ||||||||||||||||||||||
Sales Revenue, Goods, Net [Member] | Sales risk | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration Risk, Customer | 1 | 1 | 1 | 1 | |||||||||||||||||||
Sales Revenue, Goods, Net [Member] | Sales risk | Minimum [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration risk, percentage | 10.00% | 10.00% | 10.00% | 10.00% | |||||||||||||||||||
Sales Revenue, Goods, Net [Member] | Electronics distributor risk | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Concentration risk, percentage | 43.40% | 38.90% | |||||||||||||||||||||
Indemnification Agreement [Member] | Equity Method Investments [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 13,800 | ||||||||||||||||||||||
Settled Litigation [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Payment Period | 5 years | ||||||||||||||||||||||
Litigation Settlement, Number of Payment Installments | installment | 6 | ||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 2,300 | ||||||||||||||||||||||
Japan, Yen | JAPAN | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | ¥ | ¥ 127.2 | ||||||||||||||||||||||
Taiwan, New Dollars | TAIWAN, PROVINCE OF CHINA | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Sought, Value | $ 1,200.0 | ||||||||||||||||||||||
Taiwan, New Dollars | TAIWAN, PROVINCE OF CHINA | Minimum [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Sought, Value | $ 609.1 | ||||||||||||||||||||||
United States of America, Dollars | TAIWAN, PROVINCE OF CHINA | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Sought, Value | $ 39,600 | ||||||||||||||||||||||
United States of America, Dollars | TAIWAN, PROVINCE OF CHINA | Minimum [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Sought, Value | $ 19,800 | ||||||||||||||||||||||
United States of America, Dollars | JAPAN | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 1,100 | ||||||||||||||||||||||
United States of America, Dollars | BRAZIL | Settled Litigation [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Paid, Value | $ 200 | ||||||||||||||||||||||
Brazil, Brazil Real | BRAZIL | Settled Litigation [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Paid, Value | R$ | R$ 0.6 | ||||||||||||||||||||||
TOKIN [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency Accrual | $ 48,200 | $ 48,200 | |||||||||||||||||||||
TOKIN [Member] | United States of America, Dollars | CANADA | Settled Litigation [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Paid, Value | $ 2,200 | ||||||||||||||||||||||
TOKIN [Member] | Canada, Dollars | CANADA | Settled Litigation [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Damages Paid, Value | $ 2.9 | ||||||||||||||||||||||
NEC TOKIN Corporation [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Number of Payment Installments | installment | 5 | ||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 37,300 | ||||||||||||||||||||||
NEC TOKIN Corporation [Member] | Preliminary Settlement [Member] | Indemnification Agreement [Member] | Equity Method Investments [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Pending Claims, Number | suit | 2 | ||||||||||||||||||||||
Unfavorable Regulatory Action [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Accounts Payable, Trade, Current | 15,000 | 15,000 | |||||||||||||||||||||
Accrued expenses | 16,700 | 16,700 | |||||||||||||||||||||
Other non-current obligations | 16,500 | $ 16,500 | |||||||||||||||||||||
Lithium Ion Batteries Antitrust Litigation [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Number of Defendants | defendant | 8 | ||||||||||||||||||||||
Loss Contingency, Pending Claims, Number | suit | 2 | ||||||||||||||||||||||
Lithium Ion Batteries Antitrust Litigation [Member] | TOKIN [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Loss Contingency, Number of Defendants | defendant | 1 | ||||||||||||||||||||||
Battery Action Class Suit - Indirect Product Purchasers [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | 2,000 | ||||||||||||||||||||||
Battery Action Class Suit [Member] | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 4,950 | ||||||||||||||||||||||
Competition Laws of the European Union [Member] | TOKIN [Member] | United States of America, Dollars | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 10,300 | ||||||||||||||||||||||
Competition Laws of the European Union [Member] | TOKIN [Member] | Euro Member Countries, Euro | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | € | € 8.8 | ||||||||||||||||||||||
Competition Laws of the European Union [Member] | NEC TOKIN Corporation [Member] | United States of America, Dollars | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 5,900 | ||||||||||||||||||||||
Competition Laws of the European Union [Member] | NEC TOKIN Corporation [Member] | Euro Member Countries, Euro | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | € | € 5.0 | ||||||||||||||||||||||
Monopoly and Fair Trade Laws [Member] | TOKIN [Member] | United States of America, Dollars | KOREA, REPUBLIC OF | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | $ 7,200 | ||||||||||||||||||||||
Monopoly and Fair Trade Laws [Member] | TOKIN [Member] | Korea (South), Won | KOREA, REPUBLIC OF | |||||||||||||||||||||||
Concentration of Risk | |||||||||||||||||||||||
Litigation Settlement, Amount Awarded to Other Party | ₩ | ₩ 8.1 | ||||||||||||||||||||||
|
' "XVL0L-%N9F!MPL=R%K!L3;[K[E+7,&<,:U:AI:6IB@&1!T
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ML 8>/
MT_Y#F+K5EIS1^9>-_:\0'?A4-E=^A!K_P69#0N7"T0\$,>.8C8;#;OI!;/[&
M^5]02P,$% @ L8%!3@L#U 8N]DJ^%DB.V5$N;/$20.&=W0
M%\=#6SV+LDWLF_]'';?W#3"&W)&9V_V3C_&M&!E[*Y\2O4^@
5?
MA!-%9G D9NI]+\(3[P[<]Z8,SMB*>.?%6^^]%#SA&;L$HCGF.,7P5
FU7*
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MDR.%Z77 &N%NW<<[5:R*/*TD(\5TY]S'->_7L2F3PO7>*^
M3_Q(]P?53'BK1&ULE5EMC^(V&/PKB.]W
MB>W'=K)BDW]_\\-6U=]OZR?4ZZ0^O*
MS5BHKA*9IB:IR]U^OER,][ZTRT7STE>[O?O2SKJ7NB[;?U:N:H[W
OF?IX.C%SEUOU01>F_7MV#JZJA)L_C[ZG2^;G-H>#E
M[[?:?QX[[SOS6';NH:G^VFWZ[?T\F\\V[JE\J?JOS?$7-W5(SV=3[W]SKZ[R
M\(&);V/=5-WX.5N_='U33[5X*G7YX_2]VX_?QZG^MV*X@)P*R%L+J*F .A<0
M]&X!F@I04" Y=64ZR2,*)*QT GOW
M,!8(*%W$9@<+G;C062@0%WH>%0_6.7&=LT28,/8FG5.H\^MGBEC"^O^?E:P
MQH1AD%P\[ZY=^SR^2^AFZ^9EWP\F
]TK1R<,9>,2"+&_Z$ <4X
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MJ(Q!24